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Acute and Remote Thrombotic Complications in Patients with
Implanted Drug-eluting Stents; Influence of Smoking as a Risk
Factor
MAJA STOJANOVI ,1 RADE BABIC,2 ZORAN STAJIC,3 MILICA CIZMIC,1 VIOLETA IRIC CUPIC4
From 1Military Medical Academy, Belgrade; 2Institute of Cardiovascular Disease "Belgrade", Belgrade; 3Clinical
Hospital Center "Zemun", Belgrade; 4Clinical Hospital Center "Kragujevac", Kragujevac, Serbia
STOJANOVI ET AL: Acute and Remote Thrombotic Complications in Patients with Implanted Drug-eluting
Stents; Influence of Smoking as a Risk Factor. The use of percutaneous coronary intervention (PCI) with the
procedural success and continuous technological improvements contributed to a better treatment of coronary heart
disease also resulted in the development of acute and remote thrombotic complications. Environmental factors such
as smoking significantly worsen unwanted cardiac events after percutaneous coronary intervention. The aim of this
study was to determine the influence of risk factors (smoking) the number and severity of adverse cardiac events and
its possible selective effect on the formation of acute and subacute thrombotic complications during the application of
stents coated with paclitaxel (PES) and sirolimus-coated stents (SES). The study was based on a five-year follow-up
of all consecutive patients at the Institute for Cardiovascular Diseases Dedinje in which are embedded drug-eluting
stents with sirolimus (Cyphar) and paclitaxel (Taxus). Average age of the tested population was 68.4±8.4 years, of
which 585 patients were men (83.4%) and 116 (16.6%) women. Four patients (0.6%) died. Myocardial infarction
occurred in nine patients (1.3%). The overall incidence of MACE events was 14.5%, which was registered in 102
patients. Stent thrombosis, definite criteria according to ARC, occurred in 22 patients (3.14%). Probable stent
thrombosis was observed in 1 patient (0.14%), possible stent thrombosis in 1 patient (0.14%). Sirolimus and paclitaxelcoated stents are safe and effective means of percutaneous coronary interventions conducted for treatment of
atherosclerotic coronary artery disease. Research has shown a large impact of smoking as a risk factor in the development
of adverse cardiac events. (J HK Coll Cardiol 2019;27:1-10)
Coronary artery disease, Paclitaxel, Sirolimus, Smoking
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Introduction
The use of percutaneous coronary intervention
(PCI) for the treatment of coronary ischemic disease
experienced a dramatic expansion in the past two
decades. At the same time, procedural success, safety
and durability PCI dramatically improved due to
continuous technological improvements, the
periprocedure prepare patients and better understanding
early and late complications of treatment. These
improvements support the expansive use of PCI as
definitive therapy.1,2
Application of stents still has the effect of two
potentially very significant complications, such as stent
thrombosis and restenosis at the site of installation.
Therefore, attempts to create stents that will be less
thrombogenic and that will cause less inflammatory
reaction, and reduce the aforementioned complications
to a minimum. Stents coated with biocompatible
materials are not significantly reduce major adverse
cardiac events. Unlike biocompatible stents, stents with
sirolimus and paclitaxel have proved to be very effective
in reducing unwanted cardiac events.3,4
Smoking is one of the major risks of coronary
artery disease. It is known that the risk of coronary heart
disease is twice as high in smokers. It is believed that
nicotine increases the mortality rate in patients with
coronary artery disease by about 30%. The attacks of
angina are more common in smokers in about 3 times,
and last about 12 times longer. This is due to the increase
in pulse rate and blood flow resistance which burdens
the heart muscle. In a country where 40% of the
population smokes and how this needs to warn of this
danger. One should know that smoking is a sign
unenlightenement and delays in the acceptance of

2

585

83.4%
102
3.14%

1

116
MACE
0.14%

scientific knowledge. Despite the huge loss of human
lives smoking significantly affects the expenditure
envisaged for health.5,6
In relation to the timing of the stent thrombosis it
is divided into:
• Acute − 24 hours after stent implantation,
• Subacute − 24 hours to 30 days after stent implantation,
• Late − 30 days to 1 year after stent implantation,
• Very late − more than one year after stent implantation.
The definition of stent thrombosis was proposed by
the Academic Research Consortium (ARC). Some
authors believe that the use of precisely ARC definitions
of stent thrombosis provides the best estimate of the
true prevalence of this phenomenon.
According to this classification stent thrombosis are
divided into:
• Definitive − angiographic evidence of stent thrombosis
with clinical signs of myocardial ischemia within 48
hours (chest pain with ECG changes or an increase of
cardiac enzymes). Pathological evidence of stent
thrombosis,
• Probable − unexplained death within 30 days after
stent implantation. Myocardial infarction region
stentirane artery
• Possible − the unexplained death after more than 30
days after stent implantation.7

Aim
Based on all the above aim of this study was to
determine the influence of risk factors (smoking) the
number and severity of adverse cardiac events and their
possible selective effect on the occurrence of acute and
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subacute thrombotic complications during the
application of stents coated with paclitaxel (PES) and
sirolimus-coated stents (SES) .

Hypothesis
Based on the literature data is not expected
difference in the security application of stents coated
with paclitaxel and sirolimus-coated stents with regard
to the occurrence of acute and remote thrombotic
complications.

Materials and Methods
Five-year follow-up of all consecutive patients
at the Institute for Cardiovascular Diseases Dedinje, in
which the embedded drug eluting stents with
sirulimusom (Cypher) and paclitaxel (Taxus).
Monitoring methods: ambulatory visits, and
telephone contact with the patient. The study was
retrospective, clinical, nonintervention, with the followup period of five years for an individual patient. Data
on the patients included in the database formed to
monitor. Enter their demographic, clinical, angiographic
data.
Telephone interview with patients was based on
a questionnaire containing the contact details of the
patient, date of the telephone contact, presence of
diabetes mellitus, evaluation angina eventual death of
the patient, information on the occurrence of death,
hospitalization for cardiac reasons, myocardial
infarction, percutaneous coronary reintervention or
surgical myocardial revascularization. The questionnaire
contains questions related to all the drugs taken by the
patient after the intervention, especially acetyl-salicylic
acid, ticlopidine or clopidogrel, thienopyridine
derivatives duration of therapy, statin therapy, the
presence of risk factors (hiperlipoproteinemia, smoking).
Based on the questionnaire, if judged to have significant
angina patients, the patients were invited to a preview
on an outpatient basis of which were sent to the existence
of non-invasive testing provoked ischemia, and in case
of ischemia, were sent to coronary angiography and

J HK Coll Cardiol, Vol 27

subsequent percutaneous myocardial revascularization
or surgery or resume conservatively therapy.
Significant adverse cardiac events, MACE are
defined as follows. Death is defined as cardiac or
noncardiac origin. The death of unknown cause was
recorded as cardiac origin. On the basis of ischemic
changes in the ECG and / or an increase in CK three
times the upper limit of the laboratory reference value,
an increase in troponin T above the upper limit of
reference values were used for the definition of
myocardial infarction.
All reintervention within the stent implanted
during the index procedure, as well as 5 mm proximal
or distal edges of the stent imlantiranog classified as retarget lesion revascularization, TLR (target lesion
revascularization). Other percutaneous coronary
intervention on the same blood vessel outside the defined
zones are defined as repeat revascularization of the target
vessel, TVR (target vessel revacularization).
Accompanied by the outcome of patients in the
study group was also stent thrombosis according to ARC
criteria.
Initially the study included 800 patients who
underwent percutaneous coronary angioplasty. After the
indexing procedure clinical monitoring is completed
for 701 (87.6%) patients whose data after the
completion of the follow-up period subjected to
statistical analysis. Ninety-nine patients (12.3%) were
not available for cooperation. Of the 701 patients in
whom were implanted stents, 340 patients were
implanted stents coated with sirolimus and in 361
patients with paclitaxel-coated.

Statistical Analysis
In case of continuous data, variables were
presented as mean value ± standard deviation (SD).
Some of the variables were presented as frequency
of certain categories, while statistical significance of
differences was tested with the Chi square test. In the
case of low frequencies, probability is calculated by
Fisher's Exact test.
The Kaplan-Meier non-parametric statistic was
used to estimate the survival function of clinical outcome
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(MACE events) in nonsmokers and smokers. Post hoc
analysis was done by using log rank test.
Differences between groups were considered
significant at p<0.05. Complete statistical analysis of
the data was conducted with the statistical software
package, SPSS Statistics 18 (Chicago, Illinois, USA).

Results
Average age of the tested population was 68.4 +/8.4 years, of which 585 patients were men (83.4%).
Four patients (0.6%) died. Two patients death is
of noncardiac origin, so that the two patients had fatal
consequence of cardiac events. The occurrence of angina
prompting the 288 patients (36.8%). Load test was
positive in 215 patients (30.7%). Myocardial infarction
occurred in nine patients (1.3%). Re-PCI was performed
in 103 patients (14.7%). Surgical revascularization was
performed in 42 patients (5.8%). The overall incidence
of MACE events was 14.5%, or 102 pancijenata.
Repeated coronary angiography was performed in 230
patients (32.8%).
Stent thrombosis, definite criteria according to
ARC, occurred in 22 patients (3.14%), 5 patients
(0.7%) were treated with CABG, and in 17 patients
(2.4%) is done re-pci. Probable stent thrombosis in
1 patient (0.14%), possible stent thrombosis in 1 patient
(0.14%).
Of the 24 patients in whom stent thrombosis
occurred 10 (1.4%) had a stent coated with sirolimus,
14 (2%) had a stent coated with paclitaxel.
Of the 22 patients who came forward certain stent
thrombosis, 12 (1.7%) patients had a stent coated with
paclitaxel, 10 (1.4%) patients had a stent coated with
sirolimus. Probable stent thrombosis occurred in 1
(0.14%) patients with paclitaxel, possible stent
thrombosis occurred in 1 (0.14%) patients with
paclitaxel.
Distribution of patients according to the type of
stent implanted (Table 1).
After implantation of the two types of stents when
it comes to survival, there was no statistically significant
difference, despite the fact that all patients with lethal

4

results belonged to the group of PES (Table 2).
When it comes to myocardial infarction showed
statistically significantly greater number of myocardial
infarction in the PES group (p=0.004) (Table 3).
When it comes to TLR all registered cases
(N=31), took place on implanted PES (p<0.001)
compared to the group SES (Table 4).
When it comes to TVR more than ¾ of registered
cases (N=56) occurred in patients belonging to the group
SES (p<0.001), statistically highly significant difference
(Table 5).
Speaking of MACE no significant difference
between the two types of stents (Table 6).
Distribution of patients (habit of smoking) in
relation to the type of implanted stent is uniform between
groups SES and PES (Table 7).
Table 1. Distribution of patients using 2 different
drug eluting stents
Percutaneouscoronary
intervention
SES
PES
Total

Number

%

340
361
701

48.5
51.5
100.0

Table 2. Clinical outcome and stent types
implantation
Stents
Outcome

SES

PES

Total

Survivors

N
(outcome)
(stents)

340
48.8%
100.0%

357
51.2%
98.9%

697
100.0%
99.4%

Died

N
(outcome)
(stents)

0
0.0%
0.0%

4
100.0%
1.1%

4
100.0%
0.6%

Total

N
(outcome)
(stents)

340
48.5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Statistics
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A statistically significantly higher number of
smokers completed annually in the PES group (p=0.048)
(Table 8).
Statistically significantly higher MI in the PES
group of smokers (Table 9).
Statistically significantly higher number of
MACE in the PES group of smokers (Table 10)
Based on statistical processing (Table 10) and
Kaplan-Mayer curve (Figure 1), it is concluded that in
non-smokers, 50% of MACE occurs after 61,714
months, and smokers are slightly earlier (60,180

months). Using a log-rank test showed a statistically
significant difference between these two groups
(p=0.013) (Table 11).

Table 3. Myocardial infarction and stent types
implantation

Table 5. Target vessel revascularization (TVR) and
stent types implantation

Myocardial

Discussion
Stent thrombosis (TS) is a rare but potentially
fatal complication of percutaneous coronary intervention
(PCI). The frequency of TS varies in literature depending
on the type of stent, it presents patients with stable angina

Stents

infarction

Stents

SES

PES

Total

TVR

SES

PES

Total

No

N
(outcome)
(stents)

340
49.1%
100.0%

352
50.9%
97.5%

692
100.0%
98.7%

Survivors

N
(outcome)
(stents)

284
45.1%
83.5%

346
54.9%
95.8%

630
100.0%
89.9%

Yes

N
(outcome)
(stents)

0
0.0%
0.0%

9
100.0%
2.5%

9
100.0%
1.3%

Yes

N
(outcome)
(stents)

56
78.9%
16.5%

15
21.1%
4.2%

71
100.0%
10.1%

Total

N
(outcome)
(stents)

340
48.5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Total

N
(outcome)
(stents)

340
48.5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Statistics

Chi-Square = 8.587; p=0.004

Table 4. Target lesion revascularization (TLR) and
stent types implantation

Statistics

Chi-Square = 27.837; p=0.000

Table 6. Major adverse cardiac event (MACE) and
stent types implantation

Stents
TLR

Stents

SES

PES

Total

MACE

SES

PES

Total

No

N
(outcome)
(stents)

340
50.7%
100.0%

330
49.3%
91.4%

670
100.0%
95.6%

No

N
(outcome)
(stents)

284
47.4%
83.5%

315
52.6%
87.3%

599
100.0%
85.4%

Yes

N
(outcome)
(stents)

0
0.0%
0.0%

31
100.0%
8.6%

31
100.0%
4.4%

Yes

N
(outcome)
(stents)

56
54.9%
16.5%

46
45.1%
12.7%

102
100.0%
14.6%

Total

N
(outcome)
(stents)

340
48.5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Total

N
(outcome)
(stents)

340
48.5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Statistics

Chi-Square = 28.550; p=0.000
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pectoris and acute coronary syndrome in the study, etc.
The obtained data on the incidence of stent thrombosis
are consistent with the data obtained in many world
studies.
The success of drug-coated stents is highly
dependent on each component of the complex as well
as the interactions among the elements of the complex.
Different DES have different potential to inhibit
neointimal proliferation. 8,9 Given the fact that the
experiments on animal models can not be directly

translated to human populations, using the results of
clinical studies.
In cardiology, as in any other branch of medicine
revived the concept of 'evidence-based medicine'. On a
number of important questions attempted to come up
with an answer through a well-designed, controlled,
prospective, randomized trials.10,11
The first positive clinical data on the
implementation of DES come from a study that
examined the use of rapamycin (Sirolimus trade name)

Table 7. Distribution of smokers regarding stent
types implantation

Table 9. Myocardial infarction in smoking patients
regarding stent types implantation

Stents
Smokers

Miocardial

SES

PES

Total

Stents

infarction

SES

PES

Total

No

N
(outcome)
(stents)

210
46.2%
61.8%

245
53.8%
67.9%

455
100.0%
64.9%

No

N
(outcome)
(stents)

130
54.9%
100.0%

107
45.1%
92.2%

237
100.0%
96.3%

Yes

N
(outcome)
(stents)

130
52.8%
38.2%

116
47.2%
32.1%

246
100.0%
35.1%

Yes

N
(outcome)
(stents)

0
0.0%
0.0%

9
100.0%
7.8%

9
100.0%
3.7%

Total

N
(outcome)
(stents)

340
48,5%
100.0%

361
51.5%
100.0%

701
100.0%
100.0%

Total

N
(outcome)
(stents)

130
52,8%
100,0%

116
47.2%
100.0%

246
100.0%
100.0%

Statistics

Chi-Square = 2.60; p=0.107

Table 8. Lethal outcome in smoking patients
regarding stent types implantation

Statistics

Fisher's Exact Test = 8.38; p=0.001

Table 10. Major adverse cardiac event (MACE) in
smoking patients regarding stent types implantation
Stents

Stents
Outcome

SES

PES

Total

MACE

SES

PES

Total

Survivors

N
(outcome)
(stents)

130
53.7%
100.0%

112
46.3%
96.6%

242
100.0%
98.4%

No

N
(outcome)
(stents)

113
56.8%
86.9%

86
43.2%
74.1%

199
100.0%
80.9%

Died

N
(outcome)
(stents)

0
0.0%
0.0%

4
100.0%
3.4%

4
100.0%
1.6%

Yes

N
(outcome)
(stents)

17
36,2%
13,1%

30
63.8%
25.9%

47
100.0%
19.1%

Total

N
(outcome)
(stents)

130
52.8%
100.0%

116
47.2%
100.0%

246
100.0%
100.0%

Total

N
(outcome)
(stents)

130
52,8%
100,0%

116
47.2%
100.0%

246
100.0%
100.0%

Statistics

6

Fisher's Exact Test = 2.65; p=0.048
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coated stents (SES). Rapamycin is a natural macrocyclic
lactone with potent antiproliferative, anti-inflammatory
and immunosuppressive action of the inhibitory effect
on the activation of the target sites for rapamycin mammalian target of rapamycin (mTOR), ultimately
leading to cell cycle arrest.12,13
Cypher (Cordis, Johnson & Johnson) is a stainless
steel stent covered with a very thin layer of polymer
containing neerodirajuæeg rapamycin. The first
implantation of Cypher stent is made in the First in Man
(FIM) clinical study in Sao Paulo, Brazil and Rotterdam,
the Netherlands. Four months after implantation, by
using intravascular ultrasound and quantitative coronary
angiography, in both studies was demonstrated minimal
neointimal hyperplasia. In the Brazilian study of
intravascular ultrasound after 4 years of follow-up
showed continued suppression of intimal hyperplasia
in a group of 30 patients with slow-releasing SES, with
survival without significant clinical events by 87%.14
This test has demonstrated a low incidence of
stent thrombosis (definite, probable, possible) and
thereby simultaneously demonstrated safe use of stents
coated with the drug.
The results of our study were compared with
published results of the studies and meta-analyzes that
examined the long-term safety and efficacy of drugcoated stents, either through long-term monitoring of
patients revascularized only the implantation of DES,

or in comparison to patients who were implanted with a
metal stent is not coated with a drug.15,16 We analyzed
primarily studies published in reputable journals and
reference cardiology.
Demographic, clinical and angiographic
characteristics of the study group in our study are in
accordance with the same characteristics examined
groups in the studies in which they are declared.
The research showed that the use of drug-eluting
stents to treat coronary disease showed a low incidence
of major cardiac events (death, MI, TLR, TVR) during
the follow-up of five years. Application of DES leads to
lower rates of repeat revascularization (percutaneous
coronary intervention or bypass surgery).
Analyses have shown the safety of the use of
drug-coated stents, and in particular to the emergence
of thrombosis which is not higher in DES compared to
the BMS.17,18 The occurrence of thrombosis in BMS was
studied in many international studies and the data
obtained are in favor of the data from our study where
they analyzed patients with drug-coated stents, to the
emergence of thrombosis in DES is not greater than the
occurrence of thrombosis in BMS. Meta-analyzes may
increase the strength of the evidence of individual
studies, but also to distinguish quality (indicate) the
effects of certain methods of treatment. A meta-analysis

Table 11. Cumulative probability of MACE events
in nonsmokers and smokers (Kaplan-Maier method;
N=701)
Mean*
95% Confidence
Interval
Smokers Estimate

Std.
Error

Lower
Bound

Upper
Bound

No

61.714

0.454

60.824

62.605

Yes

60.191

0.763

58.696

61.686

Total

61.180

0.399

60.397

61.962

*Median could not be obtained due to distribution of MACE
data
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Figure 1. Cumulative probability of MACE events in
nonsmokers and smokers (five-year follow-up).
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of randomized studies on the implementation of
medication-coated stents compared to uncoated (Fushs
AT et al., 2008) included 28 randomized studies that
have been analyzed stent thrombosis patients undergoing
DES, BMS and balloon angioplasty. The total number
of patients from the DES group was from 5612 a BMS
Group 7639th Stent thrombosis occurred in 107 patients
(1.05%), of which 56 patients were from the DES groups
(1.01%) and 51 patients were from BMS groups
(1.10%). The results showed no significant differences
between the two groups (OR = 0.87, 95% CI 0.58 to
1.3, p<0.48). Subacute thrombosis occurred in a total
of 21 patients, of which 0.43% of the DES group and
0.53% in BMS groups (OR = 0.86, 95% CI 0.50 to 1.5,
p<0.6) . Late stent thrombosis occurred in 27 patients
(1%) in the DES group and 20 patients (0.8%) in the
BMS groups (OR = 0.92, 95% CI 0.50 to 1.68, p<0.78).
After 12 months of intervention results showed a similar
incidence of subacute thrombosis and late thrombosis
in all types of PCI.19
The study, Goy, and associates from 2009
analyzed 350 patients with a SES embedded between
April and December 2002 in three Swiss hospitals.
Patients were 63 +/- 6 years, 78% were men, 20% had
acute coronary syndrome, 19% were patients with
diabetes. Stent thrombosis occurred in 12 patients
(3.6%). Definitive stent thrombosis occurred in 6
(1.8%), probable 1 (0.3%), possible 5 (1.5%). Eightyone patients were without complications. MACE events
occurred in 74 patients (21%): cardiac death 10 (3%),
unborn death 16 (5%), myocardial infarction 6 (2%),
TLR 26 (8%), TVR 9 (3%), by-pass graft 6 (2%).20
In our research, after implantation of the two types
of stents, when it comes to survival, there was no
statistically significant difference, despite the fact that
all patients with lethal results belonged to the group of
PES. Join a statistically significantly greater number of
myocardial infarction in the PES group (p=0.004). When
it comes to TLR all registered cases (N=31), took place
on implanted PES (p<0.001). In more than ¾ of
registered cases (N=56) TVR occurred in patients
belonging to SES group (p<0.001). There is no
significant difference between the two types of stents
in terms of MACE

8

Smoking is the most important modifiable risk
factor for coronary disease and the leading cause of death
in developed countries. Today in the world smokes about
one billion people. The risk of myocardial infarction is
high even among smokers if they are exposed to passive
smoking. Among those who smoke 20 or more cigarettes
daily have a triple increase in total coronary heart
disease. Our research showed significant statistical
association of smoking as a risk factor and the occurrence
of fatal outcome, despite the fact that the number of
deaths was not alarming. Smoking as a risk factor
significantly contributes to the occurrence of myocardial
infarction (highly statistically significantly contributes
to the occurrence of myocardial infarction). Smoking
also significantly affects the occurrence of MACE.
Prospective multicentre German Drug-Eluting
Stent Registry (DES.DE) analyzed and identified 1,122
patients who had never smoked and 1,052 patients who
were current smokers. Smokers were younger (56.5 vs.
69.4 years, p<0.0001), more often males, with less
frequent diabetes and hypertension compared to nonsmokers. Smokers presented more often with acute
coronary syndromes. After a mean follow-up of
12.5 months, smokers had both higher mortality (4.6
vs. 2.7%, p<0.05) and myocardial infarction (MI) rates
(4.9 vs. 3%, p<0.01). There was no significant difference
between smokers and non-smokers in the rate of target
vessel revascularization (9.8 vs. 11.4%, p=0.26). Major
adverse cardiac and cerebrovascular events (defined as
the composite of death, MI and stroke, MACE) were
higher in smokers (10.6 vs. 6.1%, p<0.001). Moreover,
after adjustment for baseline clinical and angiographic
variables, smoking continued to be a strong independent
predictor for MACE (OR = 2.34, 95% CI 1.49-3.68).
In a subgroup analysis, we found that the increased risk
of smoking was most prominent in patients presenting
with stable angina pectoris (OR = 3.71, 95% CI 1.24-2.57,
p<0.05). Smoking almost doubled the risk for MACE
in acute MI patients, though this did not reach statistical
significance (adjusted OR = 1.91, 95% CI 0.93-3.94,
p=0.74).
This large multicentre DES registry provides
evidence that smokers treated with DES, despite lower
i n c i d e n c e o f p r e d i s p o s i n g r i s k f ac t o r s fo r
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atherosclerosis, experience higher rates of death and MI
compared to non-smokers, particularly in the setting of
stable coronary artery disease. Smoking has only
marginal effects on target vessel revascularization rates
in patients treated with DES.21

Conclusion
Sirolimus and paclitaxel-coated stents are safe and
effective means of percutaneous coronary interventions
used for treatment of atherosclerotic coronary artery
disease.
Our results agree with the results of randomized
clinical trials and large registries which examined
sirolimus and paclitaxel-coated stents.
Our research showed that the use of drug-eluting
stents to treat coronary disease has a low incidence of
major cardiac events (death, MI, TLR, TVR) during the
period of five years examined groups of patients.
Application of DES leads to lower rates of repeat
revascularization (percutaneous coronary intervention
or bypass surgery).
The significance of our study is the presentation
of results from clinical practice follow-up of patients
due to the current problem of stent thrombosis with the
drug-coated stents. The results of low incidence of stent
thrombosis are in favor of safe use of stents coated drug.
Research has shown a large impact of smoking as
a risk factor in the development of adverse cardiac
events. There is a significant correlation between
smoking as a risk factor and the occurrence of a lethal
outcome, and if the number of deaths was not alarming.
Smoking as a risk factor also significantly contributes
to the occurrence of myocardial infarction (highly
statistically significantly contributes to the occurrence
of myocardial infarction).
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Survivin Protects Neonatal Mouse Cardiomyocytes from CVB3Induced Apoptosis in a Caspase-dependent Manner
T Wu, P Li, H Li, Y Zhan, S Zhang, Y Shi, Y Yan, T Xia, Z Wang, R Wu
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou,
China
Background: Viral myocarditis (VMC) is a kind of inflammatory
cardiomyopathy mainly affecting children and young adults and resulting in
heart failure due to dilated cardiomyopathy or cardiac arrest. Cardiomyocyte
apoptosis has been shown to play a critical role in the pathogenesis of
coxsackievirus B3 (CVB3) induced VMC and blocking of this process may
contribute to the therapeutic effect towards VMC. Therefore, the aim of this
study was to examine whether survivin, one of the strongest antiapoptotic
proteins, participates in the apoptotic activity after CVB3 infection and further
reveal its related mechanisms.
Methods and results: Here the cultured neonatal mouse cardiomyocytes
(NMCs) were exposed to CVB3 to establish the cell model of VMC and we
found a time-dependent manner of survivin expression after CVB3 infection
by Western Blot. Lentivirus was next used to mediate survivin expression
thereby examine the function of survivin in CVB3-infected NMCs. TUNEL
assay demonstrated that survivin overexpression interrupted CVB3-induced
apoptosis and significantly decreased the apoptotic rate at 36h and 60h after
CVB3 infection. It was next examined whether caspase-3 and -9 were involved
in the antiapoptotic pathway initiated by survivin via Western Blot. The results
showed a reverse relationship between survivin expression and cleaved
caspase-3 and -9 expression, suggesting that survivin may inhibit apoptosis
by restraining the activity of caspase-3 and -9. Moreover, the supernatant

51
Ultrasound Ultrafast Imaging of the Carotid Artery Pulse Wave
Velocity: Is the Surrogate of Regional Artery Stiffness?
L Fang,1,2 D Zhang,1,2 F Xiang,1,2 Y Song,1,2 M Xie,1,2 J Wang1,2
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology; 2Hubei Key Laboratory of
Molecular Imaging, Wuhan, China

1

Background: Cardiovascular diseases (CVDs) are the leading causes of death
in the world and responsible for over 17.7 million deaths annually. Arterial
stiffness could be a strongest predictor for coronary heart disease and stroke.
Pulsed wave velocity (PWV) is "the most hallowed and still probably the
best" measure of arterial stiffness and closely related to the processing of
arteriosclerosis. Techniques to measure PWV present limitations. There are
based on the mathematical model calculation, or need special instruments
and required a fairly high level of technical expertise. A new ultrasoundbased technique, Ultrasound Ultrafast imaging could noninvasive assessment
of regional carotid artery stiffness. The imaging system has a very high frame
rates over than 2000 frames per second, and could quickly obtain the PWV
propagate along the carotid artery. The objective is to detect the PWV in
elder Humans carotid artery in vivo. Determine the feasibility and accuracy
to assess artery stiffness by Ultrasound Ultrafast imaging. Confirm the
relationship between the local carotid artery PWV and the stiffness of the
systemic vessels.
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from cultured NMCs was extracted to detect the quantitation of released LDH
and a sharp decrease was shown in survivin overexpressed group compared
to CVB3 infected group, indicating a protective role of survivin in CVB3induced cell damage.
Conclusions: In the present study, we demonstrated that survivin was
triggered by CVB3 infection in NMCs in a time-dependent manner and
executed its antiapoptotic effects via caspase-3- and caspase-9-dependent
signaling pathway.

Metheds: Ultrasound Ultrafast imaging was performed and obtain the velocity
propagate along the left common carotid arteries of fiftynine (n=59) healthy
volunteers. Including the PWV at the beginning of the systole and at the
ending of the systole (BSPWV, ESPWV), the mean PWV (mPWV) were
calculated. E-Tracking technology in measuring artery elasticity modulus
(PWVβ) and cardio-ankle vascular index (CAVI) were calculated in all
subjects. The correlation between parameters derived from Ultrasound
Ultrafast imaging and elastic modulus were analyzed. Indicate artery elasticity
and the impact of modifying factors such as BMI, age and hypertension.
Results: (1) The success rate of first obtain the BSPWV, ESPWV were
94.2% and 90.8%, which required a median overall duration of 73s. (2) mPWV
were significant positively correlated with PWVβ and CAVI (r=0.68,
P<0.01, r=0.48, P<0.05). BMI, age and hypertension were also positively
correlated with PWV. (3) The mPWV have a good repeatability and
conformity. Interobserver and intraobserver variabilities were 4.2% and
3.6% respectively.
Conclution: The elasticity of carotid artery is an integral part of the global
arterial elasticity. Ultrasound Ultrafast imaging is a reliable method to assess
the regional carotid artery stiffness. The technique can directly and quickly
measure PWV of local vessels, with high repeatability and provides a new
method for clinical early assessment artery elasticity.
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The Normal Biventricular Mechanical Function in the
Transplanted Heart by Three-dimensional Speckle-tracking
Echocardiography
L Zhang,1,2 W Sun,1,2 C Wu,1,2 H Li,1,2 M Xie1,2
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology; 2Hubei Province Key
Laboratory of Molecular Imaging, Wuhan, China

1

Background: Exploring the specifically normal biventricular mechanical
function of heart transplantation (HT) patients is essential during follow-up
studies. The studies about the normal biventricular mechanical function
assessed by three-dimensional speckle-tracking echocardiography (3DSTE)
of HT patients has yet to be reported. The objectives of this study were to
(1) testify the feasibility and accuracy of 3DSTE to evaluate the biventricular
function in HT patients; (2) explore the normal biventricular mechanical
function in HT patients using 3DSTE.
Methods: Protocol 1 enrolled 38 HT patients who experienced 3DSTE and
cardiac magnetic resonance (CMR) examination within 24h. Protocol 2,
3DSTE data were compared between 46 clinically stable patients at 1 year
after HT and 46 healthy controls.
Results: Protocol 1, the left ventricular (LV) and right ventricular (RV) derived
from 3DSTE had an excellent accuracy comparison with the corresponding
value of CMR: LVEF (r=0.96, LOA =-0.5±3.7%), RVEF (r=0.95,
LOA=0.5%±4.5%). LV global longitudinal strain (GLS), LV global
circumferential strain (GCS) were significantly correlated with standard CMR-

56
Angiotensin II Downregulates Vascular Endothelial Cell
Hydrogen Sulfide Production by Enhancing Cystathionine-γγ lyase Degradation Through ROS-activated Ubiquitin Pathway
L Bai,1 Y Huang,1 Y Qi,2 C Tang,3 J Du,1,2 H Jin1
Department of Pediatrics, Peking University First Hospital; 2Key Laboratory
of Molecular Cardiology, nistry of Education; 3Department of Physiology
and Pathophysiology, Peking University Health Science Center, Beijing,
China

1

Objective: Vascular endothelial dysfunction is the basic pathogenesis and
initiative factor of a variety of cardiovascular diseases. In this study, we
investigate the regulatory effect and molecular mechanism of Ang II on
endogenous hydrogen sulfide/cyctathionin-γ-lyase (H2S/CSE) pathway in
Human umbilical vein endothelial cells (HUVECs).
Methods: In this study, we used HUVECs line-EA. hy926 cells as the cell
model. We observed the effect of endogenous H2S/CSE pathway when AngII
stimulated HUVECs, and studied the effect of AngII on the ubiquitination
degradation of CSE protein. The effects of AngII on the level of radical
oxygen species (ROS), level of CSE ubiquitination and H2S/CSE pathways
were observed, and then the experiment was carried out with oxidation
scavenger NAC and antioxidant GSH to explore the role of ROS in inhibiting
H2S/CSE pathway. The content of H2S in cells was detected by H2S electrode
and H2S fluorescence probe. The expression of CSE, cystathionine β-synthase
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LVEF (r=0.85, r=0.93, respectively, P<0.001). RV free wall longitudinal strain
(FWLS) were also correlated well with standard CMR-RVEF (r=0.83,
P<0.001). Protocol 2, compared with healthy controls, lower 3D LVEF and
RVEF were observed in HT patients (P<0.001), but these two values were
still within normal range. 3D LVGLS, LVGCS, RV FWLS and LV twist were
significantly reduced in HT patients, whereas LV systolic dyssynchrony index
(SDI) was increased. And the LV global performance index (GPI) was also
reduced. Moreover, the strain values were good for differentiating between
these two groups, the cutoff value of -19.3% for the LVGLS had 94% accuracy
and the cutoff value of -21.4% for the RV FWLS had 90% accuracy.
Conclusion: Our study demonstrated that 3DSTE had a high sensitivity and
accuracy to evaluate biventricular function in HT patients. For clinically
stable HT patients with normal conventional echocardiography parameters
of ventricular function, their myocardial mechanical function was impaired.
Therefore, exploring the specifically normal biventricular mechanical function
of HT patients by 3DSTE is essential during follow-up studies.

(CBS), 3-mercaptopyruvate sulphurtransferase (3-MST), matrix
metalloproteinase 2 (MMP2), matrix metalloproteinase 9 (MMP9),
intercellular cell adhesion molecule (ICAM-1) and von Willebrand factor
(vWF) in cells was detected by western blot method. The activity of
MMP2/9 in the cells was detected by in situ gelatin zymogram. The level of
CSE mRNA in the cells was detected by RT-qPCR assay, and the cells were
transfected with ubiquitin mutant plasmids (K48 or K48R). The Co-IP method
was used to detect the level of CSE ubiquitin and the binding of different
types of ubiquitin chained to CSE. The content of superoxide anion in cells
was detected by dihydropyridine (DHE).
Results: AngII induced vascular endothelial injury by down-reguation of
H2S, while the expression of MMP2, MMP9, ICAM-1 and vWF protein was
up-regulated and the activity of MMP2/9 was increased, and on the basis of
which, H 2S was added to rescue experiment. AngII down-regulated the
endogenous H2S/CSE pathway in HUVECs in a concentration- and timedependent manner. AngII inhibited H 2S/CSE pathway in HUVECs by
increasing K48-linked ubiquitin chain-mediated CSE degradation. Superoxide
mediated AngII-induced CSE ubiquitination and degradation in vascular
endothelial cells, which was abolished by NAC or GSH.
Conclusion: AngII inhibited the endogenous H2S/CSE pathway in HUVECs.
Its inhibitory mechanism was related to the AgnII-induced CSE ubiquitination
and degradation in HUVECs. AngII promoted CSE ubiquitination by
activating ROS pathway to down-regulate the H2S/CSE pathway.
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Intranuclear Cardiac Troponin I Regulate Atp2a2 Expression
in Cardiomyocytes as a Nonclassical Transcription Factor
Q Lu
Children's Hospital of Chongqing Medical University, Chong Qing, China
Background: Past studies showed that cardiac troponin I (cTnI, encodes by
TNNI3), as a cytoplasmic protein, is an inhibitory subunit in troponin complex,
involves in cardiomyocyte diastolic regulation. However different base
mutations of TNNI3, gene of cTnI, could generate different phenotype of
inherited cardiomyopathies, indicating that cTnI is more than a structural
protein. Also, studies have demonstrated cTnI presents in nucleus.
Methods: We used immunofluorescence and Western blot assays to verify
the presence of cTnI in myocardial nuclear. Bioinformatics was also utilized
to analyze the suspicious downstream molecules. We used recombinant
adenovirus to over express cTnI both in vitro and in vivo. To knock down the
expression of cTnI, we used TNNI3 gene knockout mice and RNA interference
technique. In addition, we detected the function of cells treated with RNA
interference using calcium detection. In molecular level, Chip-sequence and
luciferase report were used to detect the interaction between cTnI and Atp2a2.
Results: We firstly find that cTnI presents in the nucleus both in human and
mouse heart tissues, and approximately 30% of total cTnI presents in nucleus
of mice. Interestingly, levels of cTnI nucleoprotein in left ventricle are higher
than that in right ventricle. Bioinformatics analysis data display that cTnI
may relate to regulate energy metabolism and calcium regulation. Guilt of

74
Treatment Option for Complex Aortic Pathology: Total Aortic
Arch Replacement with Frozen Elephant Trunk
JYK Ho, JWY Chan, SCY Chow, PSY Yu, MWT Kwok, S Wan, T Fujikawa,
M Underwood, RHL Wong
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales
Hospital, Hong Kong
Background: Aortic arch pathology commonly involves multiple segments
of the aorta. Involvement of supra-aortic and visceral branches resulting in
malperfusion insults, causing it to be one of the most challenging conditions.
We reviewed our experience on total aortic arch replacement and frozen
elephant trunk (FET) with a single hybrid stent graft system, allowing a
possible single staged surgical option.
Methods: Between August 2014 and February 2019 at the Prince of Wales
Hospital Hong Kong, patients underwent total aortic arch replacement with
FET by a commercially available one-piece hybrid stent graft system were
recruited. Perioperative parameters, clinical and radiological outcomes were
reviewed.
Results: Thirty-seven patients, including acute dissections and chronic
dissecting aneurysms in both elective and emergency procedures, were
recruited. Overall mortality rate was 11% (n=4), with 8% (n=3) of aortic
related death and post-discharge 2.4-year mean follow up survival of 100%
(n=33). Three patient (8%) developed neurological complication with two
spinal cord injury. Mean operative, moderate hypothermic circulatory arrest
and antegrade cerebral perfusion time were 421±120 min, 91±28 min, and
151±39 min respectively. Seven patients (19%) had a second staged procedure
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association analysis shows a strong expression correlation of cTnI and Atp2a2,
which encodes sarco/endoplasmic reticulum Ca2+ ATPase isoform 2
(SERCA2), (r=0.919), and involves in ATP hydrolysis and Ca2+ transient.
TNNI3 gain and loss cause Atpa2a2 increase/decrease in a dose dependent
manner both in mRNA and protein levels, in vivo and in vitro. In TNNI3siRNA myocardial cells, beat frequency are decreased significantly, total
ATP contents go up, and a significant reduced rate of Ca2+ transients is
observed. By using ChIP-sequence we demonstrate that cTnI associates with
DNA consensus sequences including the CCAT motif, which is required for
YY1 binding to the promoter region of YY1-related genes. So, by employing
luciferase report assay, we explore that pcDNA3.1 (-)-TNNI3-Luc increase
the promoter activity of Atp2a2 approximately 1.7-fold.
Conclusion: These findings indicate, for the first time, cTnI may regulate
Atp2a2 in cardiomyocytes as a nonclassical transcription factor.

for distal descending aorta with endovascular (n=6) and open (n=1)
techniques.
Conclusion: We demonstrated a reasonable outcome that total arch
replacement with FET is a safe and effective technique for complex aortic
pathologies. We have also gathered experience in endovascular and open
second stage procedure with acceptable post-discharge survival. Further study
is warranted to evaluate its impact on survival and disease progression in
descending thoracic aorta.
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Effect of RhoA/Rho-kinase Inhibitor in Human Internal
Mammary Artery and Clinical Implications
HT Hou, 1 HX Chen, 1 ZQ Wang, 1 TN Chen, 1 ZG Liu, 1 XC Liu, 1 J Wang, 1
Q Yang,1 GW He1,2
1
Department of Cardiovascular Surgery & Center For Basic Medical Research,
Teda International Cardiovascular Hospital, Chinese Academy of Medical
Sciences & Peking Union Medical College, China; 2Department of Surgery,
Oregon Health and Science University, Portland, USA
Purpose: Coronary artery bypass grafting surgery (CABG) is the best
treatment for severe Coronary artery disease (CAD). Graft spasm is one of
the main risk factor of long-term patency in CABG. RhoA/Rho-kinase
(ROCK) pathway plays an important role in cell contraction of cardiovascular
disease. ROCK is a downstream effector of small GTP-binding protein RhoA
and has two isoforms, ROCK1 and ROCK2. Fasudil is a ROCK inhibitor.
This study investigated the inhibitory effect of fasudil on the vasoconstriction
in human internal mammary artery (IMA) from patients undergoing CABG.
Methods: Isolated human IMA rings (n=51, taken from 48 patients undergoing
CABG) were studied in myograph. Cumulative concentration-relaxation
curves for fasudil (-9 to -2.5 log M) were established in IMA precontracted
with KCl (30 mM, n=8) and U46619 (-8 log M, n=8). Cumulative
concentration-contraction curves for KCl (5 to 120 Mm, n=8) and U46619

91
First Cluster-Based 24-hour Primary Percutaneous Coronary
Intervention Program for ST-Segment Elevation Myocardial
Infarction in Hong Kong: Initial Experience of a Tertiary Center
CY Wong,1 MC Chan,1 J Chan,2 NH Luk,1 SF Chui,1 KC Chan,1 CL Fu,1 CM
Lo,4 CK Wong,3 LW Tam,2 KY Lee,1 KT Chan1
1
Division of Cardiology, Department of Medicine, Queen Elizabeth Hospital,;
2
Division of Cardiology, Department of Medicine and Geriatrics, Kwong Wah
Hospital; 3Department of Accident and Emergency, Queen Elizabeth Hospital;
4
Department of Accident and Emergency, Kwong Wah Hospital, Hong Kong
Background: Primary percutaneous coronary intervention (PPCI) is a
preferred reperfusion strategy over thrombolysis in patients with ST-segment
elevation myocardial infarction (STEMI). Starting from October 2018, Queen
Elizabeth Hospital (QEH) has extended the PPCI service from weekday
8 am to 8 pm period to 24-hour service including weekends and holidays.
STEMI cases presented to other Accident and Emergency Department (AED)
within the same cluster region (Kowloon Central Cluster) outside operating
hours would also be transferred to QEH for PPCI (secondary diversion). This
study aims to review the outcome of the initial phase of this first clusterbased 24-hours PPCI program.
Method: Consecutive cases of STEMI with PPCI performed in QEH after
commencement of 24-hour PPCI program were analyzed (between 8th
October 2018 and 8th March 2019).
Results: 131 patients underwent PPCI during the study period. Male patients
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(-9 to -4.5 log M, n=8) were also established in two ways: (1) pretreated in
three groups with plasma concentrations of fasudil (-6.3 log M), 10-fold
higher concentrations of fasudil (-5.3 log M), and vehicle for 40 minutes to
estimate the depression effect of fasudil; (2) pretreated in four groups with
fasudil (-6.3 log M), NTG (0.1 mM), the combination, and vehicle for 30
minutes. Western Blot was used to measure the change of the ROCK2 protein.
Results: Fasudil caused nearly the same relaxation in KCl-contracted
(93.5%2.9%, n=8) and U46619-contracted (90.7%3.4%, n=8) IMA rings.
Pretreatment with Fasudil (-5.3 log M) significantly depressed subsequent
contraction by KCl (from 32.42.8 mN to 21.62.9 mN, n=8, p<0.05) and
U46619 (from 43.54.4 mN to 23.21.6 mN, n=8, p<0.05). Pretreatment with
the combination of NTG and fasudil depressed the contraction compared
with control (P<0.01) or fasudil alone (P<0.01) for KCl-induced contraction.
Similarly, the combination depressed the contraction compared with control
(P<0.01) or fasudil alone (P<0.05) in U46619-induced contraction. Fasudil
also caused a decrease of ROCK2 protein content (p<0.05).
Conclusions: Fasudil has a potent inhibitory effect on the vasoconstriction
mediated by KCl and U46619 in human conduit arteries (IMA). Combination
of fasudil and NTG is more effective than using fasudil or NTG alone. These
findings provide a new antispastic method in CABG and may be beneficial
to long-term patency of the grafts.

comprised of 79.4% and were significantly younger than female patients
(59.7 years vs. 73.7 years, p<0.001). The mean AED door to balloon (DTB)
time was 89.5 mins. There was no significant statistical difference of DTB
time between QEH AED cases and secondary diversion cases (87.6 mins vs.
98.8 mins, p=0.28), and between cardiogenic shock (CS) and non-CS cases
(89.2 mins vs 89.6 mins, p=0.97). However there was difference of DTB
time for patients presented at weekdays 8 am-8 pm vs. other time (76.9 mins
vs 95.4 mins, p=0.02). The crude in-hospital mortality was 14.5% (19 cases).
23 cases (17.6%) were presented with CS. There was significant in-hospital
mortality difference between CS and non-CS patients (56.5% vs. 5.5%,
p<0.001). On the other hand there was no significant difference in in-hospital
mortality in terms of gender (p=0.51), presentation time (weekday 8 am to
8 pm or not) (p=0.90) and source hospital (p=0.73). There were 2 additional
mortality cases after discharge from QEH at up to 30-days. All clinically
indicated cases of STEMI received PPCI and no thrombolysis was given during
this period.
Conclusion: The result shows that cluster-based PPCI service is feasible.
The DTB time is reasonable even for cases of secondary diversion given the
inherent system delay. While in-hospital mortality of non-CS patients was
favorable, the high in-hospital mortality of CS patients was in line with major
international studies. Future directions include streamlining the workflow to
reduce system delay, implementing pre-hospital ECG in ambulance and
primary diversion, training in management of CS and introduction of advanced
mechanical circulatory support devices.
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Role of Pre-discharge Cardiovascular Magnetic Resonance in
Myocardial Infarction with Non-Obstructive Coronary
Angiography: Regional Australian Experience
W Lam,1 R Reyaldeen,1,2 S Nyugen,1,2 S Collings,1 M Mitchell,1 A Spears,1
G Starmer1
1
Cairns Hospital, Cairns; 2Princess Alexander Hospital, Brisbane, Australia
Background: With the increasing utilization of high-sensitivity Troponin I
(hsTnI) assays, more patients are hospitalized for hsTnI-positive chest pain
and subsequently undergo coronary angiography. Hence, the prevalence of
myocardial infarction with non-obstructive coronary angiography (MINOCA)
is climbing. There are many etiologies of MINOCA and they all have different
treatments. Cardiovascular magnetic resonance (CMR) is a robust imaging
modality that can differentiate different causes of MINOCA. This abstract
aims to evaluate the increment value of CMR in MINOCA.
Methods: Between January 2017 and December 2018, Cairns Hospital
Cardiology had performed 405 CMR studies. Sixty-four of them were predischarge studies performed for MINOCA. All studies were done with a
Siemens 3T scanner. All of them included full ventricular volume analysis,
short-tau inversion recovery (STIR) sequences for edema assessment and late
gadolinium analysis. Offline analysis done with Argus CMR package.
Results: The mean age of our cohort is 50±15 years (54% female). Racial
distribution (62% Caucasians, 22% Indigenous, 10% Asians and 6% others).
43% had hypertension on one or more anti-hypertensive medications. 35%

22

had diabetes mellitus on therapies. 15% had dyslipidemia on therapies. 32%
were smoker. Specific pathologies were found in 51 studies (80%) –
Myocarditis in 33% (n=21); Small myocardial infarction in 22% (n=14);
Takotsubo cardiomyopathy in 9% (n=6); Hypertrophic or dilated
cardiomyopathy in 16% (n=10); Normal in 20% (n=13). Amongst the patients
with normal CMR, 3 had segmental pulmonary embolism. Change in therapy
based on CMR findings occurred in 82% of cases.
Conclusion: CMR is a reliable imaging modality to differentiate different
causes of MINOCA. Pre-discharge CMR can provide insights on appropriate
therapies for MINOCA patients. Hence, unnecessary therapies and
complications (e.g. bleeding) can be avoided.
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Efficacy and Safety of Novel Biodegradable Device for Closure
of Atrial Septal Defect: From Preclinical Study to First-in-Man
Experience
Y Li, Y Xie, Z Zhang
Guangdong Cardiovascular Institute, China
Background: Percutaneous closure of ASD has emerged as the treatment of
choice for the majority of defects. Closure of ASD with permanent synthetic
devices can be associated with long-term potential complications and
limitations. The biodegradable ASD closure device is a novel, absorbable
device made of poly- L -lactic acid (PLLA). This study evaluates the
feasibility, safety, and effectiveness of PLLA biodegradable ASD closure
device (AbsnowTM, Shenzhen, Lifetech Scientific) in a swine ASD model
and for the first time in humans.
Method: Preclinical safety study was done in swine ASD model. In a clinical
setting, 5 pediatric patients with a secundum ASD who had a clinically
significant left-to-right shunt were enrolled in our center. Percutaneous ASD
closure procedure with PLLA device was performed with fluoroscopic and
transthoracic echocardiography (TTE) guidance. Procedural results and
clinical outcomes at 1 day, 30 days, 3 months and 6 months after closure
procedure were analyzed.

18
Comparison of Two Different Techniques of Ultrasound Guided
Axillary Vein Access for Pacemaker Implantation
CW Wong, YH Chan, YH Cheng, CS Lam
Pok Oi Hospital, Hong Kong
Background: Axillary vein puncture under venogram guidance or landmarks
is an established technique for pacemaker lead placement but carry higher
risk of incidental axillary artery puncture. We described our initial experience
of two techniques of ultrasound-guided axillary venous access for pacemaker
implantation.
Methods: We performed ultrasound guided puncture with ultrasound probe
within the pacemaker pocket as a bailout in 16 patients (Bailout Axillary) or
prior to skin incision in 46 patients (Primary Axillary). Ultrasound were
performed with linear probe on GE Venue 40 or Philips CX50. For "Bailout
Axillary" group, axillary puncture was performed with ultrasound probe
directly over the wound If cephalic vein cutdown were failed. For "Primary
Axillary" group, axillary puncture was performed under ultrasound guidance
with longitudinal approach before skin incision. Skin insertion was then made
adjacent of puncture site and then blunt dissection was made. The wire was
pulled through the pacemaker pocket.
Results: Success rate and lead complications were similar in the two cohort.
Failed ultrasound guided axillary vein puncture were 6.3% and 8.7%
respectively. In "Primary Axillary" group, successful wiring within 5 mins
after local infiltration was achieved in 38 patients. Difficulty advancing J tip
wire despite of successful vein penetration were found in nine cases.
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Results: 24-and 36-month follow-up results of preclinical study demonstrated
that PLLA devices exhibited good endothelialization and degradability in a
swine model. In clinical study, device implantation was successfully achieved
in all of 5 patients (median age, 3.6 years; range, 3.1-6.5 years). The mean
ASD size was (13.4±2.4) mm (range, 10-16 mm).The mean pulmonary-tosystemic blood flow ratio (Qp:Qs) was (1.7±0.2):1 with a range of 1.5:1
to 2.0:1. The mean procedural time and the mean fluoroscopy time were
(36.2±11.3) and (6.4±1.0) minutes, respectively. Follow-up at 30 days, 3
months and 6 months was completed in all of 5 cases. Trivial mitral
regurgitation was detected in 4 patients (4/5) at 30 days follow-up, which
disappeared spontaneously in all of 4 cases at 3 months and 6 months followup. Complete defect closure with no residual shunt at 30 days, 3 months and
6 months follow-up were 60% (3/5), 80% (4/5) and 80% (4/5), respectively.
There was no evidence of short-term complications related to the device or
delivery system. No device dislodgement, significant aortic valve or mitral
valve regurgitation, new onset cardiac arrhythmia, or other adverse events
were reported.
Conclusion: This study is the first to demonstrate the feasibility, safety, and
effectiveness of the PLLA biodegradable ASD closure device in humans,
with no evidence of short-term complications and a high rate of early shunt
closure. We also demonstrated PLLA devices exhibited good
endothelialization and degradability in 24- and 36-month follow-up in a swine
model. Studies to evaluate long-term safety and effectiveness with the device
in a large cohort of patients are warranted.

Successful wiring was eventually achieved in seven cases with use of
hydrophilic wire or straight end of wire. No similar difficulty experienced
with "Bailout Axillary" group. There were a case of pacemaker pocket
infection leading to death in the "Bailout" cohort.
Conclusion: "Primary Axillary" technique with ultrasound guidance provide
a safe, reliable technique for venous access in a timely fashion in most cases.
The ultrasound guided axillary puncture method is effective after a training
phase and may be used as the initial attempt or bailout for venous access
during pacemaker implantation. The infection risk remains a major concern
as a bailout.
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Prognostic Value of Right Ventricular Three-Dimensional
Speckle-Tracking strain in Pulmonary Hypertension: Superiority
of Longitudinal Strain over Circumferential and Radial Strain
Y Li,1,2 M Li,1,2 L Li,1,2 L Zhang,1,2 Q Lv,1,2 J Wang,1,2 Y Yang,1,2 M Xie1,2
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology; 2Hubei Province Key
Laboratory of Molecular Imaging, Wuhan, China

1

resistance and pulmonary artery systolic pressure than CS and RS. Only LS
improved 6 months after medical treatment. RV LS (hazard ratio [HR]:
1.186; 95% confidence interval [CI]: 1.017 to 1.383; p=0.029) and RVEF
(HR: 0.878; 95% CI: 0.779 to 0.989; p=0.033) were independent predictors
of unfavorable clinical outcomes.
Conclusions: Patients with PH show decreased RV strain. LS best correlates
with CMR-derived RVEF, hemodynamic parameters and exercise capacity,
and provides prognostic information.

Aims: Right ventricular (RV) dysfunction is a predictor of adverse outcomes
in patients with pulmonary hypertension (PH). Three-dimensional speckle
tracking echocardiography (3D-STE) has been increasingly used to quantify
RV function, but we do not know which 3D-STE parameters provide the
most important clinical information. The purpose of our study was to
investigate whether RV longitudinal strain (LS) provided a better estimation
of RV systolic performance and prognostic information.
Methods: 60 patients with PH and 35 normal controls were enrolled in our
study. RV LS, circumferential strain (CS), radial strain (RS) were calculated
by 3D-STE. RV volumes and ejection fraction (EF) were obtained from
cardiac magnetic resonance (CMR) imaging.
Results: Patients with moderate and severe PH had decreased RVEF compared
with controls. Our findings revealed that LS showed significant reduction in
mild PH patients; whereas CS and RS were decreased in moderate and severe
PH patients. Patients with severe PH exhibited reduced RV LS, RS and CS
compared with patients with mild PH. RV LS had a better correlation with
CMR-derived RVEF, and 6-min walking distance, pulmonary vascular

71
Drug-coated Balloon in De Novo Small Vessel Coronary Artery
Lesion
LT Lam, MH Jim
Grantham Hospital, Hong Kong

Conclusion: The use of DCB, PCB particularly, to treat small vessel disease
had good clinical and angiographic outcomes at 1 year. Randomized trial to
compare DCB with second generation drug eluting stent is required to further
evaluate the use of DBC in small vessel disease.

Background: The aim of this study is to evaluate the clinical and angiographic
outcomes of drug-coated balloon (DCB) in treating small vessel coronary
artery lesion.
Method: 160 symptomatic patients with 183 de novo coronary artery lesions
of ≥50% diameter stenosis in small vessels ≤2.5 mm were treated with DCB.
6-month angiographic and 1-year clinical outcomes were analyzed.
Results: The mean age of the patients was 64±11 years old, with male
predominance (75%). Diabetes mellitus was found in 74 (46.3%) patients.
The mean reference vessel diameter was 2.10±0.24mm. 157 (85.8%) patients
received paclitaxel-coated balloon (PCB), whereas 26 (14.2%) patients
received sirolimus-coated balloon (SCB). The mean size and length of the
DCB were 2.16±0.26mm and 22.75±7.25 mm respectively. Restudy
angiography was performed in 144(78.7%) patients at mean duration of
6.4±1.7 months. Angiographic restenosis was found in 18 (12.4%) lesions;
the late loss was 0.17±0.28 mm. At one year there were 2 (1.1%) cardiac
death, 8 (4.4%) myocardial infarction and 9 (4.9%) target lesion
revascularization (TLR), resulting in major cardiovascular event rate (MACE)
of 10.9%. When comparing with SCB, PCB yielded a lower 1-year MACE
(8.9% vs 23.1%, p=0.04), a trend of lower TLR rate (3.8% vs 11.5%,
p=0.09) and angiographic restenosis rate (10.7% vs 20.8%, p=0.15).
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Enhancement of High-density Lipoproteins Quantity and Quality
to Treat Dyslipidemia and Hypertension by Policosanol
KH Cho
Yeungnam University, South Korea
Background: Metabolic syndrome is closely associated with higher risk of
hypertension, cardiovascular disease, diabetes and stroke. It has been reported
that Cuban policosanol improves lipid parameters and HDL functionality in
human participants. The aim of the present study was to investigate the longterm effects of policosanol supplementation on blood pressure (BP) and the
lipid profile in healthy Korean participants with pre-hypertension.
Methods: This randomized, double-blinded, and placebo-controlled trial
included 84 healthy participants who were randomly assigned to three groups
receiving 10 mg of policosanol, 20 mg of policosanol, or placebo upto 24
weeks.
Results: The BP, lipid profile, and anthropometric factors were measured
pre- and post-intervention and then compared. Based on an average of three
measurements of brachial BP, the policosanol 20 mg group showed the most
significant reduction in average systolic BP (SBP) from 138±12 mmHg at
week 0 to 126±13 mmHg at week 24 (p<0.0001). The policosanol 10 mg
group showed a 4% reduction in SBP from 135 mmHg at week 0 to
128 mmHg at week 24 (p=0.016), whereas the placebo group showed no
change in BP between weeks 0 and 24. The policosanol consumption for 12
weeks, the policosanol 20 mg group exhibited the most significant reduction

147
Air Pollution (PM2.5) and Arterial Endothelial Dysfunction in
Modernizing China: A Report from CATHAY Study
YJ Hu,1 P Chook,2 PWA Lee,3 CYT Kwok,3 AN Wei,4 XQ Lao,5 KHA Lau,6
DS Guo, 7 YH Yin, 8 WYT Yi, 9 WJ Chen, 8 KS Leung, 10 Y Leung, 10
DS Celermajer,11 KS Woo10
1
Nineth Peoples' Hospital of Chongqing, China; 2Institute of Chinese Medicine,
The Chinese University of Hong Kong, Hong Kong; 3Department of Medicine
& Therapeutics The Chinese University of Hong Kong, Hong Kong; 4Xuefu
Hospital of Chongqing, Second Hospital of Chongqing Medical University,
China; 5School of Public Health and Primary Care, The Chinese University of
Hong Kong, Hong Kong; 6 Department of Civil and Environment and
Engineering, Hong Kong University of Science and Technology, Hong Kong;
7
Department of Medicine, Yu County Provincial Hospital, China, 8Second
Hospital of Chongqing Medical University, China; 9Big Data Decision Analytics
Research Centre, The Chinese University of Hong Kong, Hong Kong; 10Institute
of Future Citites, The Chinese University of Hong Kong, Hong Kong;
11
Department of Cardiology, The University of Sydney, Australia
Background: Air pollution (AP) has been associated with prevalence of
cardiovascular diseases and stroke (atherosclerosis), but whether as a triggering
or atherogenic factor remains to be elucidated. Arterial endothelial dysfunction
(FMD) is a surrogate marker of atherosclerotic disease, predictive of
cardiovascular outcome and prognosis.
Aims: To establish a clinical model of AP-related atherogenesis (brachial flow
mediated dilation FMD) as a potential surrogate marker and intervention target
for atherosclerosis prevention.
Methods: 1656 Han Chinese adults (mean age 46.0±11.2 years, male 47%) in
Hong Kong, Macau, Pun Yu, Yu County (coal mine in Shanxi), and 3-Gorges
(Yangtze River) were studied in 1996-2007 (CATHAY Study). Cardiovascular
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of BP, up to 7.7% reduction of average systolic BP (SBP) from 136.3±
6.1 mmHg (week 0) to 125.8±8.7 mmHg (p<0.001). Between group
comparisons using repeated measures ANOVA analysis showed that the
policosanol 20 mg group had a significant reduction of SBP (p=0.020) and a
reduction of DBP (p=.035). The policosanol 10 mg and 20 mg groups showed
significant reductions in aortic SBP of 7.4% and 8.3%, respectively. The
policosanol groups showed significant reductions of total cholesterol (TC) of
9.6% and 8.6% for 10 mg and 20 mg of policosanol, respectively. Lipoprotein
functionality improved by policosanol to be more anti-atherogenic; LDL
showed more anti-oxidant while HDL showed more anti-glycation properties
Conclusion: Consumption of policosanol resulted in significant reductions
of peripheral SBP and DBP, aortic SBP and DBP, and mean arterial pressure
(MAP) and serum TC and LDL-C with elevation of %HDL-C.

risk profiles (smoking, body mass index BMI, waist hip ratio WHR, blood
pressure SBP/DBP, LDL-cholesterol LDL-C, triglycerides TG, and fasting
glucose) were evaluated. PM2.5 parameters were computed from satellite remote
sensing technology. Brachial FMD (vascular reactivity) were measured by high
resolution B-mode ultrasound.
Results: Their health parameters (age, gender, BMI, WHR and glucose) were
similar in lowest and top PM2.5 tertile groups. SBP, DBP, and TG were higher
and LDL-C was lower in top AP tertile. Brachial FMD (7.76±0.5 vs 8.72±0.6,
p<0.0001) was significantly lower in top PM2.5 exposure tertile compared
with lowest tertile.
PM2.5 (µg/m3)
Smoking (%)
Age (yrs)
Male (%)
SBP (mmHg)
DBP (mmHg)
BMI
WHR
LDL-C (mmol/l)
TG (mmol/l)
Glucose (mmol/l)
FMD (%)

Lowest AP Tertile (N=552)
42.9±4.9
8%
48.0±12.5
48±0.5
119.1±17.8
75.2±10.2
23.2±3.4
0.85±0.06
3.2±1.0
1.19±0.76
5.39±1.24
8.72±0.6

Top AP Tertile (N=552)
83.8±9.7
28%
46.8±10.2
41±0.5
123.4±16.5
79.6±10.8
23.7±3.3
0.86±0.07
2.5±0.8
1.50±1.50
5.55±1.03
7.76±0.5

P-Values (Bonferroni adjustment)
<0.0001 (<0.001)
<0.0001 (<0.001)
0.334 (>0.9)
0.027 (0.27)
<0.0001 (<0.001)
<0.0001 (<0.001)
0.016 (0.16)
0.027 (0.27)
<0.0001 (<0.001)
<0.0001 (<0.001)
0.021 (0.21)
<0.0001

On multiple regression of the whole cohort, FMD was significantly related to
PM2.5 (beta=0.134, p=0.015) independent of gender (beta=0.228, p<0.0001),
age (beta=0.188, p<0.0001) and DBP (beta=0.205, p<0.007) but not related to
smoking, BMI, WHR, SBP, blood glucose and TG (R2=0.158; F-value=7.6;
P<0.0001). These variables accounted for 39% of variation in brachial FMD
(P<2.2x10-14).
Conclusion: AP has an impact on early atherogenic process in modernizing
China, proposing a practical surrogate target for preventive intervention of
atherosclerosis.
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A Case Showing How Impella and ECMO Can Worsen
Haemodynamics Synergistically
SY Au
Intensive Care Unit, Queen Elizabeth Hospital, Hong Kong
Background: An ECMO was added on top of Impella for inadequate
perfusion. Severe aortic regurgitation due to impella impringing on the valves,
resulting in increased left ventricular end diastolic pressure causing acute
pulmonary edema, and stasis of blood in pulmonary artery causing pulmonary
embolism.
Case: A 59-year-old man developed cardiogenic shock after a complicated
percutaneous coronary intervention. Echocardiography showed left ventricular
ejection fraction of 15%, and no aortic regurgitation. An Impella-CP was
inserted which provided 3.1 L/min flow at P8 revolution. A peripheral VA
ECMO was added on day 5 due to inadequate systemic perfusion. The ECMO
ran at 4.2 L/min retrograde flow and the Impella gave a forward flow of
1.9 L/min at P2 revolution to vent the left ventricle. In a few hours' time, the
blood pressure dropped precipitously and the patient developed severe acute
pulmonary edema (APO). The APO was unexpected as we usually expected
good left ventricular venting by the Impella. An urgent echocardiogram
showed an acute severe eccentric aortic regurgitation (AR). It was caused by
the Impella which sat between the non and right cusps of the aortic valve,
hindering its proper coaptation. Aggregated by the fast retrograde ECMO
flow, acute severe AR developed. In fact, there was recirculation of blood
between the AR and the Impella flow, with the former faster than the latter,
resulting in APO. We stepped up the Impella flow for venting, but failed to
reposition the catheter. The haemodynamic further worsened. There was

17
The Culprit of Recurrent Pain
CK Au,1 GM Tan,1 BPY Yan2
1
Division of Cardiology, Prince of Wales Hospital; 2The Chinese University
of Hong Kong, Prince of Wales Hospital, Hong Kong
Background: Coronary spasm is not uncommon in young patients presenting
with chest pain. Identification of precipitating factors are crucial in preventing
recurrence.
Case: A 39-year-old lady, non-smoker and non-drinker, enjoying good past
health, with known family history of hyperthyroidism, presented with onemonth history of intermittent chest pain with no specific precipitating factors.
Initial evaluation, including blood tests for cardiac enzymes, blood counts,
liver and renal function were normal. Electrocardiography was unremarkable
with no ischemic changes. Chest X-ray did not show widened mediastinum
or pneumothorax. Echocardiography showed normal chamber sizes and
normal left ventricular systolic function. There was no significant valvular
lesion or pericardial effusion. Initially plan for discharge, but she developed
recurrent severe chest pain. Repeated electrocardiography showed diffuse
ST depression over inferolateral leads (II, III, aVF, V3-6) with 1mm ST
elevation over aVR. Urgent coronary angiography showed severe diffuse
narrowing from left main to distal left anterior descending artery. There was
also severe narrowing over proximal right coronary artery after catheter
engagement. Intracoronary nitroglycerin was given with immediate resolution
of chest pain and restoration of normal coronary artery calibers. Subsequent
optical coherence tomography (OCT) confirmed normal vessel wall without
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gradual progression of pulmonary embolism at the main trunk, despite full
systemic anticoagulation. This was likely due to stasis of blood in the
pulmonary artery, due to high left ventrciular end diastolic pressure and
reduced venous return as blood was shunted to the ECMO. The patient was
not fit for transport nor for open heart operation. Systemic fibrinolytic would
be shunted by ECMO. Bedside local alteplase was given through the PA
catheter and we aimed to crack the thrombus by gentle manipulation of the
PA balloon. The above bail-out treatment all failed and the patient finally
succumbed.
Decision-making: It was postulated that the Impella was shifted when its
revolution was turned down after ECMO set up. A good aortic valve short
axis view was necessary to confirm the proper positioning of the Impella
each time its flow is adjusted, especially when it was in combination with
peripheral VA ECMO.
Conclusion: ECMO and Impella could synergistically worsen
haemodynamics.

significant atherosclerotic plaque. Overall features are compatible with
coronary spasm. Oral nitrates and diltiazem were initiated. However, the
patient still developed few episodes of severe recurrent chest pain requiring
nitrates infusion. Otherwise, she denied use of any ilicit drugs eg. cocaine or
traditional Chinese medicine all along.
Decision-making: Given recurrent history of coronary spasm in a young
female in the absence of cardiovascular risk factors or suspicious drug use, it
prompted us to search for alternative precipitating factor. Subsequent detailed
systemic enquiry revealed three months history of heat intolerance. Subtle
goiter with mild hand tremor were detected in clinical examinations. Thyroid
function test confirmed thyrotoxicosis with raised anti-thyroglobulin
antibodies, suggesting diagnosis of Grave's disease. Carbimazole and
propranolol were given, and the patient was free of chest pain thereafter.
Conclusion: Coronary spasm especially in young female without
cardiovascular risk factors should raise suspicion for thyrotoxicosis, which
if treated early, is the key of preventing future spasm.
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Complete Atrioventricular Block in a Patient with a History of
Henoch-Schönlein Purpura: A Case Report
CM Manalastas, M Nieves, HM Gomez, G Alfonso
Angeles University Foundation Medical Center, Angeles City, Philippines
Background: Henoch-Schönlein Purpura (HSP) is a common condition
which mostly affects cutaneous, gastrointestinal and renal systems. However,
due to the immune-complex deposition causing its characteristic vasculitis,
it can also affect the heart.
Case: A 15-year-old Filipino male, weighing 100 kilograms with a height of
183 centimeters presented with one week bilateral leg pain, inability to
ambulate, abdominal pain, vomiting and purpura on his ankles. Physical exam
showed normal blood pressure, normal heart rate and was afebrile. Complete
blood count showed leukocytosis and thrombocytosis, normal serum
creatinine and ANA; negative anti-dsDNA; elevated ESR. No skin biopsy
performed. He was diagnosed with HSP, started on Prednisone 15 mg daily
and discharged well. Eight months after, he started complaining of dizziness,
without accompanying nausea, vomiting or syncope. During an episode of
dizziness, he was found to have a heart rate of 40 beats per minute with
normal blood pressure. A resting electrocardiogram (ECG) showed a complete
atrioventricular block with junctional escape rhythm. A 2D echocardiography
with Doppler was normal. 24-hour Holter monitoring was not done. Thyroid
function tests including TSH, fT3, and fT4 to rule out hypothyroidism as a
cause of bradycardia were normal. He was started on clopidogrel 75 mg daily

108
A Rare Case of Anomalous Origin of Left and Right Coronary
Artery
X Li, X Huang
Department of Pediatrics, Affiliated Hangzhou First People's Hospital,
Zhejiang University School of Medicine, Hangzhou City, China
Background: Congenital coronary artery anomalies (CCAAs) are
abnormalities in the origin, course or structure of these arteries, and their
incidence varies from 0.2% to 5.6%. CCAAs may cause myocardial ischemia
and sudden cardiac death. Anomalous origin of the left coronary artery from
the pulmonary artery (ALCAPA) is more common in CCAAs.
Case: Our case was a thirty eight day old female infant born by normal
vaginal delivery. She was asymptomatic till 30th day of life when parents
noticed that baby had a cough and wheezing. Chest X-ray showed enlargement
of cardiac shadow, echocardiogram revealed dilation of left atrium and
ventricle with severe LV dysfunction in local hospital. She was admitted to
our hospital for endocardial fibroelastosis. In our hospital, the ECG displayed
normal sinus rhythm, abnormal Q (q) waves in high lateral wall with QRS
waveform of anterior lateral wall fragmentation, prolonged QT interval, and
T-wave inversion in leads I, II, avL, avF, V5, V6. On 2D echo the beginning
of the left coronary artery was invisible, a similar echo of left coronary artery
(LMCA) was seen to connect with the main pulmonary artery (PA) however
on color Doppler anterograde-flow was seen in the left coronary artery, right
coronary artery (RCA) was visible from aorta and its starting position was
about 1 o'clock. It was discussed CT angiogram (CTA) could help to
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and monitored with monthly ECG's. Due to no spontaneous resolution of the
complete AV block, the patient underwent permanent pacemaker implantation
(PPI). A dual chamber pacemaker was placed on the right atrium and right
ventricle via the left cephalic vein using the Modified Seldinger Technique.
On follow-up eight months after, the ECG showed regular ventricular-paced
rhythm with a rate of 90. However, echocardiogram shows a decline in ejection
fraction (55% from 72% Simpson's), Grade 1 left ventricular diastolic
dysfunction and mitral valve thickening without prolapse. There is no
recurrence of dizziness.
Decision-making: The decision to do a permanent pacemaker implantation
was based on the American College of Cardiology/American Heart Association
Class I, Level C recommendation that treatment of symptomatic bradycardia
a PPI.
Conclusion: The natural history of HSP and the possibility of coexsiting
cardiac dysrhytmia warrant an electrocardiogram, at the bare minimum, to
unveil these rhythm and conduction abnormalities early on. Further
investigations may be considered to uncover underlying structural heart
disease.

demonstrate diagnosis. Baby was administered oxygen inhalation, digitalis
and diuretics during this period. After 6 days CTA demonstrated that RCA
originated from the left side of the ascending aorta, and LMCA originated
from the PA. Transthoracic echocardiogram was repeated. Interestingly, the
bi-directional shunt was showed in the left coronary artery this time, and it
was mainly shunt of right-to-left on color Doppler.
Decision-making: Correction of abnormal origin of coronary artery and
ECMO placement were performed in the baby. Unfortunately, owing to poor
left ventricular function, the infant could not be weaned from ECMO. She
died on the 7th day after the operation.
Conclusion: We are reporting a case of abnormal position of RCA and
ALCAPA with severe LV dysfunction. It is result of pulmonary hypertension
due to left ventricular heart failure. By anti-heart failure treatment, pulmonary
artery pressure decreased. The blood-flow was transferred anterograde-flow
pattern to bi-directional and right-to-left shunt in left coronary artery.
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Progressive Dyspnea: Pulmonary Embolism Refractory to
Anticoagulation
J Chen, Y Liu, X Guo, J Ye, Y Liang, H Tan, J Chen
Guangdong General Hospital, Guangzhou, China
Background: Anticoagulation is the treatment of choice for pulmonary
embolism. Poor treatment response warrants further differential diagnosis.
Case: A 44-year-old housewife complained with progressive shortness of
breath for 2 months. Initially, dyspnea occurred after heavy physical activities,
accompanied with chest pain which relieved after rest. Her exercise capacity
continued to decrease, and dyspnea with cyanosis could be triggered by
emotional fluctuation. Her pulmonary artery CT scan showed multiple filling
defects in arteries. She was therefore diagnosed with pulmonary embolism
and was given thrombolytic therapy. Her symptoms deteriorate two days
later, and she was transferred to our hospital. She denied any history of
coronary heart disease, hypertension or diabetes. Physical examination: Vital
signs: T 38.5°C, P 111 bpm, R 31/min, BP 117/71 mmHg. BMI: 18.03 kg/cm2.
Distension of jugular vein was noted. Laboratory tests: Arterial blood gas: pO2
57 mmHg, pCO2 29 mmHg, pH 7.5, HCO3- 22.6, BE -0.6, Lactate 1.8, SO2
92%. NT-proBNP: 2977 pg/ml. NSE: 25.5ng/ml (ref: 0-16.3 ng/ml). D-dimer
and cardiac enzyme was normal. ECG: Sinus rhythm, with T wave inversion in
V1-V5. Echocardiogram: Enlargement of right atrium and right ventriculum.
Marked pulmonary hypertension. Pulmonary artery CT scan: Multiple filling
defects in both left and right pulmonary arteries. Medication: Riociguat
0.5 mg Bid, Tracleer 62.5 mg Bid, and Enoxaparin 4000U q12h. However,
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Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy
Associated with Apical Aneurysm and Left Ventricular
Thrombus
W Ho, TM Mok, UP Lam, MF Ip, M Evora
Centro Hospitalar Conde De São Januário, Macau
Background: This case report reviewed a patient with Mid-Ventricular
Obstructive Hypertrophic Cardiomyopathy (MVOHCM) with initial
presentation mimicking acute coronary syndrome and Takotsubo
cardiomyopathy.
Case: A 72-year-old female presented with worsening of shortness of breath
without significant chest pain. She developed ventricular tachycardia with
unstable hemodynamic condition soon within 1 hour of emergency room
arrival. The arrhythmia was converted to sinus rhythm after total 4 times of
electrical cardioversion (150-200J) followed by amiodarone infusion. Post
conversion 12-leads ECG showed ST segment depression over lead I, aVL,
V2-V6 with T wave inversion throughout the anterior, inferior and lateral
leads. Pre-cardioversion blood test later reported elevated levels of cardiac
enzymes including creatin kinase-MB and troponin T. With the provisional
diagnosis of suspected acute coronary syndrome with ventricular arrhythmia,
coronary angiography and left ventriculography were performed. Coronary
angiogram revealed patent coronary arteries. Left ventriculography showed
an akinetic apex with ballooning appearance and hyperkinesia at basal region.
A contrast defect image consistent of thrombus was also noted at apex.
Echocardiography was repeated showing significant LV eccentric hypertrophy
(IVS=1.9 cm, LVPW=0.9 cm). LV contraction is preserved but apical
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her symptoms worsened, with pulmonary pressure reaching 112 mmHg,
compared with 95 mmHg at admission. Heart MR: Cancer focus in pulmonary
arteries. PET-CT: Filling defects in pulmonary arteries with increased glucose
absorption, indicating pulmonary arterial sarcoma. Pulmonary arterial tumor
resection was performed. Pathological report revealed endarterial sarcoma.
Patient suffered from recurrent airway bleeding on postoperative day 2, and
develop infection and MODS afterwards. She was discharged upon deamand
by family.
Decision-making: Progressive dyspnea, pulmonary hypertension and arterial
filling defects supported pulmonary embolism, while poor therapeutic
response suggested otherwise. Weight loss and hypoalbuminemia indicated
catabolic state including malignancy, which was corroborated by elevated
NSE. MR and PET-CT were therefore performed, leading to the rare finding
of pulmonary artery sarcoma.
Conclusion: Pulmonary artery sarcoma is a rare disease with an incidence
of 0.001-0.003%. Surgery was the only cure with survival benefit reported
by retrospective studies. In patients with pulmonary embolism refractory to
anticoagulation, differential diagnosis of rare etiologies should be considered.

aneurysm with an organized thrombus size 1.8x1.7 cm was found. Severe
left ventricular obstruction at mid-cavity level during systole was observed.
Using continuous wave Doppler, the pressure gradient was measured as
70 mmHg. The patient was eventually diagnosed as having Mid-Ventricular
Obstructive Hypertrophic Cardiomyopathy (MVOHCM) with apical
aneurysm and LV thrombus, and medical treatment with a beta blocker and
warfarin was started.
Decision-making: Patient is haemodynamically stable and no more
arrhythmia including premature ventricular beat presented during hospital
stay. ICD implantation after cardiac magnetic resonance (CMR) examination
were scheduled. Yet patient developed another episode of sustained
ventricular fibrillation before the CMR study and did not make through the
resuscitation. The patient eventually succumbed.
Conclusion: Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy
(MVOHCM) is an uncommon form of hypertrophic cardiomyopathy. This
case showed a patient with MVOHCM with early presentation mimicking
acute coronary syndrome and Takotsubo cardiomyopathy. Patients with
Takosubo cardiomyopathy usually recovers from the acute stage and had
favourable prognosis. However, patients with MVOHCM and apical aneurysm
are commonly associated with adverse clinical course, including sudden death
events. CMR is the preferred imaging study for hypertrophic cardiomyopathy.
Yet timely recognition of MVOHCM with apical aneurysm by
echocardiography is still important because it may change the clinical decision
of management and provoke early ICD implantation for prevention of
malignant arrhythmia or sudden death.
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Weathering an Adenosine Insensitive Right Ventricular Outlow
Tract Ventriclular Tachycardia (Adenosine Insensitive RVOT
VT) Storm in an Adolescent Female. A Case Report
JE Duya, G Gervacio, L Go, MJ Agbayani
University of The Philippines-manila, Manila, Philippines
Majority of VT's are associated with structural heart disease. However, 10%
are idiopathic such as RVOT-VT which hallmark is its sensitivity to adenosine
(ADO), consistent with triggered mechanism. Exceptionally, only 11% of
RVOT-VT is ADO-insensitive, posing a diagnostic challenge.
Case Summary: A 15-year-old female, asthmatic, had palpitations,
lightheadedness and dyspnea. She had a similar episode of incessant
palpitations a month ago, which necessitated electrical cardioversion and
amiodarone. No family history of sudden death. On admission, she was in
cardiorespiratory distress and very tachycardic. Cardiac exam was
unremarkable except for faint pulses. A wide complex tachycardia was
documented. Initially managed as a case of myocarditis and supraventricular
tachycardia with aberrancy, vagal maneuvers, adenosine, amiodarone and
diltiazem were given. Echocardiogram showed a structurally normal heart.
All work-ups for alternate diagnosis were normal. Despite treatment, VT
recurred in 24 hours, yet she remained hemodynamically stable. Detailed
analysis showed wide complex tachycardia, LBBB morphology, AV
dissociation, positive QRS complexes in inferior leads, suggestive of RVOTVT storm. Adenosine was given however, the patient did not revert back to
sinus, hence, ADO-insensitive RVOT-VT was considered. Synchronous
cardioversion terminated the tachyarrhythmia. On EPS, VT was induced/

30
Where is the ASD?

localized at the RVOT via 3D-electroanatomical mapping. RFA of the focus
was performed, immediately terminating the tachycardia. Post ablation, she
was asymptomatic and discharged with excellent prognosis.
Discussion: ECG remains accessible/reliable in recognizing and localizing
RVOT-VT. Albeit very rare, ADO-insensitive RVOT-VT was documented
and it linked to somatic myocardial mutations in A1-ADO receptor-associated
CAMP-mediated pathway. We highlight the importance of prompt recognition
of this arrhythmia, because management/prognosis is dissimilar from common
causes of VT. By correctly managing this arrhythmia, long-term complications
such as tachycardia related cardiomyopathy and sudden death can be
prevented.

Conclusion: Multimodality imaging including echocardiography, CT and
magnetic resonance imaging of heart is essential for definitive diagnosis and
subsequent treatment planning.

WK Chi
Prince of Wales Hospital, Hong Kong
Background and Case: A 71-year-old man with history of hypertension and
hyperlipidemia underwent transthoracic echocardiography (TTE) for the
assessment of incidental systolic heart murmur during routine check-up. TTE
color flow Doppler revealed left-to-right shunt across the inter-atrial septum
suggestive of secundum atrial septal defect (ASD). Subsequent
transesophageal echocardiography (TEE) demonstrated turbulent color flow
in mid-portion of coronary sinus (CS) but no evidence of ASD Transvenous
agitated saline injection test was negative for right-to-left shunt.
Decision-making: Computed Tomography (CT) of the heart showed a dilated
and tortuous right coronary artery (RCA) with a small (approximately 2 mm
in diameter) posterior descending artery (PDA) fistulating into CS draining
into the right atrium. Invasive coronary angiogram revealed giant aneurysmal
dilatation of the RCA with fistula to CS through distal circulation and
significant stenosis in left anterior descending artery (LAD) and left circumflex
artery (LCx). The patient was referred for surgical ligation of RCA fistula
with bypass grafting to PDA and left coronary system (LAD and LCx).
Schematic illustrations of the heart denote the rationale how abnormal Doppler
flow from coronary sinus mimicked a secundum ASD. RCA fistulation to
CS resulting in aneurysmal dilatation of RCA is a rare congenital anomaly,
usually presenting late with right heart volume overload secondary to left-toright shunt. Spontaneous rupture of aneurysmal fistula leading to
hemopericardium has been reported.
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Two Tachycardias, One Cause
S Ching, CS Yue
Division of Cardiology, Department of Medicine and Geriatrics, United
Christian Hospital, Hong Kong
Background: Aconite poisoning is an uncommon yet important cause of
serious arrhythmias.
Case: A 72-year-old woman presented with confusion, vomiting, diarrhea
and tongue numbness 2 hours after consuming home-made herbal soup. Her
blood pressure was 118/90 mmHg, heart rate 104 beats per minute. She had
incoherent speech. Thirty minutes later her blood pressure dropped to
58/39 mmHg, heart rate 144 bpm. The electrocardiogram (ECG) showed a
regular wide complex tachycardia, right bundle-branch block (RBBB)
morphology, extreme right axis and atrioventricular dissociation consistent
with fascicular ventricular tachycardia (VT). As the rhythm spontaneously
aborted, another ECG was obtained showing a tachycardia with a rapidly
alternating QRS axis. Troponin T was <14 ng/L.
Decision-making: The second ECG was characteristic of bidirectional VT.
A notable example is digoxin overdose. However, digoxin level was
undetectable, and the patient's symptom closely following ingestion of herbs
is concerning for alkaloid poisoning. The patient reported ingestion of Fuzi,
a medicinal plant containing cardio- and neurotoxic aconites. Her blood
pressure was stabilized with intravenous fluids, ionotropes and amiodarone.
Bidirectional tachycardia was gradually replaced by occasional premature
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Development of Deep Vein Thrombosis After Achieving
Remission in a Patient with Acquired Hemophilia A
V Ramiro, CA Tanchanco, JP Cerrado, JM Torres, A Mirasol, T Dumagay,
MT Abola
Philippine General Hospital, Manila, Philippines
Background: Acquired hemophilia A (AHA) is an uncommon autoimmune
disease caused by immunoglobulin G antibodies against Factor VIII (FVIII).
Occurrence of clinical thrombosis rarely occurs in congenital or acquired
hemophilia. We report a case of AHA, in remission, with subsequent
development of deep vein thrombosis (DVT).
Case: A 53-year-old Filipino male presented with left lower quadrant
abdominal pain. Diagnostics revealed anemia, isolated activated partial
thromboplastin time (APTT) prolongation, and left psoas hematoma on
ultrasound. Based on decreased FVIII levels and PTT mixing studies
confirming presence of an inhibitor, AHA was diagnosed. Acute bleeding
was managed with supportive transfusion (Fresh Frozen Plasma or
cryoprecipitate), bypassing agents (FEIBA and rFVIIa) and FVIII concentrates.
For inhibitor eradication, Prednisone and Cyclophosphamide were used. Upon
discharge, steroids and factor concentrates were maintained. After 2 months
of treatment, he achieved partial remission based on normal repeat FVIII and
reduced hematoma size. However, sudden left leg swelling prompted
readmission. Venous duplex scan (VDS) showed DVT of the distal external
iliac, common femoral, deep femoral and popliteal veins.
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ventricular complexes, which together with her gastrointestinal and neurologic
symptoms, completely resolved the day after. Analysis of herbal remnant and
urine sample returned positive for aconite alkaloids and their metabolites.
Fuzi is used in Chinese herbal medicine for pain relief and cardiotonic effects.
Consumed in large quantities, aconites are highly neurotoxic and
proarrhythmic. Toxicity usually appears 30 minutes after consumption,
including vomiting, numbness, confusion, arrhythmias and hypotension.
Sensory symptoms are prevalent. Besides bidirectional tachycardia, fascicular
VT has also been reported. Since no antidote is available, supportive care is
the only treatment. Aconites are lipophilic and are not dialyzable. The duration
to recovery ranges from 2-7 days.
Conclusion: Aconite poisoning may cause arrhythmias that mimic digoxin
overdose. A careful history is often revealing.

Decision-making: Balancing the treatment of thrombosis with the high risk
of bleeding at any time was a major concern in this patient's case. Because
the patient did not have bleeding at the time, treatment for DVT with
appropriate anticoagulation was prioritized. He was treated with low molecular
weight heparin and bridging anti-coagulation. The consensus was that if
bleeding occurred at any point, the treatment paradigm would shift to prioritize
treatment for acquired hemophilia A, control bleeding with bypassing agents
and factor replacement, transfuse blood products supportively, and monitor
for progression of thrombosis or development of new thrombotic events.
Fortunately, bleeding never occurred during anticoagulation. Upon discharge,
he was maintained on Prednisone, which was tapered down gradually, and
Warfarin 5mg daily, with INR target of 2 to 2.5. After 10 months of Warfarin
treatment, repeat venous duplex scan revealed full resolution of the DVT.
Conclusion: Thrombosis occurring in the setting of hemophilia is a paradox.
Rapid increase in FVIII activation during remission phase leads to elevated
FVIII levels and a dose-dependent predisposition to thrombosis. Massive local
tissue factor generation in response to widespread vascular injury can activate
Factor X directly. Bypassing agents also confer significant thromboembolic
risk. Hence, AHA patients with risk factors for thrombosis should be
monitored closely by clinical assessment and coagulation testing. Treatment
of thrombosis must be vigilantly balanced with the high bleeding risk innate
among hemophiliacs.
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An Atypical Left Atrial Mass
SM Wong
Princess Margaret Hospital, Hong Kong
Background: A 63-year-old gentle was incidentally found to have a large
left atrial mass
Case: A 63-year-old gentle with past history of Hypertension, Diabetes
mellitus and ischemic stroke was admitted for Chest pain. Electrocardiogram
show diffuse ST elevation over chest leads. Urgent coronary angiogram was
done showing mild disease over Left anterior descending artery and Left
circumflex artery only. However, there is a 5 cm x 6 cm mass obliterating
Left atrium identified by echocardiogram. Trans-esophageal echocardiogram
was done show a 5 cm x 4 cm x 4.5 cm well cirumscribed non-mobile mass
with multiple cavitation and septae attaching to atrial septum and inferior
wall of left atrium. There is another 3.4 cm x 3.1 cm x 2 cm mass attaching to
superior wall of Left atrium. The masses filled a large portion of Left atrial
lumen but allow passages for blood flow from all four pulmonary veins to
mitral valve. The left atrium is dilated but left atrial pressured was not
increased. MRI heart was done for better delineation of the Left atrial mass.
It has discovered that the 2 mass detected in Trans-esophageal echocardiogram
were actually one large bilobed oval shape mass adherent to posterior Left
atrial wall. Main bulk of the mass has shown no significant contrast
enhancement, it is therefore more suggestive for large left atrial thrombus.
The patient developed atrial fibrillation during hospital stay and dabigatran
was started for stroke prevention.

143
Investigate the Indications of Percutaneous Ablation for Atrial
Fibrillation in Patients with Rheumatic Mitral Stenosis
B Luo, Y Li, D Lu
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
City, China
Background: Atrial fibrillation is frequent in patients with rheumatic mitral
stenosis. The ablation of targeted atrial tissue has emerged as an effective
rhythm management strategy in patients with atrial fibrillation. But the
indications of atrial fibrillation ablation in patients with mitral stenosis is
not addressed in recent atrial fibrillation management guidelines.
Case: A 63-year-old woman was admitted to the hospital on July 30, 2018.
She complained recurrent onset of chest discomfort for more than 4 years
and became significant after the activity with shortness of breath for more
than one month. She has hypertension for 4 years. The highest blood pressure
was 160/100 mmHg and take medical treatment to control blood pressure
well. She had no history of stroke and diabetes. She once was in the
hospitalization in January 2014. During that time, she underwent examination,
including CAG and echo. There was no obvious abnormality in CAG. The
cardiac echo showed rheumatic heart valve disease, mitral stenosis (valve
area 1.9 cm 2 ). In 2015, She was diagnosed with "atrial fibrillation" in
community hospitals and did not take anticoagulant therapy and rhythm
control treatment.
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Decision-making: What is the most appropriate treatment of choice for this
patient? Although the Left atrial thrombus may resolve with anticoagulation
therapy, the patient was still at risk of thromboembolic event or mitral valve
obstruction. The patient was referred for surgical excision of the left atrial
mass. A 9 cm lesion over Left atrium was excised. Tissue pathology shows
organizing thrombus with amyloid deposit and amyloidosis in myocardium.
Typing of amyloidosis was uncertain but in favour of transthyretin
amyloidosis. Abdominal fat pad biopsy found no amyloid deposition.
Pyrophosphate scan reveal minimal uptake over heart and bilateral maxilliary
sinuses. The subtype of amyloidosis cannot be determined despite intensive
investigation. After discussion with hematology team, we decided for
supportive management and monitoring of paraproteinemia.
Conclusion: It is a case of very atypical presentation of amyloidosis.

Decision-making: We discuss which choices would be more beneficial, safe
and useful to the patient: (1) percutaneous ablation? (2) PMC? (3)
Percutaneous ablation after or during PMC? (4) surgical ablation during mitral
valve surgery? (5) Anticoagulation treatment? (6) Left atrial appendage
closure? Through comparing all the examination, especially echo data, the
patient suffered the percutaneous ablation and take oral Warfarin
postprocedure until now. The patient resumed sinus rhythm on the second
postoperative day followed by chest discomfort disappeared. Holter
examination showed maintenance of sinus rate after 8 months follow up.
Conclusion: In our experience, percutaneous atrial fibrillation ablation could
be performed in the highly selected patient with mitral valve stenosis. Still,
more studies are needed to evaluate the efficacy and clinical impact of
percutaneous ablation at different stages of mitral stenosis.
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Successful Retriveal of Entrapped Rotablator after Failure of
Traditional Method
AYW Li, S Chung, D Lo, N Mui
United Christian Hospital, Hong Kong
A 70-year-old housewife presented chest pain and severe calcified stenosis
in pLAD in CT angiogram. PCI was performed via RRA using a 6F EBU
catheter. LAD was wired but 2.0 balloon would not dilate the proximal lesion.
Rotablation was performed, using a 1.25 mm burr with short peckings at
180k rpm, could pass pLAD. Further attempt at mLAD bend suddenly resulted
in burr entrapment, just distal to D1. Separate 7F EBU engaged LM via new
right femoral access. Attempt to pass various parallel wires beyond the burr
all failed despite supported by micro-catheter. The second wire was then
directed to D1 to support balloon dilatation at pLAD. Simple traction of burr
still failed, though hemodynamics of patient remained stable. The plan was
then changed to disassembly of rotablator to allow child-in-mother technique
for enhancement of traction. The driveshaft and its encircling plastic sheath
were cut with preservation of rotawire inside. With its radio-opaque spring
tip withdrawn to the tip of burr, traction of rotawire together with countertraction of Guideliner along the burr resulted in successful retrieval without
complication. The D1 wire was directed to dLAD. We decided to upsize the
burr to 1.5 mm, which crossed mLAD lesion upon the 26th short run. However
patient presented slow flow afterwards, which was improved with
intracoronary adenosine plus intravenous inotrope. After IVUS assessment

66
Thrombus in LAA: Nothing Ventured, Nothing Gained
ICH Tsang, NY Chan, RCY Fung
Princess Margaret Hospital Hong Kong
We implanted a left atrial appendage occluder (LAAO) into a patient with
very high bleeding and stroke risk. Our patient was a 69-year-old Chinese
lady with multiple comorbidities including IgA nephropathy with renal
transplant done in 2009, hypertension, diabetes, hepatitis E infection,
hypothyroidism, and sleep apnoea. She was also known to have AF on oral
anti-coagulation (OAC). CT coro in 2017 already noted suspicious thrombus
in the LAA. She was admitted to our hospital surgical unit in 5/2018 for
epigastric pain and anaemia with subsequent OGD showed acute GU.
Colonoscopy showed diverticula and piles. OAC was then withheld until
7/2018 when repeated OGD showed healed GU but still with diffused gastritis
and erosion at antrum. She was re-admitted in 8/2018 for dizziness. Physical
examination showed right homonymous hemianopia. CT brain showed left
occipital Infarction. OAC was not resumed due to persistent anaemia and
positive faecal occult blood testing. Her CHA2DS2VASc score was 7. Because
of the very high bleeding risk, we decided to proceed to LAAO implantation.
However, the pre-procedure TEE in 11/2018 and 1/2019 showed severe LA
smoke and LAA thrombus. The procedure was abandoned. She was put on
Pradaxa and hopefully it would dissolve the clot. She was admitted to our
surgical unit in 2/2019 for PRB with proctoscopy showed first degree
haemorrhoids. CT showed multiple diverticula with inflammatory changes.
Pradaxa was stopped. TEE was repeated on 12/2/2019 and still showed LAA
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and OPN pre-dilatation, Synergy 2.5 x 48 mm stented ostial to mid LAD.
3.5 NC upsized proximally. Final IVUS and angiographic result was good.
Traction via a transected driveshaft alone may lead to unwinding and
elongation of its helical structure, thus reducing the traction force. On the
other hand, preservation of intact rotawire, with cut and removal of the
driveshaft and its sheath, allows the local application of traction distal to tip
of entrapped burr via a child-in-mother system. This partial disassembly,
unlike other publications of complete disassembly with rotawire cut off, has
not been reported, to the best of our knowledge.

thrombus. After thorough discussion with patient and her relatives on the
risk and benefit of LAAO, they agreed to proceed. The procedure was done
on 4/3/2019 under general anaesthesia. We inserted the Sentinel cerebral
protection device via the right radial artery to minimize the stroke risk. We
injected contrast into the pulmonary artery in order to visualize the LA and
LAA morphology. The positioning of LAAO was heavily rely on TEE guidance
instead of injecting contrast directly into the LA to avoid dislodgement of
the LAA thrombus. Finally we successfully implanted a Lambre 30/36 into
the LAA in 1 attempt with satisfactory TEE results. The patient recovered
well with no clinical stroke or systemic embolization. She was put on aspirin
and clopidogrel and discharged from our hospital 2 days after the procedure.
A follow up TEE was arranged in 45 days post LAAO implantation. In
conclusion, we successfully implanted a LAAO in a patient with LAA
thrombus with no evidence of systemic embolization.
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A Missing Vessel
LT Lam
Grantham Hospital, Hong Kong
Background: Dual left anterior descending artery (LAD) is a rare congenital
anomaly. Concomitant dual LAD with anomalous origin and right coronary
artery chronic total occlusion (CTO) is challenging for coronary intervention.
Case: A 60-year-old man, chronic smoker with diabetes mellitus presented
with stable effort angina. Angiogram found moderate left main disease,
significant proximal LAD and left circumflex artery (LCx) stenosis, suspected
mid LAD CTO with retrograde filling from right side coronaries and mid to
distal right coronary artery (RCA) total occlusion with retrograde filling from
left coronaries. The left main bifurcation lesions were first stented with culotte
technique. Subsequently, attempt to wire the mid LAD CTO with antegrade
approach was unsuccessful. Initially plan to wire the mid LAD CTO from
right side collateral vessel. However, upon careful examination, the 'right
side collateral' was actually an anomalous origin LAD from right coronary
cusp supplying the mid to distal LAD territory. It was a dual LAD system
rather than a LAD CTO lesion. Therefore, no intervention was required to
perform to mid LAD. There was a stenosis at the distal anomalous LAD.
Attempt to wire across the lesion using Runthrough and Fielder XT wires
supported by Corsair with 7Fr AL1 guiding catheter was made. However, it
was unsuccessful due to the angulation of the vessel. In view of the difficulty
and distal disease, the strategy was changed to tackle the RCA CTO. Finally
the RCA CTO intervention was successful through epicardial collaterals from
LCx with reverse CART technique.

92
Coronary Artery Fistula – A Nightmare to the Patient and
Doctors
SC Leung, KL Lee, YK Yau
Ruttonjee Hospital, Hong Kong
Background: Coronary artery fistulas (CAF) is anomaly with abnormal
connection between coronary arteries and cardiac chambers or great vessels.
Although it is a rare disease, it can result in undesirable consequence.
Case: An 82-year-old man with history of hypertension and diabetes mellitus,
presented with chest pain and hemodynamic unstable ventricular tachycardia.
His condition was stabilized after cardioversion. Echocardiogram reviewed
ejection fraction 50% with hypokinesia over anteroseptal region. Urgent
coronary angiogram showed coronary fistula arised from proximal left anterior
descending artery (LAD) connected to a giant aneurysm and drained into
pulmonary artery, flow to distal LAD was markedly diminished due to
coronary steal.
Decision-marking: He was referred to surgical intervention in view of
symptomatic coronary fistula with large aneurysm. Fistula ligation, repairment
of aneurysm and CABG with LIMA to LAD were performed. Four months
later, patient presented again with chest pain and hemodynamic unstable
ventricular tachycardia. Restudy coronary angiogram showed persistent
coronary artery fistula and aneurysm. Cardiothoracic surgeons were consulted
again but they concluded no more benefit from another surgical intervention.
Thus, we discussed with the patient for transcatheter coil embolization, but
the patient refused. Patient was intolerant to betablocker due to bradycardia
and refused ICD as a backup therapy. Few weeks later, he presented with
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Decision-making: The short LAD originating from left main artery terminated
early, it is easily mistaken as mid LAD CTO. However, it is essential to
distinguish it from the dual LAD anomaly. Moreover, intervention to the
anomalous LAD was difficult due to the acute angulation. Stent delivery
may not be easy even if wiring to distal LAD was successful. Therefore,
percutaneous coronary intervention to the distal LAD was abandoned after
brief attempt. Also, it is mandatory to perform computer tomography (CT) of
coronary arteries afterwards to identify the types of dual LAD. In this patient,
CT confirmed the anomalous LAD travelling between aorta and pulmonary
artery, a potential malignant course. The patient was advised to avoid
strenuous exercise.
Conclusion: Dual LAD anomaly is a rare but important disease entity. It is
crucial to identify the course of dual LAD by CT scan in order to have a
successful coronary intervention and best clinical management.

another episode of chest pain and hemodynamic unstable VT. Eventually,
the patient agreed for transcatheter coil embolization to the coronary artery
fistula. He was asymptomatic after the intervention. Myocardial SPECT scan
9 months later showed no evidence of myocardial perfusion defect. Relevant
learning points would be the indication of intervention and management
approach to coronary fistula.
Conclusion: In conclusion, surgery was the traditional treatment method for
coronary fistula, but percutaneous catheter closure appears as an alternative
treatment option, which is proven feasible and safe in the anatomically suitable
vessel.
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Tackling Knot & Fracture in Transradial Procedure
CMS Kabir
Ibrahim Cardiac Hospital & Research Institute, Shahbag, Bangladesh
Background: Transradial access has nowadays become a standard of care
for percutaneous coronary angiography & intervention. This approach has
demonstrated significant reduction in bleeding rate, length of hospital stay
& improvement in clinical outcomes when compared to the traditional TF
approach. However this novel approach may lead to severe catheter kinking
& twisting & further manipulation may be required to unravel the catheter &
avoid complication. An interesting case of complete fracture of a 6 Fr Ikari
guide catheter in the brachial artery during transradial coronary intervention
is presented.
Case: A 58-year-old hypertensive, diabetic, dyslipidaemic lady with prior
history of PCI to OM & RCA 2 years back was admitted with Unstable Angina.
Her ECG revealed inferior ischaemia. LAD has mild to moderate disease in
its mid part. Stent in principal OM branch is patent. Dominant RCA has 70%
stenosis in its mid part. Stent in distal RCA is patent. PLV branch has 80%
proximal disease. So PCI to mid RCA & PLV branch was planned. Guide
catheter Ikari 1.5 5 Fr & Guide wire Sion blue were used. Predilataion balloon
was 2.0x8 mm. PLV lesion was stented by 2.25x12 mm DES & mid RCA
lesion by another 2.75x20 mm DES. There was sudden displacement of guide

132
Unstable Pulmonary Embolism Contraindicated for
Thrombolytic
PH Lee, M Chiang
Queen Elizabeth Hospital, Hong Kong
Background: A 56-year-old female had gynaecological operation performed
and post-operatively the patient was having on and off severe bleeding over
surgical wound. She developed shortness of breathe and severe shock shortly
after; CT scan was performed showing bilateral pulmonary embolism.
Case: Patient's blood pressure remained very low despite fluid resuscitation
and triple inotropic support, hence she was put in VA ECMO circulatory
support. Due to haemodynamic comprimisation, she is indicated for
thrombolytic therapy; However, as patient had recent surgery with active
bleeding from surgical site, she was contraindicated for thrombolytics.
Decision-making: Invasive pulmonary artery arthrectomy was performed
with various method. As EKOS was not available in our hospital, various
other methods were attempted including angioget, direct catheter suction,
snaring to decrease the clot size, etc. Different support to facilitate the
procedure (e.g. Shuttle Sheath) was also employed. Finally pulmonary
angiogram showed much improved flow. Patient was continued on
anticoagulation post-operatively with close monitoring of the haemoglobin
level and bleeding over surgical site. She was able to gradually wean off
ECMO and discharged.
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catheter before taking final image due to deep inspiration by the patient.
Final images revealed TIMI 3 flow in RCA after reengagement of Ikari guide
catheter. There was partial dampening of pressure curve on monitor.
Fluoroscopy revealed a tight knot within the right brachial artery along with
the PTCA guide wire. A long guide wire was advanced to untie the knot but
failed. Guide catheter was broken into two pieces at the level of elbow.
Proximal part of broken catheter was removed through the radial sheath. Snare
catheter was used to retrieve the remaining broken segment but failed. Finally
a 6 Fr JR guiding catheter was advanced and the distal part of the broken
catheter was captivated into the JR guiding catheter and was removed
successfully removed through the ipsilateral radial approach.
Conclusion: As TR approach becomes more diffusely used, complications
related to this procedure will likely be encountered more frequently. Extra
care should be taken when engaging an Ikari guiding catheter. All retrieval
techniques are part of endovascular practice & need to be known & applied
where necessary.

Conclusion: Pulmonary Embolism is a relatively common post-operative
complication, which in most cases, are relatively stable. However it could
also be potentially very severe with haemodynamic comprimisation and in
these group of post-operative patients, not all are fit for thrombolytic therapy.
This case illustrated various methods we could help this group of patients
and different technical difficulty that we may encounter with corresponding
trouble-shooting demonstrated.
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A Case of Kleinfelter Syndrome with Cardiomyopathy
N Sadick
Westmead Hospital, Sydney, Australia
A 54 year of male with no previous cardiac history presented with rapid
atrial fibrillation with left ventricular hypertrophy (LVH) on his ECG requiring
cardioversion to restore sinus rthym. At the age of 39 he was investigated for
infertility and was diagnosed to have Klinefelter syndrome but his
documentation was not available. He was having three monthly injection of
testosterone. His father died of a myocardial infarction at 50. He had 2
brothers, one of whom required fortnightly treatment for a heart condition.
The other brother was well and refused medical assessment. On examination
the patient had gyaecomastia, abdominal obesity and tiny testicles on scrotal
ultrasound (8x8x7 mm on the right and 11x10x7 mm on the left). There was
a late crescendo systolic murmur in the mitral area on auscultation. His
echocardiogram showed symmetrical 17 mm LVH with mild diastolic
dysfunction and a mildly enlarged left atrium. Cytogenetic study confirmed
XXY karotype. Further history was obtained after reviewing his
echocardiographic findings. The patient revealed that he had hypohydrosis,
distal neuropathic pain, tinnitus and a long history of abdominal pain with
diarrhorea after meals since childhood. The patient's symptoms with his
suggestive family history and symmetrical LVH raised the possibilty of Fabry

24
Ablation with Absolute Alcohol in Cardiac Vein
TK Tam
Prince of Wales Hospital, Hong Kong
Background: PVCs originating from left ventricular summits are difficult
to be treated with traditional endocardial or epicardial catheter ablation.
Case: A 53-year-old male with history of non-ischemic dilated
cardiomyopathy was noted to have monomorphic PVC possibly contributing
to his poor ejection fraction of 18%. He agreed for electrophysiology study
and ablation for his PVC. EP study was performed with Carto electroanatomical mapping system. Spontaneous monomorphic PVCs with an inferior
axis, transition at V3 and slurred upstroke, QS complex in lead I were recorded.
The morphology suggests possible exit from left ventricular summit. Pace
mapping with ablation catheter in RVOT and aortic cusps did not match
with the PVC morphology. Mapping at distal great cardiac vein showed good
but not perfect pace map, local signal around 30 msec preceding PVC.
Ablation with irrigation ablation catheter at this site fail to suppress the PVC.
Detailed mapping with coronary wire shielded with a microcatheter (finecross
catheter) showed excellent pacing mapping at a branch of distal coronary
vein, with local unipolar signal preceeding PVC by 40 msec suggesting a
promising site for ablation. However, ablation catheter, with its large caliber,
cannot reach this small venous branch. Decision was made for ablation with
absolute alcohol. With a monorail 2.0 mm balloon to occlude the vien,
2.5 mL of absolute alcohol was slowly injected into this venous branch. Slow
run of idioventricular rhythm was resulted. After that PVCs were noninducible. Post procedure echocardiogram confirmed absence of pericardial
effusion.
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disease with cardiomyopathy despite his XXY karotype. Fabry disease is a
sex-linked recessive mutation involving the alpha- galactosidase (α-gal) A
gene. The diagnosis was confirmed with his low leucocyte alphagalactosidase level (0.04 nmol/min/mg, NL 0.7-3.3). His brother also had
a low α-gal level with an XY karotype. Female carriers with Fabry disease
often have minimal symptoms and an intermediate to near normal α-gal
enzyme level. This patient with Kleinfelter syndrome with XXY karotype
had a very low α-gal level with clinical manifestations of Fabry disease and
cardiomyopathy indicating that he was homozygous for the X-linked recessive
mutation. This is a unique case of Kleinfelter syndrome with XXY karotype
and concomitant recessive sex-linked mutation in the α-galactosidase gene.
Non-dysjunction of the X chromosome must have occured at meiosis II to
account for the patient's homozygous state resulting in a low α-gal enzyme
level. If this patient was a heterozygote he would have a much higher enzyme
level with minimal symptoms and he might not have significant
cardiomyopathy.

Decision-making: Because the PVCs were not suppressed by endocardial
ablation, epicardial approach can be considered. Yet usually LV summit is
hidden beneath a thick fat pad, making it inaccessible via epicardial route.
Because of excellent pace mapping and well preceded local signal, ablation
with absolute alcohol guarded by a balloon to prevent spill over was decided.
Conclusion: Ablation with absolute alcohol in coronary veins is a potential
approach for selected PVC cases if endocardial approach fails.
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An Obstacle in the Way
JWL Poon,1 E Lo,1 K Chan,2 CY Yung,1 KL Lee,1 YK Lau1
1
Ruttonjee Hospital; 2University of Hong Kong, Hong Kong
Background: Pheochromocytoma could have cardiovascular manifestations
mimicking cardiomyopathies. We present a case of pheochromocytoma
presenting with features suggestive of hypertrophic obstructive
cardiomyopathy (HOCM), which completely resolved after curative therapy
of pheochromocytoma.
Case: A fifty-one years old lady with good past health was admitted for
headache, palpitation and chest discomfort. She was hemodynamically stable.
Physical examination revealed loud ejection systolic murmur over left lower
sternal border. ECG showed normal sinus rhythm and left ventricular strain
pattern. She developed episodic hypertension after admission, with blood
pressure rising up to 210/120 mmHg. Echocardiogram (ECHO) showed
features suggestive of HOCM. There was concentric left ventricular
hypertrophy (LVH) with interventricular septum and posterior wall thickness
measuring up to 1.7 cm, systolic anterior motion (SAM) of mitral valve leaflet
and left ventricular outflow tract (LVOT) obstruction. The LVOT peak
gradient was 90 mmHg. Pheochromocytoma was suspected and the patient
was given phenoxybenzamine followed by betablocker. 24-hour urine
catecholamines were elevated. Abdominal ultrasound showed a mixed solid/
cystic lesion adrenal tumor. Computed tomography of abdomen showed
a 4.7x4.8x4.5 cm circumscribed left adrenal hypervascular mass.

63
Mitral Annulus Disjunction: More Than Just the Valve
TS Wong, CY Yung, KL Lee
Department of M&G, Ruttonjee Hospital, Hong Kong
Background: Mitral Annulus Disjunction (MAD) Arrhythmic Syndrome is
a condition that should be consider in patient presenting with ventricular
arrhythmia / SCD. We described a case of MAD presented with VF arrest
and its subsequent management.
Case: Mr S is a 40-year-old gentleman who travel to HK from Canada for
business. He has history of palpitation and was previously seen by a
cardiologist in Canada. Screening ECG has shown frequent PVC and
echocardiogram has revealed a prolapsed mitral valve with mild regurgitation.
He present to us with VF arrest that required in total 7 defibrillation shock
with a downtime of 38 minutes. Diffused ST depression was noted on initial
ECG. Echocardiogram on admission has shown a heart with poor LVEF of
20% and MVP with mild MR. Urgent coronary angiogram was done showing
a normal coronary vasculature. Cardiac MRI revealed a dilated LV with global
hypokinesia, there was no abnormal tissue signal or LGE. Evidence of mitral
annulus disjunction was noted on both echocardiography and CMR upon
image review (See figure). Mr S was put on bisoprolol and a single chamber
ICD was implanted. His ejection fraction has improved to 50% on subsequent
echocardiogram.
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Metaiodobenzylguanidine (MIBG) scan showed findings suggestive of
pheochromocytoma. Laparoscopic adrenalectomy was performed. Followup echo several months after surgery showed complete resolution of LVH
and SAM. The patient remained well at follow-up.
Decision-making: Pheochromocytoma could present with features mimicking
HOCM. The presence of paroxysmal headache and hypertensive crisis should
raise the suspicion of this condition. A detailed history taking, dedicated
examination and relevant investigations are of utmost importance for accurate
diagnosis and appropriate management. It is crucial to recognize
pheochromocytoma as the cause of HOCM-like phenotype, because
administration of betablockers, which is the standard treatment for HOCM,
could be disastrous if they were given before adequate alpha blockade. Lastly,
it is noteworthy that HOCM-like features could resolve completely after
removal of pheochromocytoma. Follow-up echo is essential to avoid
misdiagnosis of HOCM which could lead to inappropriate decision of
implantable cardioverter defibrillator implantation.
Conclusion: Early recognition of pheochromocytoma as a cause of HOCMlike phenotype is important. Hypertrophic obstructive cardiomyopathy-like
features could resolve completely after removal of the pheochromocytoma.

Decision-making: On initial presentation, our working diagnosis was that
of an ischaemia-related arrhythmic event causing the VF arrest. However,
this was quickly call into doubt by the normal coronary angiogram. In a
young patient without any known family history of SCD / Risk factor for
atherosclerotic heart disease, the diagnosis of myocarditis will also need to
be contemplated. Readily available CMR imaging has facilitated us in ruling
out this diagnosis by using the Lake-Louise Criteria (Myocardial oedema,
hyperaemia and fibrosis). It also allowed the recognition of the presence of a
MAD that might otherwise be missed. Although genetic testing was not
available, there is no evidence of channelopathy from history and on ECG.
As there is no definitive treatment for this condition, a single chamber ICD
was implanted after thorough discussion with the patient for secondary
prevention.
Conclusion: Mitral Annulus Disjunction Arrhythmic Syndrome is an entity
that should be considered in patient presenting with ventricular arrhythmic
event.
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A Neurogenic Block
S Ching, SCS Yue
United Christian Hospital, Hong Kong
Background: Seizure may masquerade as conduction block. We describe
the first case in the literature of high-grade atrioventricular block due to
complex partial seizure in a patient with herpes encephalitis.
Case: A 57-year-old man presented with recurrent syncope. He had had
malaise and flu-like illness days prior. Telemetry showed intermittent highgrade atrioventricular block. While he was prepared for pacemaker
implantation, he became febrile, confused and had two complex partial
seizures coinciding with occurrence of high-grade block. Cerebrospinal fluid
tested positive for herpes simplex virus type 1. Magnetic resonance imaging
(MRI) of the brain revealed swelling and FLAIR hyperintense signals at left
temporal lobe and limbic region. Electroencephalography (EEG) was
compatible with left temporal lobe seizure. Following initiation of valproate
and acyclovir, he remained seizure-free, and made a complete neurologic
recovery. Telemetry showed complete resolution of atrioventricular block. A
Holter recording four weeks after discharge was also normal.
Decision-making: Development of atrioventricular block is rare at time of
seizure, having been reportedly only several times in the literature and never
for herpes encephalitis. In the absence of EEG correlation, it is difficult to
discern from cardiogenic syncope, where arrhythmia is the primary event
leading to impaired consciousness. The diagnosis becomes challenging when

102
Just Another PE?
S Ching,1 D Lo,1 SCS Yue,1 R Fung2
1
United Christian Hospital; 2Grantham Hospital, Hong Kong
Background: Chronic thromboembolic pulmonary hypertension is an
infrequent complication of pulmonary embolism, but its mimickers are lesser
known. We report a case of presumed pulmonary embolism refractory to
treatment, the identity of which was only unveiled following surgery.
Case: A 67-year-old woman was evaluated for non-resolving pulmonary
embolism. Four years prior to presentation, she underwent pancreatectomy
for a benign cystic tumor. Postoperative computed tomography (CT)
incidentally found filling defect in the right pulmonary artery, for which she
was anticoagulated for presumably asymptomatic perioperative pulmonary
embolism. Meanwhile, she was diagnosed and being treated for
mycobacterium avium intracellulare (MAI) pulmonary infection. Subsequent
CT showed progression of filling defect to involve the left and main pulmonary
artery despite adequate anticoagulation. Echocardiogram showed worsening
right ventricular systolic function and severe pulmonary hypertension. She
became hypotensive with poor organ perfusion requiring ionotropic support.
The cardiothoracic service was consulted for pulmonary endarterectomy.
Decision-making: Pulmonary angiogram confirmed total occlusion of the
right pulmonary artery. Position emission tomography (PET) with
fludeoxyglucose (FDG) was obtained to exclude malignancy before major
surgery, which showed uptake in the filling defect in the pulmonary arteries
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aura is present, such as a rising epigastric discomfort preceding syncope,
which simulates a vasovagal attack. This is particularly true in patients thought
to have cardioinhibitory type of vasovagal syncope, in whom exclusion of
partial seizure should be considered.
Conclusion: Seizure may mimic atrioventricular block both symptomatically
and electrocardiographically. There should be a low threshold to obtain EEG
correlation.

as well as in cavitary lesions in the right lung raising the suspicion of septic
embolism from MAI infection. Pulmonary endarterectomy was performed
under deep hypothermic arrest. A yellowish white mass was seen extending
from right ventricular outflow tract to the pulmonary arteries. Unexpectedly,
pathology revealed pulmonary artery intimal sarcoma, a rare tumor arising
from the intima of the pulmonary artery that carries a poor prognosis. Mean
survival is 11 months. An unusual attribute of this case is that the tumor
progressed slowly over a period of four years, though lead-time bias is also
possible. The concurrent MAI infection complicated the interpretation of
the PET study. The rarity of pulmonary artery intimal sarcoma makes noninvasive diagnosis challenging. FDG-PET and magnetic resonance imaging
(MRI) are two modalities often found useful but data on test performance is
limited.
Conclusion: Pulmonary embolism refractory to anticoagulation should trigger
a search for alternative etiologies. FDG-PET and MRI may be useful for
diagnosis.
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Effect of Percutaneous Interventional Treatment for Pulmonary
Branch Stenosis in Children
CP Sun
Guangdong Cardiovascular Institute, Guangzhou, China
Objective: To evaluate the safety and curative effect of percutaneous
interventional treatment for pulmonary branch stenosis in children.
Methods: This is retrospective clinical study including 40 children were
treated with percutaneous interventional treatment for pulmonary branch
stenosis from January 2012 to December 2017 in Guangdong Cardiovascular
Institute. The general clinical data, echocardiography, cardiac CT,
angiography, interventional results, the procedure-related complications,
follow-up result were particularly assessed.
Results: A total of 40 patients consisting of 28 boys and 12 girls underwent
the procedure, with mean age (4.7±3.6) years (range from 1 to 17 years).
Including 16 patients were accepted balloon angioplasty and 6 patients are
accepted covered stent implantation. The catheter-measured peak systolic
the narrowest aortic gradient was successfully relieved in all the patients,
the diameter were increasing greatly. The follow-up period was 1 month to 5
years. The blood flow was unobstructed int the stent, but there was a case of
thrombosis int the stent. The peak systolic valve gradient was no significant
increasing, that measured by Doppler echocardiography during the followup of balloon angioplasty.
Conclusion: Percutaneous balloon angioplasty and stent implantation have
reliably effect and high security for children's pulmonary branch stenosis.

27
Follow Up Outcomes and Risk Factors of Complete Left Bundle
Branch Block after Transcatheter Closure of Perimembranous
Ventricular Septal Defect in Children
C Wang, K Zhou, Y Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, China
Backgrounds: The incidence of complete atrioventricular block after
transcatheter closure of perimembranous ventricular septal defect (VSD) has
been remarkably decreased. However, post-procedure complete left bundle
branch block (CLBBB) remains to be an issue of concern since it may lead to
left ventricular dysfunction. Data regarding prognostic implications of postprocedure CLBBB is lacking.
Objectives: The present study intended to determine the overall incidence,
risk factors and follow up outcomes of CLBBB after transcatheter closure of
perimembranous VSD in children.
Methods: All available clinical and follow-up data of children with CLBBB
after transcatheter closure of perimembranous VSD using modified symmetric
double-disk occluders between January 2005 and December 2017 were
retrospectively reviewed, and were compared with that of children without
arrhythmias.
Results: CLBBB after transcatheter closure of perimembranous VSD occurred
in 57 cases, with an incidence of 2.70% (57/2114). Fifty-five cases developed
CLBBB within 2 weeks post procedure and most of them (51/55) recovered
to normal conduction or reverted to other types of bundle branch block three
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weeks post operation after steroids treatment. Late-onset and reversible
CLBBB were observed in 2 and 2 cases, respectively. Persistent CLBBB
was presented in 8 cases. One of them suffered from heart failure and received
cardiac resynchronization therapy. Larger occluder size and delivery sheath
diameter were identified as independent risk factors for occurrence of CLBBB.
The later CLBBB occurred, the less likely it would recover to normal
conduction. Reversible CLBBB was another risk factor for persistence.
Conclusions: The overall incidence of CLBBB after transcatheter closure of
perimembranous VSD was relatively low and the outcome was satisfactory.
Close follow-up needs to be applied since late-onset and reversible CLBBB
could occur, and persistent CLBBB could result in heart failure. Oversized
occluder and delivery sheath should be avoided.
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Hybrid Procedure for Pulmonary Atresia with Intact Ventricular
Septum in Neonate
X Li,1 J Liao,1 L Sun,2 J Huang,2 H Huang1
1
Department of Cardiothoracic Surgery; 2 Department of Cardiology,
Children's Hospital, Soochow University, Suzhou, China
Background: Pulmonary Atresia with Intact Ventricular Septum (PA IVS)
accounts for 2.5% of critically ill infants with congenital heart disease. The
percutaneous transcatheter approach has a variable rate of procedural failure
and most of patients require subsequent operation in the neonatal period.
The surgical approach under cardiopulmonary bypass (CPB) carries a high
mortality. The hybrid approach consisting of a sternotomy followed by
perventricular pulmonary valve perforation and balloon dilation has an
important advantage of avoiding cardiopulmonary bypass (CPB) in neonate.
Methods: Retrospective review of consecutive neonates with PA IVS who
underwent a hybrid procedure between September 2016 and September 2018
in our institute was completed. The acute and mid-term outcomes were also
reviewed.
Results: Six consecutive neonates with PA IVS with prospected bi-ventricular
circulation underwent a hybrid procedure. Median age at operation was 4.5
days (2-10 days). Median body weight was 3 kg (2.1-3.7 kg). Before operation,
all the patients had been stablized with prostaglandin E1 (PGE1) infusion
and two patients required mechanical ventilation together with inotropic
support. The procedure was technically successful in all patients, and none

73
Fetal Pulmonary Valvuloplasty for Pulmonary Atresia with Intact
Ventricular Septum in 10 Cases
S Pan
Qingdao Women and Children’s Hospital, Qingdao, China
Background: To summarize and evaluate the clinical effect of ultrasoundguided fetal pulmonary valvuloplasty (FPV) in the treatment of intrauterine
pulmonary atresia with intact ventricular septum (PA/IVS).
Methods: From July 2018 to January 2019, 10 PA/IVS fetuses were
successfully operated on by FPV in our center. The median gestational age
was 27+3 weeks (26+2~28+4 weeks). To summarize and analyze the changes
of the morphological and functional parameters, complications and fetal
postnatal outcomes.
Results: All 10 PA/IVS fetuses were successfully operated on by FPV under
combined intravenous and inhalation anesthesia. The transvalvular forward
blood flow was observed immediately after operation by echocardiography.
The technical success rate was 100%. Transient bradycardia and a little
pericardial effusion were observed during the operation. Adrenaline was
injected into the right atrium of some fetuses.In case 8, sustained fetal
bradycardia accompanied by increased pericardial effusion occurred 3 days
after operation. Pregnancy was terminated. The remaining 9 fetuses were
followed up for 2 weeks. Echocardiographic findings showed that the fetal
ratio of the tricuspid valve annulus and mitral valve annulus, ratio of the
length diameter right ventricle and left ventricle, ratio of pulmonary valve
annulus and aortic valve annulus, ratio of the tricuspid inflow duration and

J HK Coll Cardiol, Vol 27

required CPB. Ductus was ligated in two patients at the time of initial hybrid
procedure (including one patient had a simultaneous modified Blalock-Taussig
shunt). In the rest 4 patients, PGE1 infusion was maintained to keep the
ductus opening after the procedure until an acceptable forward blood flow
from the right ventricle to the pulmonary artery was detected by serial
echocardiography. In one patient, stenting of the ductus was done on
postoperative day 12 and this was subsequently ligated after 13 days. One
patient died on postoperative day 2 due to sudden cardiac arrest. In the early
postoperative period, two patients required peritoneal dialysis. The median
ventilation time, ICU stay and hospital stay was 4, 14 and 21 days respectively
for the survivors. Follow-up was completed for all survived patients (median
follow-up time 8-30 months). Three patients were followed up more than
two years, all achieved bi-ventricular status. No further intervention was
required.
Conclusions: Hybrid Perventricular balloon pulmonary valvotomy is a safe,
effective and reproducible approach for PA IVS in neonate. Maintaining the
ductus opening for the time being is important for babies to get through the
early postoperative critical phase.

cardiac cycle increased from 0.81 (0.44-0.88), 0.56 (0.52-0.80), 0.69 (0.581.00), 0.35 (0.26-0.43) to 0.92 (0.80-1.08), 0.83 (0.68-0.88), 0.98 (0.85-0.1),
0.45 (0.37-0.53), the difference was statistically significant (P<0.05). The
tricuspid regurgitation was improved by 3.9 m/s (3.2-4.6 m/s) to 3.2m/s (2.64.0 m/s) compared with that pre-operation, and the difference was statistically
significant (P<0.05). Follow-up for 4 weeks, echocardiography showed
coronary artery circulationcdependent on right ventricle in csae 4, indicating
poor prognosis and termination of pregnancy. Three fetuses were followed
up to full-term for cesarean section and delivery. Case 1 had hypoxemia
after birth. Percutaneous pulmonary valvuloplasty and arterial canal stenting
were performed successively. Case 2 and case 3 were achieved biventricular
circulation. Follow-up for 1-2months is still to be observed for further
treatment. The other fetuses were followed up regularly, and the related right
ventricular indexes did not deteriorate.
Conclusions: FPV for PA/IVS fetuses in the second and third trimesters of
pregnancy is safe. It can effectively decompress the right ventricle and
promote the development of the right ventricle. Bradycardia is the main
complication leading to death after operation. It is possible for PA/IVS fetuses
to increase biventricular circulation after birth, and even avoid early surgical
intervention.
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Tricuspidization with Continuous Autologous Pericardium for
Aortic Valve Reconstruction in Children
W Zhang, B Jia
Cardiovascular Center, Children's Hospital of Fudan University, Shanghai,
China

Conclusion: Our new simplified tricuspidization way offers reliable and
competent new pericardial valve function in case of valve replacement or
ROSS operation in early age. This technology employs a simple measurement
and reproducible process. It should be further assessed on valve function and
pericardial calcification issues.

Background: To find a simplified aortic valve reconstruction way with
autologous pericardium in children.
Metheds: From April 2014 to August 2018, aortic valve reconstruction with
continuous autologous pericardium was performed in 6 patients aged less
than ten years. There were 2 patients with aortic regurgitation, 3 patients
with aortic stenosis, 1 patient with aortic stenosis and aortic regurgitation.
The surgical procedure is based on the independent tricuspid using autologous
pericardium. Firstly, pericardial patch was tailored into three continuous aortic
valve cusps by using template while the aortic annular was divided equally
into three parts, and landmarks were noted. The continuous cusps were fixed
to the noted position of aortic annular and then sutured from bottom to both
sides in order. Lastly the commissure were reconstructed by suturing out
aortic wall separately and then tieing.
Results: There was no in-hospital death. Postoperative echocardiography
showed an average peak pressure gradient of 22.0±13.9 mmHg 3 month after
surgery while that of 107.3±20.6 mmHg before surgery. All the six patients
showed less than mild aortic regurgitation. No patient required reoperation
during the follow-up.

105
Initial Experience of Transcatheter Closure of Doubly Committed
Subarterial Ventricular Septal Defect Using Amplatzer Duct
Occluder II
C Tang, C Wang, K Zhou, Y Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, Sichuan, China

Conclusion: Transcatheter closure of small doubly committed subarterial
VSD with ADO-II is technically feasible and safe in selected children.
However, development or worsening of aortic regurgitation requires longterm follow-up.

Backgrounds: The traditional treatment of doubly committed subarterial
ventricular septal defect (VSD) is open-heart surgery. This study aimed to
evaluate the feasibility, safety and outcome of transcatheter closure using
Amplatzer duct occluder II.
Methods: Between January 2016 and December 2018, a total of 12 patients
(8 male and 4 female) with doubly committed subarterial VSD who received
transcatheter closure with ADO-II were enrolled retrospectively. All their
available clinical and follow-up data were evaluated.
Results: Their age ranged from 1.7 to 12.7 years, with the median of 4.9
years and their body weight ranged from 10 to 36 kg, with the median of
17.7 kg. Left ventricular angiography showed VSD size ranged from 1.5 to
3.0 mm. The device was successfully implanted in 11 patients
(11/12, 91.67%) and 1 patient failed to be closed due to severe aortic
regurgitation after device deployment, with 4 patients by antegrade approach
and 8 patients by retrograde approach. The operation time ranged from 20 to
75 minutes, with a median of 45.2 minutes. The diameter of device used
ranged from 3/4, 4/4 and 5/4. With a follow-up duration of 3 to 18 months,
only 1 patient presented with new-onset mild aortic regurgitation.
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Incidence and Prognosis of Femoral Arteriovenous Fistula after
Cardiac Catheterization in Children: Single-center Experience
Q Li
Shantou University Medical College; Guangdong Cardiovascular Institute;
Guangdong Provincial People's Hospital, Guangzhou, China
Background: Femoral arteriovenous fistula (FAVF) is one of the most
common detrimental complications following cardiac catheterization in
children, which leads to anxiety in their parents and the clinician as well.
Our study is to find out the incidence of FAVF, and follow up of the outcome
of FAVF.
Method: Between October 2016 and September 2018, 4131 children (<18year-old) who underwent cardiac catheterization examination or intervention
therapy were included in this study. New occurred continuous murmur in
the inguinal region was recognized by auscultation and then a color doppler
ultrasonography was done to confirm the diagnosis of the FAVF after the
procedure. When FAVF was once recognized, patient may receive
compression bandaging for 2 to 7 days. Follow-up studies was done for those
with FAVF.
Results: 22 children were certainly diagnosed with FAVF. The incidence of
FAVF following cardiac catheterization in children is 0.5% in this study. The
average size of all FAVF is 1.71 (±0.12) mm measured by doppler
ultrasonography and 95.5% (21/22) of all FAVF is less than 3 mm. Of all
FAVF, 77.3% (17/22) was spontaneously closed in 5.24 (±1.41) months,
9.1% (2/22) was found smaller in size in 6 to 12 months and still being

110
Cardiac Transplantation in Pediatric Patients − A Report of Five
Cases
JL Li
Guangdong Cardiovascular Institute, China

followed up.13.6% (3/22) patients with FAVF underwent surgical repair, one
of them was due to a big size (3 mm) FAVF with a pseudoaneurysm, two of
them was because of the anxiety of their parents. None of the patients with
FAVF has severe complications because of FAVF during follow-up, such as
cyanosis, lower limbs swelling and so on.
Conclusion: The incidence of FAVF following cardiac catheterization in
children is lower compare to the researches in adults reported at home and
abroad. Most of all AVF in this study have favorable prognosis and have a
tendency to close spontaneously. If the size of FAVF is less than 3 mm and
there is no sever complications, continuing follow-up is suggested. If the
size FAVF is more than 3 mm, surgery repair is recommended when the
condition of wound is stable.

Conclusions: Technical success rate and short-term pediatric heart transplant
results at our institution were quite satisfactory. Close follow-up is needed
to evaluate long-term prognosis and survival quality of these patients.

Background: Cardiac transplantation remains the gold standard for end-stage
cardiomyopathies and congenital heart diseases in pediatric patients. By the
end of 2016, a total of 2,149 patients had undergone cardiac transplantation
in China, 103 of them younger than 18 years old.
Objective: To review records of 5 children under 14 years old who underwent
cardiac transplantation last year at our institution and reveal the outcome of
short-term follow-up.
Methods: 5 patients received cardiac transplantation at our institution from
March 2018 to February 2019 have been involved. Three of them were girls
and 2 were boys, whose age ranged from 6 to 13 and body weight ranged
from 15 kg to 37 kg. Their principle diagnoses were dilated cardiomyopathy
in 4 patients and restricted cardiomyopathy in 1. All patients were recognized
as heart function grade IV (NYHF Classification) and underwent orthotopic
heart transplantation.
Results: All patients survived. The average clamping time was 93 minutes,
CPB time 217 minutes, and the mean cold ischemic time was 220 minutes.
Average intubation time, ICU time and postoperative hospitalization time
was 5.6, 11.6 and 26.2 days, respectively. Two patients needed ECMO support
after surgery. Tacrolimus, mycophenolate mofetil and methylprednisolone
have been routinely prescribed for anti-rejection purpose. All patients’ heart
function had been improved to grade I-II (NYHF Classification) by the end
of following-up from 1 month to 1 year.
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Outcome of Fontan conversion in patients with failing Fontan
circulation
MY Cheng,1 TC Yung,1 SY Kwok,1 HS Chen,1 KS Lun,1 N Yam,2 BA Rocha,2
WK Au,2 PC Chow,1 S Tsao1
1
Department of Paediatric Cardiology; 2Department of Cardiothoracic Surgery,
Queen Mary Hospital, Hong Kong
Objectives: We reported the outcomes of conversion to extracardiac Fontan
circuit with arrhythmia surgery from previous atriopulmonary Fontan
connection in patients with failing Fontan circulation.
Methods: Between August 2012 to August 2017, 11 patients who had failing
Fontan circulation and development of atrial arrhythmias underwent
conversion from atriopulmonary Fontan to fenestrated extracardiac Fontan
circuit combined with atrial arrhythmia surgery and implantation of an
epicardial dual chamber pacemaker. Before Fontan conversion surgery,
3 patients were classified as New York Heart Association Class (NYHA) class
II and 8 as class III. Ten patients (91%) had diagnosis of tricuspid atresia. The
mean age at the initial Fontan procedure was 6.5±4.4 years (range, 2 to 16
years). The median age at Fontan conversion was 27.4±7.1 years (range, 17
to 39 years), and the median interval between initial operation to Fontan
conversion was 19.9±5.4 years (range, 13 to 29 years). The median followup period was 4.5 years (range, 1.5 to 6.5 years).
Results: There was no operative death and no late death. The median
postoperative hospital stay was 22 days (range, 12 to 50 days). Early
postoperative complications included: acute renal failure (n =1), prolonged /

135
Clinical Characteristics and Treatment of Congenital Vascular
Rings in 78 Infants
J Rao, S Sun, H Li, Q Liu, J Huang, W Xu
Guangdong Women and Children Hospital, Guangzhou, China
Objective: To summarize the clinical characteristics and treatment effect of
congenital vascular rings in infants.
Method: The clinical data of 78 children with vascular rings were
retrospectively analyzed from August 2011 to June 2018 at our center for
surgical treatment.
Result: Age is from 2 days to 11 months, the median age is 22 days. weight
is from 1.4 to 9.2 kg, the average weight is 4.80±2.15 kg. The types of vascular
ring includes 41 cases of double aortic arch, right aortic arch with left aortic
duct / ligament with or without vagal left subclavian artery in 20 cases, 15
cases of pulmonary artery Sling, 6 cases of left aortic arch with right aortic
duct / ligament, 3 cases of nameless arterial compression syndrome, 2 cases
of other types of vascular rings. All cases underwent echocardiography, chest
radiography, and Cardiac Computed Tomography, and 66 cases were
examined by bronchoscopy before operation or intraoperative. Sixty-one cases
(78%) have been confirmed with tracheal stenosis.
Result: 30 patients underwent surgery with an average extracorporeal
circulation time of 160±61 min and 48 patients underwent extracorporeal
circulation. Postoperative mechanical ventilation 1 to 22 days, the median
number of days 2 days; hospitalization time 5 to 62 days, the median of 10
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recurrent pleural effusion (n=3), haemothorax (n=1), recurrent atrial
arrhythmias (n=5), seizure (n=1). Follow-up haemodynamic study was
performed in 10 patients more than 1 year after the operation. There was
significant improvement in: Fontan circuit pressure, ventricular end diastolic
pressure, pulmonary vascular resistance index and cardiac index (12.9±2.2
vs 10.1±2.0 mmHg, 12.9±2.2 vs 10.1±2.0 mmHg, 1.8±1.3 vs 0.9±0.6 WU.
m2, 1.9±0.6 vs 3.3±1.2 L/min/m2 respectively, all were statistically significant,
P<0.05). While the left ventricular ejection fraction remained similar to before
Fontan conversion (63.0±12.4% vs 66±9.5 %, P>0.05). At the last followup, the resting heart rhythm were sinus (n=1), intermittent /persistent atrial
pacing (n=9), ventricular pacing (n=1). Atrial arrhythmias recurred in 4
patients (36%), severe protein losing enteropathy (PLE) occurred in 1 patient.
Nine patients had improvement in NYHA class. One patient had no change
and 1 had worsening of NYHA class. These 2 patients, including the one
with PLE had attempts of transcatheter balloon dilation of extracardiac circuit
fenestration to improve the haemodynamics.
Conclusions: Fontan conversion with arrhythmia surgery in selected patients
with failing Fontan circulation can be performed with low morbidity and
mortality. Most patients benefited from the operation with improvement in
cardiac output, exercise capacity and satisfactory control of atrial arrhythmias.

days, hospital death in 3 cases (3.8%). Discharge patients were followed up
for 1 to 90 months, respiratory symptoms disappeared or improved
Significantly.
Conclusion: Airway stenosis is a serious complication of the vascular ring.
CT is the best way to diagnose vascular ring. To avoid serious airway
complications, the vascular ring should be operated as soon as possible, and
the airway stenosis and intracardiac malformation should be operated at the
same time, this can improve the survival rate of surgery and improve the
prognosis of children.
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A Prediction Model of Kawasaki Disease
X Tan,1 H Wang,2 W Zhao,1 B Pan,1 L Liu,1 X Huang,3 J Tian1
1
Department of Cardiology, Heart Centre, The Children's Hospital of
Chongqing Medical University, Chongqing, China; Ministry of Education
Key Laboratory of Child Development and Disorders, Key Laboratory of
Pediatrics in Chongqing, Chongqing International Science and Technology
Cooperation Center for Child Development and Disorders, 136 Zhongshan
2nd Road, Yu Zhong District, Chongqing 400014, PR China; 2College of
Medical Informatics, Chongqing Medical University, Chongqing 400016,
China; 3Department of Biomedical Science, Charlie E. Schmidt College of
Medicine, Florida Atlantic University, Boca Raton, FL, USA.

Results: A total of 10367 subjects were enrolled in this study, including
5642 cases (54.4%) of KD and 4725 other febrile diseases (45.6%).
Multivariate regression analysis showed that the independent risk factors
were C-reactive protein (CRP), Percentage of lymphocyte (P-LYM),
Percentage of monocytes (P-MON), Platelet count (PLT), Uric acid (UA),
Globulin (GLB), Prealbumin(PALB), Lactic dehydrogenase (LDH), Aspartate
aminotransferase/Alanine transaminase (AST/ALT) and age. A prediction
model was built, with an AUC of 0.90, sensitivity of 83% and specificity of
84%.
Conclusions: Our study suggests that using of CRP, P-LYM, P-MON, PLT,
UA, GLB, PALB, LDH, AST/ALT and age is accessible to evaluate
individual's risk of KD.

Background: Kawasaki disease (KD) is an acute autoimmune systemic
vasculitis disease of unknown etiology. At present, diagnosis of KD is strongly
relied on non-specific clinical symptoms. Accurate, efficient and objective
evaluation of individual’s risk of KD is critical for preventing childhood
from acquired heart disease. This study was aimed to investigate the
independent risk factors and build a model for predicting KD.
Methods: The patients with KD and other 13 kinds of febrile diseases who
were hospitalized in Chongqing Children’s Hospital from October 2007 to
December 2017 were retrospectively reviewed. The demographic
characteristics and laboratory data were collected and then compared between
KD group and other febrile diseases group. The independent risk factors were
further obtained using multivariate regression analysis. A prediction model
was built. Receiver operating characteristic (ROC) curve and the area under
the curve (AUC) were used to evaluate the predictive ability, sensitivity and
specificity of the model.

28
Platelet Indicators: New Makers of Severity and Reversibility in
Pulmonary Arterial Hypertension Secondary to Congenital Heart
Disease with Left-to-right Shunt in Children?
F Ma, C Wang, C Tang, K Zhou, Y Hua
West China Second University Hospital of Sichuan University, China
Background: Pulmonary artery hypertension is a serious cardiovascular
disease, and associated with vasoconstriction, thrombotic lesions, extensive
remodeling of the pulmonary circulation and increasing pulmonary vascular
resistance. Previous studies have proved that platelet abnormalities and
abnormal platelet activation are important mediators of PAH progression,
but the effectiveness of platelet indicators in predicting the severity and
reversibility of PAH secondary to congenital heart disease with left to right
shunt in children have rarely been studied. This study aimed to investigate
the platelet indicators in PAH.
Methods: A total of 155 children with CHD who underwent transcatheter
closure or cardiac catheterization, were prospectively recruited from March
2012 to July 2014 at the West China Second University Hospital of Sichuan
University. Patients were divided into five groups: group 1 consisted of 30
children with CHD but no PAH, group 2 contained 51 children with CHD
and mild PAH, group 3 comprised 33 children with CHD and moderate PAH,
group 4 included 31 children with CHD and severe PAH, and group 5
contained 10 children with CHD and irreversible PAH. Platelet counts(PLT),
mean platelet volume(MPV), platelet distribution width(PDW), platelet crit
(PCT) and platelet-larger cell ratio(P-LCR) are compared among groups.
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Results: Comparing with group 1, the group 2, 3 and 4 had no significant
differences in platelet counts and PCT, but had a significant decrease in MPV,
PDW and P-LCR. In group 5, a significant decrease in platelet counts was
found, and a significant increase in MPV, PDW and P-LCR was noted when
comparing with group 1. In comparison among group 2, group 3 and group 4,
three PAH group in different degrees, we found that these platelet indicators
had no significant differences among these groups except MPV and P-LCR
decreased in group 2 when comparing with group 1. When group 4 and group
5, we found a significant decrease of platelet counts in group 5, but MPV,
PDW and P-LCR was significant increased in group 5. Pearson's correlation
test found significant negative linear correlation between PAP, PVR and
platelet indicators like MPV, PDW and P-LCR and receiver operating
characteristic curve showed the cutoff values of PDW, MPV, P-LCR, and
PLT are 14.6 fL, 11.35 fL, 35.75% and 235.5x109/L.
Conclusion: Platelet indicators might be a new method to evaluate the
progress of PAH and to distinguish irreversible patients from severe PAH
patients.
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Combination of N-terminal Pro-brain Natriuretic Peptide and
Seven Risk-scoring Systems for Intravenous Immunoglobulin
Resistance Prediction of Kawasaki Disease in West China
S Shao, K Zhou, Y Hua, C Wang
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, China
Backgrounds: Data regarding predictive effectiveness of diverse scores on
intravenous immunoglobulin (IVIG) resistance for Kawasaki disease (KD)
in west China is lacking. Addition of specific indicators to current systems
may provide a better performance. This study aimed to testify validity of
Kobayashi, Egami, Sano and four Chinese risk scores in isolation or
combination with N-terminal pro-brain natriuretic peptide (NT-ProBNP) in
predicting IVIG resistance in a population of west China.
Methods: A total of 393 patients with KD were prospectively recruited
between June in 2015 and March in 2018 who had been hospitalized at the
Department of Pediatrics in West China Second University Hospital of
Sichuan University (WCSUH-SCU). The clinical and laboratory data were
compared between IVIG responders (n=339) and IVIG nonresponders (n=54).
The high-risk patients for IVIG resistance were determined by protocols of
Kobayashi, Egami, Sano, Formosa, Tang's, Hua's, and Yang's risk scores.
The predictive value of each risk-scoring system, in isolation or combined
with NT-ProBNP, in predicting IVIG resistance were determined.

57
Clinical Features and Outcomes of Ischemic Cardiomyopathy
Resulted from Kawasaki Disease
Y Wang, X Huang, Z Wang, W Li, X Xie, P Huang, L Zhang
Guangzhou Women and Children's Medical Center, Guangdong, China
Background: Coronary artery aneurysms (CAAs) caused by Kawasaki
disease (KD) can lead to severe complications in childhood. This study was
designed to conclude the clinical features and outcomes of ischemic
cardiomyopathy in KD in a single center.
Methods: The data of patients with ischemic cardiomyopathy resulted from
KD diagnosed between January 2008 and December 2018 in Guangzhou
Women and Children's Medical Center were analyzed retrospectively.
Results: There were ten patients with ischemic cardiomyopathy caused by
KD, including 8 boys and 2 girls with a median age of 38 months. Nine
patients had giant CAAs, and only one had median CAA. Nine children were
administrated with intravenous immunoglobulin (IVIG) in acute or subacute
stage of KD with the initial use on the 7th to 19th day from the onset of
disease. There was a second dose of IVIG application in 2 patients with
IVIG resistance, one of which had a combination treatment with plasma
exchange, and another one was treated with intravenous methylprednisolone
in addition. Aspirin was given to all patients in acute stage and three patients
had clopidogrel therapy in combination. Low molecular weight heparin was
used in one patient with coronary thrombosis in subacute stage. Combined
with aspirin, warfarin was applied for anticoagulation in three children. The
median duration from the onset of KD to ischemic cardiomyopathy was 9.6
months. Three patients once had chest pain and symptoms of cardiac
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Results: Serum NT-ProBNP level of nonresponders was significantly higher
than responders. ROC curve analysis revealed best cut-off value of NTProBNP was 3755 pg/ml (area under the curve=0.64, P<0.001), yielding a
sensitivity of 44.4% and a specificity of 84.1%. The seven models testified
in our population showed low sensitivity (16.7%-61.1%) and moderate/high
specificity (54.0%-94.1%) in IVIG resistance prediction when in isolation.
The parallel test combining NT-ProBNP ≥3755 pg/ml with Formosa or Tang's
models could elevate sensitivity to 72%-74%. Addition of NT-ProBNP ≥3755
pg/ml to all models could increase specificity to more than 90%.
Conclusion: All seven published scores were not ideal for IVIG resistance
prediction of KD in west China. NT-ProBNP might provide additional
information to these models for IVIG resistance prediction in KD patients.

insufficiency and myocardial infarction. The remaining 7 patients had no
symptoms, but there were evidences of myocardial ischemia or arrhythmia
in ECG, heart dysfunction, regional wall motion abnormality or ventricular
aneurysm formation in echocardiography, and coronary artery occlusion in
cardiac CT or angiography. Three patients with symptoms received
thrombolytic therapy with heparin and urokinase, other 7 patients without
symptoms added warfarin and/or clopidogrel as intensive treatment when
ischemic cardiomyopathy was discovered. All patients are alive without any
subjective symptoms and a median follow-up time is 7.6 years. Left ventricle
dysfunction still exists in four patients with the ejection fraction of 40% to
50%. Formation of collateral vessels was found in three patients.
Conclusion: Ischemic cardiomyopathy is one of the most serious
complications of KD and occurs mostly in patients with giant CAA or those
receive delayed IVIG treatment. Most patients had no clinical signs but should
consult the doctor regularly and receive anticoagulation and antiplatelet
therapy standardly. Follow-up may be needed long-term and even life-long.
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The Association Between Alanine Aminotransferase/Aspartate
Aminotransferase Ratio(AST/ALT Ratio) and Kawasaki disease
J Wang, M Chu
Department of Children's Heart Center, The Second Affiliated Hospital and
Yuying Children's Hospital, Institute of Cardiovascular Development and
Translational Medicine, Wenzhou Medical University, Wenzhou, China
Background: Kawasaki disease is a systemic small and medium vascular
vasculitis that primarily occupies the coronary arteries. The primary objective
of this study was to investigate the association between aspartate
aminotransferase to alanine aminotransferase ratio (AST/ALT ratio, AAR)
and IVIG resistance, coronary artery lesions (CAL), coronary artery aneurysm
in (CAA) Kawasaki disease (KD)
Method: We retrospectively studied 2679 children with Kawasaki disease
and divided them into two groups, low-AAR group, and high-AAR group,
with median AAR=1.13 as the dividing line. The differences between the
two groups of laboratory data, clinical manifestations, and coronary artery
damage rates were compared.
Result: In the low-AAR group, the incidence of CAL, CAA after onset 2
weeks, 3-4 weeks and IVIG resistance rate was significantly higher than that
of the high-AAR group (2 weeks: 21.70% vs. 29.46% p<0.001; 1.75% vs.
3.63% p<0.001; 3-4 weeks 17.83% vs. 24.11% p<0.001; 1.52% vs. 3.78%
P=0.003; IVIG resistance 21.71% vs. 29.94% p<0.001 respectively) and
laboratory data, such as C-reactive protein (CRP), Erythrocyte sedimentation

68
Genotype and Phynotype of Chinese Pediatric Patients with
IPAH/HPAH
H Zhang, H Gu
Beijing Anzhen Hospital, China

rate(ESR), White blood cell count (WBC), Glutamyltranspeptidase (GGT),
Bilirubin, Fibrinogen, TT, D-D dimer, Brain natriuretic peptide-, were also
significantly higher than high-AAR group, album and IgG significantly lower
than later, and clinical manifestations were different (Oral Changes: 81.09%
vs. 70.02% p<0.001; rash: 92.33% vs. extremity changes: 80.76%
p<0.001; 75.50% vs. 69.78% p=0.001 respectively).
Conclusions: low-AAR is a useful predictor to the coronary artery damage
and IVIG resistance in Kawasaki disease.

gene screening for pediatric patients with idiopathic pulmonary arterial
hypertension and heritable pulmonary arterial hypertension is recommended,
and more aggressive treatment for mutation carriers are advisable.

The aim of this study was to determine the clinical outcomes of gene mutations
in Chinese pediatric patients with idiopathic and heritable pulmonary arterial
hypertension. We screened gene mutations in 82 pediatric patients visited at
Beijing Anzhen Hospital from 2008 September to 2018 December with
targeted exome kits containing 22 pulmonary arterial hypertension-related
genes. The clinical and hemodynamic characteristics, and outcomes of these
patients were retrospectively analyzed. In a cohort of 82 patients, a total of
39 gene mutations were identified with 25 mutations in BMPR2, 5 mutations
in ACVRL1, 2 mutations in KCNK3, 3 mutations in NOTCH3, 2 mutations
in HTR2B, 1 mutation in ENG and 1 mutation in EIF2AK4. The average age
at diagnosis was 86.4±55.1 months. Forty-eight patients (28 mutation carriers)
underwent cardiac catherization examinations, with the acute vasodilator
testing. Mutation carriers had higher pulmonary vascular resistance index,
and tended to have higher pulmonary arterial pressure and right atrial pressure
than mutation non-carriers. Ten patients responded to acute vasodilator testing
and 9 of them were mutation non-carriers (p=0.001). Although similar
treatments were employed, mutation carriers had higher mortality rates than
mutation non-carriers (p=0.0012). The 1-, 2-, 3- year survival rate of mutation
non-carriers were 95.1%, 87.8%, and 82.5%, respectively, while for mutation
carriers, the proportion were 86.6%, 63.8%, and 52.2%. In conclusion, early

J HK Coll Cardiol, Vol 27

April 2019

45

HK COLLEGE OF CARDIOLOGY, TWENTY-SEVENTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS

PAEDIATRIC CARDIOLOGY II
70
Sulfur Dioxide Inhibits Proliferation of Vascular Smooth Muscle
Cells by Reducing Intracellular pH
Y Wang, X Wang, X Tian, L Zhang, Y Huang, C Tang, J Du, H Jin
Peking University First Hospital, Beijing, China
Background: Aberrant proliferation of VSMCs is an important pathological
feature of vascular injury diseases such as hypertension and atherosclerosis.
Probing into the regulatory mechanisms for the proliferation of VSMCs
proliferation of VSMCs is an important research topic in the field. The
previous studies indicated that SO2 could inhibit VSMCs proliferation, but
the mechanisms remain unclear. In this study we focused on the intracellular
pH pathway to elaborate the molecular mechanism by which SO2 inhibits
the proliferation of VSMCs.
Methods: Rat thoracic aortic smooth muscle cell line A7r5 VSMCs, pHsensitive fluorescent indicator BCECF/AM loads cells, laser confocal
microscopy were used to detect pHi changes of VSMCs. DIDS, a Cl-/HCO3exchanger (anion exchanger, AE) inhibitor, was used and the inhibitory effect
of SO2 on pHi was explored. AE activity was measured by NH4Cl perfusion
method. AE2 sulfenylation were detected by western blot (WB) method. Ki67
protein expression was detected by WB method and CCK8 activity was
measured by colorimetry.

78
Prediction for Intravenous Immunoglobulin Resistance
Combining Genetic Risk Loci Identified from Next Generation
Sequencing and Laboratory data in Kawasaki Disease
L Chen,1 S Song,1 Q Ning,2 J Jia,2 J Zhao,1 L Xie,1 T Xiao,1 M Huang1
Shanghai Children’s Hospital Affiliated to Shanghai Jiaotong University;
2
Shanghai Center for Bioinformation Technology, Shanghai, China

1

Background: Kawasaki disease (KD) is the most common cause of acquired
heart disease. The primary treatment for Kawasaki disease is intravenous
immunoglobulin (IVIG), and there were a substantial proportion of patients
who were resistant to IVIG treatment. However, the mechanism of IVIG
resistance remains unclear and the accuracy of models used to predict IVIG
resistance do not meet the level of clinical expectations.
Methods: We recruited 330 KD patients (50 IVIG non-responders, 280 IVIG
responders) and 105 healthy children to explore the susceptibility loci of
IVIG resistance in Kawasaki disease. A next generation sequencing
technology focused on 4 immune-related pathways and 466 susceptibility
sites found in GWAS studies were performed in all these samples. Then an R
package SNPassoc was used to identify the risk loci and student’s t test was
used to find risk factors associated with IVIG resistance. Finally, a prediction
model of IVIG resistance which combined the identified specific SNP loci
with the laboratory data was built using a random forest classifier.
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Results: 1) SO2 donor could reduce the pHi in VSMCs. The results showed
that compared with the control group, the pHi in VSMCs decreased
by 0.120±0.012, 0.134±0.011 and 0.200±0.020 after 50 µM, 100 µM and
200 µM SO2 donors treatment for 9 minutes, respectively (all p<0.01); 2)
SO2 donor activated AE in VSMCs. The results showed that AE was
significantly activated by the administration of 100 µM and 200 µM SO2
donors (p<0.05 and p<0.01). The pretreatment with 30 ìM AE inhibitor DIDS
for 20 minutes prevented the reducing effect of SO2 on pHi (p<0.01), further
confirming that SO2 could reduce pHi in VSMCs by activating AE; 3) SO2
donor could activate AE by AE2 sulphenylation in VSMCs. The results
showed that the 200 ìM SO2 donor for 9 minutes significantly promoted
AE2 sulphenylation and activated AE (p<0.05 and p<0.01), and the thiol
reductant DTT 0.4 mM reversed the AE2 sulphenylation and AE activation
(p<0.05); 4) SO2 donor reduced pHi by AE activation to inhibit proliferation
of VSMCs. SO2 donor could significantly inhibit PDGF-BB-induced
proliferation of VSMCs (p<0.01). When DIDS blocked AE, SO2 donors could
not inhibit proliferation induced by PDGF-BB in VSMCs any longer.
Conclusion: SO2 donor could reduce the pHi in VSMCs by sulphenylating
AE2 and activating AE, thus inhibiting the proliferation of VSMCs.

Results: A total of 537 significant risk loci were found associated with IVIG
resistance, in which 27 previous published SNPs were confirmed by our data.
Additionally, laboratory factors, like erythrocyte sedimentation rate (ESR),
platelet (PLT), C reactive protein, were significantly different in IVIG
unresponsive and IVIG responsive groups. Using top 9 SNPs and 5 clinical
features, a predictive model of IVIG resistance with an area under the ROC
curve of 0.974 was established.
Conclusions: It is the first study that focuses on immune system in Kawasaki
disease using high-throughput sequencing technology. Our findings provide
a new perspective on the pathogenesis of IVIG resistance and could improve
the accuracy of prediction for IVIG resistance in clinical integrating the
genotype and laboratory data.

April 2019

J HK Coll Cardiol, Vol 27

HK COLLEGE OF CARDIOLOGY, TWENTY-SEVENTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS

PAEDIATRIC CARDIOLOGY II
101
A Clinical Study of Warfarin Combined with Aspirin in the
Treatment of Giant Coronary Artery Aneurysm with Kawasaki
Disease
P Huang,2 Z Peng1
1
Pediatric Branch, Shenzhen Hospital of Southern Medical University;
2
Pediatric Branch, Guangzhou Women and Children's Medical Center, China
Background: To investigate the safety and efficacy of warfarin combined
with aspirin in the treatment of multiple medium-sized and giant coronary
artery aneurysms (GCAA) in kawasaki disease.
Case: Clinical and follow-up data of 45 children diagnosed with kawasaki
disease (KD) complicated with multiple medium-sized and giant coronary
artery aneurysms from April 2014 to December 2018 at guangzhou women
and children's medical center were collected. These children were divided
into two groups. The experimental group received regular oral warfarin
combined with aspirin, with a total of 31 cases, including 27 males and 4
females, aged (3-157) m, with an average age of (44±0.19) m. The
experimental group reached the target international standard value (INR)
within the oral warfarin (2-20) w. In the control group, there were 14 patients
(10 males and 4 females), aged (6-99) m, with an average age of (44±0.71)
m, who were treated only with oral aspirin and clopidogrel for reasons
including family members' inability to accept warfarin and adverse reactions,
difficulty in adjusting INR value in remote families and poor treatment
compliance. The patients were followed up once every 3, 6, 9 and 12 months
to track the general conditions, laboratory examinations, echocardiography,
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electrocardiogram results, and bleeding complications of the two groups.
SPSS 22.0 statistical software was used for statistical analysis of the data.
P<0.05 for the difference was statistically significant.
Decision-making: The number of new blood clots in the experimental group
was lower than that in the control group (=6.310, P<0.05). The number of
new cases of medium and large coronary artery aneurysms in the experimental
group increased slowly (12.90% vs. 14.28%). The number of giant aneurysms
in the experimental group decreased rapidly (23.91% vs. 10.00%). The number
of tumor retraction cases in the experimental group was more than that in the
control group (74.19% compared with 42.85%). No active bleeding, epistaxis,
epistaxis, petechiae and no death occurred in the two groups.
Conclusion: (1) Warfarin combined with aspirin is very safe and effective
in the treatment of kawasaki disease coronary tumor, which can effectively
reduce thrombosis; (2) Compared with oral aspirin or clopidogrel alone,
warfarin combined with aspirin can reduce the number of multiple mediumsized and large coronary artery aneurysms and reduce the diameter of coronary
artery aneurysms; (3) Warfarin combined with aspirin at a regular dose has
fewer side effects and fewer adverse reactions in the treatment of kawasaki
disease.
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Diagnosis and Treatment of Inherited Arrhythmia in Pediatric
Patients − 10-year of Single Center Experience
ZL Li, S Zeng, Z Zhang
Guangdong Cardiovascular Institute, Guangzhou, China
Objective: To analyze and summarize the 10-year single-center diagnosis
and treatment experience of common inherited arrhythmia in pediatric
patients, and to explore the best treatment methods.
Methods: The treatment and follow-up results of 30 cases of pediatric patients,
diagnosed with long QT syndrome (LQTS), Brugada syndrome (BrS),
catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic
cardiomyopathy (HCM), arrhythmogenc right ventricular cardiomyopathy
(ARVC) from January 2008 to December 2018 in the Pediatric Cardiology
Department, Guangdong Provincial People's Hospital were analyzed
retrospectively. Treatment included: drugs,implantable cardioverter
defibrillator (ICD), radiofrequency ablation, and left cardiac sympathetic
denervation. Except for 3 cases of BrS, the remaining 27 cases were admitted
to hospital due to syncope. Through regular outpatient clinic and telephone
follow-up, the general situation of the patients after discharge, the occurrence
of arrhythmia and the working condition of ICD.
Results: Among the 30 patients, the onset age was (129.5±40.16) months.
Nineteen males and 11 females, 19 patients had gene detection and the median
follow-up time was 40 months. Fifteen cases were implanted with ICD and
all survived. Ten cases were treated with drugs and 4 cases died. Three cases
had no special treatment, 1 case died, 2 cases died after refusing treatment
by family members.

19
Clinical Characteristics and Prognosis of NC/C<2 Patients with
Noncompaction Cardiomyopathy
Y Gan
The Chrildren's Hospital of Chongqing Medical Univercity, China

Conclusion: (1) inherited arrhythmia sudden death rate is extremely high;
(2) gene detection is an important means of diagnosis, family screening of
high-risk patients is essential.Especially early and rapid gene detection is
helpful for the diagnosis, treatment and prognosis evaluation of diseases; (3)
primary electrical disease, especially long QT syndrome in the diagnosis,
need to be identified with epilepsy, part can be at the same time, drug treatment
effect is not ideal, ICD is the most effective and most reliable treatment
method, but need to be careful.

Conclusions: Most NC/C<2 noncompaction patients were coexisting cardiac
abnormalities. Outcomes for i-NCC patients with NC/C<2 were better than
NC/C>2 patients. No prognostic factor was found to be statistically important.

Background: Clinical manifestations and prognosis is unclear in NCC
patients with noncompaction to compaction ratio <2. We examined late
outcomes for patients with NCC enrolled in our hospital, divided them
according to the NC/C ratio, analyze the clinical features and prognosis.
Methods: Children in the Children's Hospital of Chongqing Medical
University with NCC who were diagnosed at 0-<16 years of age, between
January 2007 and December 2018. Outcomes for NCC subjects with NC/C
<2 and NC/C>2 were compared with the use of the Kaplan-Meier method.
Propensity-score analysis was used for risk factor adjustment.
Results: During the 10-year period 124 newly diagnosed cases of NCC.
Among them, 47 cases were i-NCC, accounting for 8.1% of the total number
of hospitalized cardiomyopathy patients. A total of 16 patients died during
follow-up. Freedom from death was 68.1% (95% confidence interval [CI],
52.9 to 80.9) for i-NCC patients. The median (interquartile interval) duration
of follow-up was 12 (3-30) months for all cases and 16 (6-36) months for
survivors. No prognostic factor was found to impact statistically on the
prognosis. Compared to NC/C>2 patient, cases with NC/C<2 patient were
low age of diagnosis, and were most diagnosed in recent 5 years. Compared
with patients with NC/C<2, the survival rate of patients with NC/C>2 was
lower than that of patients with NC/C<2 (p=0.022).
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Novel Mutations of CASQ2 in Chinese Children with
Catecholaminergic Polymorphic Ventricular Tachycardia
Q Li, L Gao, Y Yuan, X Xu
Beijing Children's Hospital, Capital Medical University, Beijing, China
Background: Mutations in the CASQ2 gene cause the autosomal recessive
form of catecholaminergic polymorphic ventricular tachycardia (CPVT), a
malignant disease that predisposes young individuals to syncope and sudden
cardiac death. To date, only 24 pathogenic mutations in the CASQ2 gene
have been reported in association with CPVT, but it remains unstudied in the
mainland of Chinese population.
Methods: The clinical characteristics of six Chinese children (three male
patients) provided by Beijing Children's Hospital were investigated. Highthroughput targeted gene panel sequencing was used to screen the gene
mutations. Sanger sequencing was applied to confirm the candidate mutations
in CPVT probands and detect the corresponding sequences in their family
members.
Results: Here, we report six Chinese children from four unrelated families who
satisfied clinical criteria for CPVT. Then using targeted next-generation
sequencing, we identified seven different mutations, with four being novel:
two frameshift mutations c.1074_1075delinsC (p.G359Afs*12), c.1175_1178del
(p.D392Vfs?), a missense mutation c.748C>T (p.R250C), a splicing mutation
(c.838+1G>A), and two reported nonsense/missense mutations c.97C>T
(p.R33*), c.98G>A (p.R33Q) and a splicing mutation (c.532+1G>A) in CASQ2.
Conclusion: To our knowledge, it is the first study of Chinese children with
mutations in the CASQ2 gene. Our work further expands the genetic spectrum
of CASQ2-associated CPVT.

55
The VVI Ventricular Function Assessment in Second-third
Trimester Fetus with Tricuspid Regurgitation
L Hong,1,2 H Cao,1,2 L Zhang,1,2 Q Chen,1,2 M Xie1,2
1
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology; 2Hubei Province Key
Laboratory of Molecular Imaging, Wuhan, China
Objective: To evaluate the changes of ventricular function in second-third
trimester fetus with tricuspid regurgitation by velocity vector imaging (VVI).
Methods: The fetus include in this study diagnosed as tricuspid regurgitation
during January 2014 to August 2017 in the Union Hospital of HUST. They
were divided in: group A-mild tricuspid regurgitation, group B- severe
tricuspid regurgitation. The control group included 36 normal fetuses in the
same period. To evaluate the global ventricular motion of the group A, B and
the control group by VVI. The following parameters of the left and right
ventricular were obtain by manual tracing endocardial at the end of ventricular
diastolic in four-chamber view: the global systolic longitudinal velocity
(GLVs), the global diastolic longitudinal velocity (GLVd), the global systolic
longitudinal strain rate (GLSRs), the global diastolic longitudinal strain rate
(GLSRd) and the global longitudinal strain (GLS). The differences of baseline
and parameters between groups A, B and the control group were analyzed.
Results: (1) Comparison of general data: There were no significant differences
among the group A, B and the control group (P>0.05). (2) Comparison of
right ventricular parameters: There were significant differences among the
group A, B and the control group in terms of the right ventricular GLVs,
GLVd, GLS, GLSRs and GLSRd (P<0.01); there were significant differences
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between the group B and the control group in terms of the right ventricular
GLVs, GLVd, GLS, GLSRs and GLSRd (P<0.01). (3) Left ventricle parameter
comparison (ANOVA analysis): There were significant differences between
group A and B in terms of the left ventricle GLVs, GLVd, GLS, GLSRs and
GLSRd (P<0.01); There were significant differences between group B and
the control group in terms of the GLVs, GLVd, GLS, GLSRs and GLSRd
(P<0.01).
Conclusion: The ventricular function is significantly different among the
fetus diagnosed as mild/severe tricuspid regurgitation and normal, the
ventricular systolic and diastolic function is obviously impaired. There were
no significant differences between the mild tricuspid regurgitation fetus and
control in terms of the ventricular function index, which means mild tricuspid
regurgitation did not cause fetal ventricular function damage. The qualitative
and quantitative measurements of prenatal fetal tricuspid regurgitation is
beneficial to evaluate the effects of cardiac structure, activity and rhythm,
which helps to predict the prognosis, guide clinical practices, and give
recommendations of good birth and good care.
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Mechanism of De Novo Mutation Microtubule Associated
Scaffold Protein 1 (MTUS1) in the Process of Compaction of
Ventricular Myocardium
X Bai, Y Zhou, N Oyang, L Liu, J Tian, T Lv
Department of Cardiology, Children's Hospital of Chongqing Medical
University, Chongqing, China

Conclusion: A de novo mutation in MTUS1 is a protective mutation for
noncompaction of ventricular myocardium, which decreased the stability of
microtubules and increased cell migration by regulating the expression of
RhoA.

Objective: To investigate molecular mechanisms of de novo mutation
microtubule associated scaffold protein 1 (MTUS1) in compaction of
ventricular myocardium.
Methods: Lentiviral vectors containing MTUS1 wild type and containing
the mutation MTUS1 were constructed and co-infected into CP15-5a cells
(mutantion group, wild type group and vector group, respectively). The mRNA
expression of MTUS1 and ras homolog family member A (RhoA) were
evaluated by Real-time PCR. Expression level of RhoA protein was measured
by Western blot. The proteins α-tubulin was detected by immunofluorescence
assays. Cell migration was determined by Wound-Healing Assay.
Results: Lentiviral vectors containing MTUS1 wild type and containing the
mutation MTUS1 were constructed successfully, verified by fluorescence
staining and Real-time PCR. Immunofluorescence assays revealed the
fluorescence intensity of α-tubulin decreased in the cells expressing the
mutated MTUS1 (P=0.006, P<0.01). Real-time PCR and Western blot showed
that expression of RhoA was significantly increased in mutation than that in
wild type group (P=0.005, P=0.01, P<0.05, P<0.01). In Wound-Healing Assay,
after the scratch 6 h and 12 h, the percent wound closure of the mutation
group was significantly increased than that in wild type group (P=0.000,
P=0.000, P<0.001).

117
Respiratory Syncytial Virus Associated Infection in Infants with
Haemodynamically Significant Congenital Heart Disease before
12 Months of Age in Hong Kong: The Implication on Potential
Use of Monoclonal Antibody Prophylaxis
R Chen, S Chiu, SL Lee, TC Yung
Queen Mary Hospital, Hong Kong
Background: Infants with congenital heart disease (CHD) are at increased
risk for severe respiratory syncytial virus (RSV)-associated hospitalization.
In Hong Kong, RSV season is prolonged and peak seasons can be
unpredictable, hence the efficacy of Palivizumab, an immunoprophylaxis
against RSV, in the group of hemodynamically significant congenital heart
disease (HsCHD) is largely unknown. The current study aim to address the
issue of cost effectiveness of Palivizumab use in Hong Kong.
Methods: Medical records of all HsCHD patients below 12 months of age
referred to our centre between 1 January 2014 and 31 December 2016 were
reviewed. Patients who fulfilled the American Academy of Pediatrics (AAP)
guidelines for Palivizumab prophylaxis were selected, amongst which RSV
infections requiring hospitalization were identified and reviewed. Palivizumab
efficacy was assessed by calculating number needed to treat (NNT) to prevent
hospitalization or mortality using either a 5 or 6 monthly dose regime starting
from first hospital discharge after the diagnosis of HsCHD was made. Cost
effectiveness was also assessed.
Results: Two hundred and thirty six patients fulfilling the AAP criteria were
identified out of 1,505 patients referred to our centre during the study period.
Fourteen out of 236 patients were excluded since there were no window
period to administer Palivizumab. Out of 222 patients, the indication for
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palivizumab included CHD with heart failure requiring surgical or catheter
intervention (n=160, 72%); significant pulmonary hypertension associated
with CHD (n=4, 1.8%) and cyanotic CHD (n=58, 26.2%). Twenty patients
had RSV-associated hospitalization, amongst which 4 required intensive care.
There were no mortality. The NNT to prevent hospitalization for the whole
cohort using 5 and 6 dose regime is 54.9 and 38 respectively. NNT for cohort
excluding cyanotic CHD using 5 and 6 dose regime is 45.5 and 33.1
respectively. As there were no mortality, cost effectiveness was assessed
based on comparison of palivizumab program expenditure versus cost for
RSV-associated hospitalization. For the whole cohort, total RSV-associated
hospitalization cost was HK$ 2,959,600; while palivizumab program cost
for 5 and 6 dose were HK$5,809,710 and HK$ 6,856,110. For cohort excluding
cyanotic heart disease, total RSV-associated hospitalization cost was HK$
2,796,400; while palivizumab program cost for 5 and 6 doses were HK$
4,745,070 and HK$ 6,546,040.
Conclusion: RSV-associated hospitalization in HsCHD is not uncommon.
However, in Hong Kong, the use of RSV monoclonal antibody is probably
not cost effective as reflected by the high NNT and comparative high cost.
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Respiratory Ciliary Dysfunction and Airway Symptoms in
Congenital Heart Disease with/without Heterotaxy
T Zhao, W Chen, S Li, W Sheng, G Huang
Children's Hospital of Fudan University, Shanghai, China
Background: The congenital heart disease patients with/without heterotaxy
show increased ciliary dysfunction(CD) and low nasal nitric oxide with
postoperative respiratory complications, which are similar to primary ciliary
dyskinesia. These findings suggest that the role of motile cilia play a critical
role in both mucociliary clearance and nodal flow which is fundamental for
establishing embryonic left-right patterning. In this study, we process a
retrospective study about CHD patients with/without heterotaxy to access
the prevalence of ciliary motion and sinopulmonary symptoms.
Methods: We recruited 1181 CHD patients, 87 with heterotaxy and 1094
without heterotaxy. Collect information from clinical electronic medical
records, including demographics, diagnosis and respiratory symptoms. Video
microscopy of nasal biopsies were conducted to test ciliary motion and Nasal
nitric oxide(nNO) were measured. Sinopulmonary symptoms were reviewed
by questionnaires and outpatient records.
Results: Our study showed patients with congenital heart disease without
heterotaxy a high frequency of ciliary dysfunction (33.5%) and low or
borderline low nasal nitric oxide (8.8%) levels. In congenital heart disease
with heterotaxy patients, we obseverd 57% of ciliary dysfunction and 36.8%
of abnormal nNO value. Increased sinopulmonary symptoms were observed
in the patients with ciliary motion dysfunction or low nasal nitric oxide,
while both abnormal ciliary motion and low nitric oxide individual had more
respiratory symptoms. Our study displayed that abnormal ciliary motion and
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Association between Mitochondrial DNA Copy Number and
Cardiovascular Disease: Current Evidence Based on a Systematic
Review and Meta-analysis
Y Li, P Yue, K Zhou, Y Hua
West China Second University Hospital, Sichuan University, China
Background: Mitochondria are energy-producing structure of the cell and
help to maintain redox environment. In cardiovascular disease, the number
of mitochondrial DNA (mtDNA) will changes accordingly compare to normal
condition. Some investigators ask whether it has a clear association between
mtDNA and cardiovascular disease with its adverse events. Thus, we conduct
the meta-analysis to assess the role of circulating mtDNA in evaluating
cardiovascular disease.
Methods: The meta-analysis was conducted in accordance with a
predetermined protocol following the recommendations of Cochrane
Handbook of Systematic Reviews. We searched the Pubmed, Embase, the
Cochrane Central Register of Controlled Trials and World Health
Organization clinical trials registry center to identify relevant studies up to
the end of October 2017. Data were analyzed using STATA. Besides,
publication bias and meta-regression analysis were also conducted.
Results: We collected results from 5 articles for further analyses with 8,252
cases and 20,904 control. The normalized mtDNA copy number level is
lower in cardiovascular disease (CVD) than the control groups with a pooled
standard mean difference (SMD) of -0.36(95%CI, -0.65 to -0.08); The pooled
odds ratio (OR) for CVD proportion associated with a 1-SD (standard
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low nasal nitric oxide were more essential in predicting risk of sinopulmonary
symptoms than heterotaxy.
Conclusions: A high prevalence of abnormal ciliary motion and low or
borderline nasal nitric oxide were observed in patients with congenital heart
disease without heterotaxy, which is relative to more airway symptoms. These
findings suggest that respiratory symptoms and ciliary motion dysfunction
are more important in screening for congenital heart disease than heterotaxy
status, and the role of cilia in pathogenesis of congenital heart disease no
matter heterotaxy status.

deviation) decrease in mtDNA copy number level is 1.23 ( 95% CI, 1.061.42); The OR for CVD patients with mtDNA copy number lower than median
level is 1.88 (95% CI, 1.65-2.13); The OR for CVD patients with mtDNA
copy number located in the lowest quartile part is 2.15 (95% CI, 1.46-3.18);
the OR between mtDNA copy number and the risk of sudden cardiac death
(SCD) is 1.83 (95% CI, 1.22-2.74).
Conclusion: Although inter-study variability, the overall performance test
of mtDNA for evaluating CVD and SCD revealed that the mtDNA copy
number presented the potential to be a biomarker for CVD and SCD prediction.
Given that, the fewer copies of mtDNA, the higher the risk of CVD.
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High-density Mapping of Atrial Tachyarrhythmia in Congenital
Heart Diseases
SY Kwok,1 TC Yung,1 NL Ho,1 J Hai,2 S Tsao,1 HF Tse2
1
Department of Paediatric Cardiology; 2Division of Cardiology, Department
of Medicine, Queen Mary Hospital, Hong Kong

(37.5%). Additional targeted substrate ablation was performed in 6 patients
with multiple IART circuits. Near-miss anatomical pouches were identified
in 3 patients.
Conclusion: High acute success rate of atrial arrhythmia ablation can be
achieved using high-density anatomical mapping in CHD. Multiple IART
circuits were often identified.

Aims: The use of high-density electroanatomical mapping in Chinese
population for congenital heart disease (CHD) is not well reported.
Methods: Retrospective review of consecutive transcatheter ablation of atrial
tachyarrhythmia using high-density mapping for CHD patients (at least
moderate complexity) in the only tertiary congenital heart centre in the
territory from Jan 2017 to Jan 2019 was conducted. Orion mapping catheter
in Rhythmia system (Boston Scientific) was used to create activation and
voltage maps. Parameters including mechanism of arrhythmia, acute success,
and follow-up data were recorded.
Results: Eight patients were identified (mean age 38.0±9.0 years) who
underwent transcatheter ablation of atrial arrhythmia (focal atrial tachycardia1; intra-atrial reentry tachycardia (IART)-3; both-4). More than one reentry
circuits of IART were identified in 5 patients, in which 3 patients had three
or more IART mechanism. A median of two maps were acquired per person
and it took in median 32.4 minutes (IQR 15.6-50.6) with median number of
15,952 (IQR 13, 395-18,530) mapping points per map. Cavo-annulus isthmus
dependent mechanism was the predominant reentry mechanism. Acute success
was achieved in all patients, among which it was considered partial success
in 2 patients (25%). There was recurrence of atrial arrhythmia in 3 patients
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Amiodarone-related Pure Red Cell Aplastic Anemia and
Hypothyroidism After Complex Congenital Heart Surgery: One
Case Report
H Ba, Y Qin, H Wang
Department of Pediatric Cardiology, Heart Center, The First Affiliated
Hospital, Sun Yat-sen University, Guangzhou, China
Background: Amiodarone is an effective anti-arrhythmia drug, but there
are many clinical side effects that limit its application.
Case: The patient was a child with complete anomalous pulmonary venous
drainage (intracardiac type) who underwent cardiac surgery at the age of 2
months. The preoperative body weight was 4.1 kg. On the 11th day after
operation, atrial tachycardia was disturbed. The fastest heart rate was about
200 beats per minute. Amiodarone was given orally (15 mg/kg.d). The
arrhythmia was controlled. Amiodarone was reduced to 10 mg/kg.d after 4
days and 5 mg/kg.d after 1 week. The patient were discharged with amiodarone
(5 mg/kg.d). At 7 months old (5 months after operation), the patients returned
to the hospital for reexamination. Physical examination showed that the heart
rate was slow, 80 times per minute, and there was no significant increase in
body weight. The electrocardiogram showed intermittent sinus bradycardia,
occasional junctional escape, hemoglobin 79 g/L, and thyroid function: TSH
9.660 uIU/mL. Taking amiodarone excess into account, amiodarone was
discontinued and given orally to eumethylle. Heart rate improved and TSH
returned to normal. Re-visit at 8 months old, weight increased by 1.3 kg,
TSH was normal, but still anemia, hemoglobin 70 g/L. Considering nutritionrelated anemia, nutritional therapy was recommended. Re-visit at 9 months

43
Very Late-onset Complete Atrioventricular Block after
Transcatheter Closure of Perimembranous Ventricular Septal
Defect
X Liu,1,2,3,4 C Wang,1,2,3,4 K Zhou,1,2,3,4 Y Hua1,2,3,4
1
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University; 2The Cardiac Development and Early Intervention Unit,
West China Institute of Women and Children's Health, West China Second
University Hospital, Sichuan University; 3Key Laboratory of Birth Defects
and Related Diseases of Women and Children (Sichuan University), Ministry
of Education Chengdu; 4Key Laboratory of Development and Diseases of
Women and Children of Sichuan Province, West China Second University
Hospital, Sichuan University, Chengdu, Sichuan, China
Background: Transcatheter closure of perimembranous ventricular septal
defect (PmVSD) with Amplatzer VSD occluder (AVSDO) had a high
incidence of complete atrioventricular block (cAVB) post closure, ranging
from 8.7%-20% during early and middle term follow-up, leading to
disapproval of this interventional therapy by FDA. Despite the abandonment
of AVSDO by most centers thereafter, long-term outcomes of patients
received AVSDO, still remain an issue of concern and the late occurrence of
potentially catastrophic heart block long after hospital discharge is especially
worrying. Herein, we firstly reported a case with very late-onset cAVB
occurring over ten years following transcatheter closure of PmVSD using
AVSDO.
Case: A five-year-old female, with a PmVSD was referred to our hospital for
transcatheter closure of the defect. Transthoracic echocardiography (TTE)
revealed an 11-mm sized defect with a left to right shunt, moderate pulmonary
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old, weight increased ideally, but Routine blood test indiacated that
hemoglobin 59 g/L, positive cell anemia, and low reticulocyte count; Bone
marrow cytology examination suggested pure red cell aplastic anemia.
Prednisone was given orally (2 mg/kg.d). After 2 weeks, the hemoglobin
increased to 82 g/L. After 1 month, the hemoglobin increased to 112 g/L.
After 2 months, prednisone maintained at low doses (0.5 mg/kg.d) and
maintained. At present, the patient is 1 year old, weighs 7 kg and 67 cm in
length. The latest hemoglobin was 113 g/L. The thyroid function was normal.
Decision-making: The use of amiodarone in children should be closely
followed up. Once the problem is found, the drug should be stopped and
treated in a timely manner.
Conclusion: The use of amiodarone in small infants and young children
should be used for as short a time as possible, and the side effects should be
closely monitored.

hypertension and left ventricle enlargement. The defect measured 11.5 mm
on left ventricular angiography and a 14-mm AVSDO was chosen. No
arrhythmias, residual shunt and aortic regurgitation was documented following
occluder deployment and the device was released. Oral administration of
aspirin was initiated and ECG monitoring and echocardiography post
procedure were performed, during which time the patient was uneventful.
After discharge, all ECG recordings and TTE examination were completely
normal during the first year and annually thereafter. Unfortunately, the child
lost follow-up six years post procedure. Ten years after operation, the patient
was re-admitted into our hospital due to recurrent syncope. cAVB with a
minimal heart rate of 42 bpm was noted on ECG. Notably, device flattening
was revealed on two-dimensional TTE and the occluder appeared to return
to its original size and shape. Similar findings were showed on fluoroscopic
evaluation. The child was empirically treated with prednisone, but with no
improvement. Lastly, a permanent pacemaker was implanted and the
following course was uneventful.
Decision-making: This case report proved that the at-risk period for
developing heart block after device closure appears to be much longer than
we speculated. Most importantly, this finding was of clinically amount
significance for underscoring the importance and necessity of long-term,
perhaps life-long follow-up for these patients, since lots of patients receiving
transcatheter closure of PmVSD with this kind of device had been documented
in the literature.
Conclusion: The present case provided additional evidences that the
progressive device flattening could occur and it may account for the very
late-onset cAVB after device closure with AVSDO.
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One Case of Primary Carnitine Deficiency
Y Yan, R Wu, Z Wang, Y He, P Li, Y Zhan, Y Shi, H Li, T Wu, Q Ye, Q Wang
The Second Affiliated Hospital of Wenzhou Medical University, Zhejiang,
China
Background: In this case, the female, who was 5 years old at the time of
diagnosis, was admitted to hospital due to cardiomyopathy.
Case: The child was found to have enlarged left ventricular and hypertrophy
of the left ventricular wall due to cough by Echocardiography. She had
frequent respiratory infections. Her physical and mental development was
age appropriate. Her elder sibling had died at the age of one in a context of
dilated cardiomyopathy and cardiac insufficiency. Physical examination only
showed her liver enlarged to 2 cm below the costal margin; neurological
examination was normal and no audible heart murmur was noted. Laboratory
testing showed high blood ammonia increased to 110 µmol/L (normally 9-30
µmol/L) ; echocardiography showed left ventricular hypertrophy: left
ventricular posterior wall during diastole was 8.0 mm (normally 5-7 mm);
left ventricular enlargement: Left ventricular internal diameter at end-diastolic
is 38 mm (normal value is less than 34 mm) and EF is 58%; chest radiographs
suggest an increase in cardiothoracic ratio with 57.8%; electrocardiogram
showed high T waves; screen plasma free carnitine concentration was
decreased to 1.19 µmol/L (normal value 10-60 µmol/L) and with other kinds
of acylcarnitine decreased, which indicated the PCD.
Decision-making: Finally, the child did the SLC22A5 gene testing and further
diagnosed as PCD. At the early stage of diagnosis, 100 mg/(kg·day)

72
The Outcome of LBBB Complicated with Transcatheter Closure
of VSD in Two Children
W Li, L Zhang, P Huang, ZP Wang, YF Wang
Guangzhou Women And Children's Medical Center, Guangzhou, China
Background: To evaluate outcome of left bundle branch block (LBBB) after
transcatheter closure of perimembranous ventricular septal defect (pmVSD)
in children.
Methods: From January 2017 to December 2018, 208 patients with pmVSD
underwent transcatheter closure. There were two children complicated with
LBBB. The incidence of LBBB was 0.96%. Case 1: A 4-year-old boy. The
Weight was 15 Kg. He was admitted to hospital for heart murmur in August
6, 2018. The diameter of VSD measured by transthoracic echocardiography
(TTE) was 2 mm. The result of cardiac catheterization were PA 46/18 (31)
mmHg, AO 106/59 (79) mmHg, Pp/Ps =0.43, Qp/Qs=1.34. The diameter of
VSD in LV angiography was 2.0 mm. We used 3-4 mm ADOII (AGA) for
pmVSD. Case 2: A 4 years and 5 months boy. The Weight was 16.8 Kg. He
was admitted to hospital for heart murmur in August 19, 2018. The diameter
of VSD measured by TTE was 6.3 mm in LV and 2.9 mm in RV. The result of
cardiac catheterization were PA 24/10 (16) mmHg, AO 101/62 (75) mmHg,
Pp/Ps =0.24, Qp/Qs=1.85. The diameter of VSD in LV angiography was
4.0 mm.We used 6mm domestic symmetric double-disk VSD occluder.
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L-carnitine was given intravenously to supplement carnitine. After two weeks,
the serum carnitine level returned to normal, and then changed to L-carnitine
oral solution (Dong Wei Li) 100-130 mg/(kg·day) for long term oral supportive
therapy. Two years after the treatment, L-carnitine oral solution was adjusted
to 100-140 mg/(kg·day) according to body weight and serum free carnitine
concentration.
Conclusion: (1) PCD is one of the causes of cardiomyopathy in children.
Detection of serum free carnitine and acylcarnitine levels by tandem mass
spectrometry is the preferred screening method for PCD. SLC22A5 gene
detection is an important means for the diagnosis of PCD. (2) Whether PCD
heterozygous carriers are affected by various factors, there is no consensus
at home and abroad about whether there is a need to supplement carnitine
prevention and treatment. Therefore, long-term follow-up of PCD
heterozygous carriers is still needed to avoid adverse events. (3) Combined
with the long-term follow-up data, it can be found that continuous L-carnitine
supplement can achieve good and positive mid- and long-term effects in the
treatment of PCD.

Results: Case 1: CLBBB was found in Day 1 after intervention. He was
treated with albumin and methylprednisone. The ECG was intermittent
incomplete LBBB in Day 9. He was discharged in Day 10 because of ECG
was normal. Afterwards, he was lost clinic follow-up. CLBBB was found in
7 months after intervention. Case 2: CRBBB was found in Day 1. He was
also treated with albumin and methylprednisone and discharged in Day 4
with CRBBB. He was readmitted to hospital for slow pulse rate in Day 6.
The ECG showed high AVB, ventricular escape rhythm and CRBBB. he was
retreated with methylprednisone. ECG were CLBBB and I degree AVB in
Day 8 and were incomplete LBBB and RBBB in Day 14. He was underwent
VSD repair and occluder removal in Day 16. The ECG was incomplete RBBB
in Day 2 after surgery and he was discharged in Day 5 post-operation. During
6 months follow-up, the patients recovered well and ECG did not occurred
with LBBB.
Conclusions: LBBB complicated with transcatheter closure of pmVSD would
be close follow-up even if ECG recovered normal after treatment. If not, it is
better to withdraw the occluder as soon as possible.
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Removal of a Pacemaker Lead in an Infant Through Left
Subclavicular Vein
W Ji
Shanghai Children's Medical Center, Shanghai/Pudong New District, China
Background: The removal of pacemaker electrode in infant was rarely tried.
Case: An 8 months old and 8 kilogram weight infant with permanent
pacemaker implantation who suffered from complete atrioventricular block
after surgery for Tetralogy of Fallot was admitted to our hospital on September
last year. During three months after the implantation of the pacemaker, the
pacing output was instable, which was upregulated to 5 Volts/ 0.1 ms with
the pacing threshold fluctuated at 2-3 Volts with pulse width at 0.4 ms.
Decision-making: The heart cavity is very small in such an infant. To implant
a new electrode with the problem electrode remaining in the cardiac chamber
is not feasible. We decided to remove the pacemaker lead then. The direct
pulling, unscrewing back the inner core of the electrode and unscrewing back
the outer edge of the electrode were adopted respectively to release the
electrode from the myocardial tissue and then pull out the electrode. In situ
puncture of left subclavian vein was made to erect a track along which the
sheath was loaded into. A new ventricular electrode was implanted and linked
to the original pacemaker and sutured in situ pouch. During the follow-up
the pacemaker programming was did to monitor the parameter.
Conclusion: The direct pulling was not able to pull out the electrode.
Unscrewing back the inner core of the electrode and unscrewing back the
outer edge of the electrode at the same time released the electrode from the

93
Pulmonary Venous Channel Stenosis Accompanying Thrombus
after the Senning Procedure in a Child
H Li, L He, B Wang, L Zhang, YM Li, MX Xie
Union Hospital, Tongji Medical College, Huazhong University of Science
and Technology, Wuhan, China

ventricle tissue and then was pulled out slightly. During the follow-up the
pacing threshold were 1.75 volts with pulse width at 0.4 ms. No complications
such as vascular laceration, cardiac perforation, pericardial effusion, massive
hemorrhage, pacemaker infection and impaired wound healing relevant to
the removal of pacemaker lead and re-implantation of electrode occurred
after the operation. If the indications were strictly grasped and under careful
operation, the removal of electrode implanted within the short term should
be safe.

Conclusion: The complication of pulmonary venous channel stenosis can
appear just after the surgery. Therefore, it is important to recognize that the
PV channel is predisposed to venous obstruction. Transthoracic
echocardiography is the only reliable tool for detecting the presence of a
pulmonary venous and the complications.

Background: Obstructions in newly created atria are well-known
complications after the Senning operation. Venous stenosis can be present at
the superior vena cava channel, inferior vena cava channel, or PV-channel
after a Senning operation
Case: We present a case of pulmonary venous channel stenosis accompanying
thrombus in a 8-year-old female 3 months after a Senning operation for levoTGA. On postoperative day 7, we found a slight acceleration of the blood
flow at the PV channel in the newly created left atrium derived from the
incision on the original left atrium by transthoracic echocardiography. At
3-month follow-up, a large thrombus surrounding the opening of left the
pulmonary vein and the severe acceleration of the blood flow at the PV
channel.
Decision-making: On 1-month follow-up, diuretic and anticoagulant therapy
was given as her face swelling occurred frequently. And thoracentesis was
performed for treating pleural effusion. Unfortunately, the patient died 3
months after the surgery.
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Anomalous Origin of Left and Right Coronary Artery Result
from Pulmonary Hypertension due to Heart Failure
X Li, X Huang
Department of Pediatrics, Affiliated Hangzhou First People's Hospital,
Zhejiang University School of Medicine, Hangzhou City, China
Background: Congenital coronary artery anomalies (CCAAs) are
abnormalities in the origin, course or structure of these arteries, and their
incidence varies from 0.2% to 5.6%. CCAAs may cause myocardial ischemia
and sudden cardiac death. Anomalous origin of the left coronary artery from
the pulmonary artery (ALCAPA) is more common in CCAAs.
Case: Our case was a thirty eight day old female infant born by normal
vaginal delivery. She was asymptomatic till 30th day of life when parents
noticed that baby had a cough with wheezing. Chest X-ray showed
enlargement of cardiac shadow, echocardiogram revealed enlargement of
left atrium and ventricle with severe LV dysfunction in local hospital. She
was admitted to our hospital for endocardial fibroelastosis. In our hospital,
the ECG displayed normal sinus rhythm, abnormal Q (q) waves in high lateral
wall with QRS waveform of anterior lateral wall fragmentation, and prolonged
QT interval. On 2D echo a similar echo of LMCA was seen to be arising from
pulmonary artery, RCA was visible from aorta and its starting position was
about 1 o'clock. However, color Doppler antegrade flow was seen in the left
coronary artery. It was discussed CT angiogram (CTA) could help to
demonstrate diagnosis. Baby was put on oxygen inhalation, cardiotonic drug
and diureticum in the during. After 3 days CTA demonstrated that RCA

109
Catecholaminergic Polymorphic Ventricular Tachycardia with
Complex Arrhythmia: A Case Report
H Ge, X Li, M Li, H Jiang, H Liu, Y Zhang
First Hospital of Tsinghua University, Beijing, China
Background: Catecholaminergic polymorphic ventricular tachycardia
(CPVT) is an uncommon severe inherited arrhythmia syndrome. However,
the diagnostic process of CPVT remains very challenging due to normal
resting ECG and cardiac imaging.
Case: A 6-year-old boy with complex arrhythmias and syncope was referred
to the Division of Pediatric Cardiology in August 2018. In 2015, when he
was 4 years old, the patient was found to have sinus bradycardia and normal
cardiac imaging. No further examination and treatment were given. In 2018,
the patient suffered a sudden syncope while sleeping. His ECG and 24-h
ambulatory ECG revealed sinus bradycardia, sinus arrest, atrial tachycardia,
atrial fibrillation, atrial flutter, premature ventricular contraction and VT
alternately. His echocardiogram showed mildly enlarged left ventricular with
left ventricular internal diastolic diameter (LVIDd) of 49 mm and cardiac
dysfunction with left ventricular ejection fraction (LVEF) of 23%. The
treatment of gamma globulin, methylprednisolone and amiodarone was
ineffective. His ECG monitoring showed that complex arrhythmias persisted
with heart rates between 30 and 200 bpm. Bidirectional and polymorphic VT
were detected. Tachyarrhythmia frequently occurred during emotional stress
at daytime, whereas sinus bradycardia persisted at night.
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originated from the left side of the ascending aorta, and LMCA originated
from the pulmonary artery. Transthoracic echocardiogram was done.
Interestingly this time showed the right-to-left bi-directional shunt in the left
coronary artery.
Decision-making: Correction of abnormal origin of coronary artery,
expansion of pulmonary artery patch and ECMO placement were performed
in the baby. Unfortunately, due to the cardiac function recovered poorly during
post-operation and ECMO assisted period. On the 7th day after operation,
the baby died.
Conclusion: We are reporting a case of abnormal position of RCA and
ALCAPA with severe LV dysfunction with normal-flow pattern in left
coronary artery and demonstration of right-to-left bi-directional shunt on antiheart failure treatment. It is result from pulmonary hypertension due to left
ventricular heart failure. Pulmonary artery pressure decreased after treatment,
so the third time echocardiogram was seen the right-to-left bi-directional
shunt in the left coronary artery

Decision-making: Low dose beta-blocker (0.9 mg/kg/d split into 3 doses)
was initiated. The patient responded to propranolol and presented with sinus
bradycardia within a heart rate of 37 to 82 bpm, meanwhile, no sinus arrest
and tachyarrhythmia were detected. Due to sinus tachycardia, the patient
underwent implantation of permanent pacemaker pacing at 80 ppm. The dose
of propranolol was increased to 3 mg/kg/d gradually under continuous blood
pressure. Ventricular pacing rhythm was present for 95.8% of the time with
heart rates 80 to 90 bpm, and atrial tachycardia within 1 to 5 minutes
occasionally occurred during emotional stress. During a follow-up of 6
months, no syncope occurred. His LVID reduced to 45 mm, LVEF increased
to 55%. The results of his genetic testing revealed a missense mutation,
H4762Y (C14284T transition in the exon n99 of RYR2) which is strongly
associated with CPVT.
Conclusion: CPVT can present with exercise or emotional stress-induced
ventricular and/or atrial tachyarrhythmia, and with sick sinus syndrome. The
pediatrician should pay attention to this clinical feature and avoid
misdiagnosis or a delay to diagnosis of CPVT.
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Two Cases Report of Sinus Rhythm Restored after Surgical
Removal of the Occluder for Late Complete Left Bundle Branch
Block Developed Post-occlusion of Perimembernous Ventricular
Septal Defect
YM Xie, YF Li, XY Wang
Guangdong Cardiovascular Institute, Guangzhou, China
Background: To investigate the treatment, outcome and prognosis of delayed
left bundle branch block after percutaneous perimembernous ventricular septal
defect occlusion in paediatric patients.
Methods: Retrospectively reviewed the clinical characteristics and outcomes
of two patients developed late complete left bundle branch block (CLBBB)
after 1-month post-procedure of percutaneous closure of perimembranous
ventricular septal defect (pmVSD), to discussed the therapeutic methods of
these patients.
Results: Both cases with a pmVSD and a history of recurrent respiratory
infections, were referred to us for percutaneous closure of the defect, which
measured 5 mm and 4 mm by left ventricular angiogram. Qp / Qs were 1.84
and 1.78 respectively and there was no pulmonary hypertension. HeartRTM
and CeraTM VSD devices were chosen, which the diameter of the occlude
was 6 mm symmetrical and 8 mm asymmetrical (large-left-disc) respectively
for closure in November 2017 and October 2018. The EKG recorded 24 hr
after the procedure both showed normal sinus rhythm. Two-dimensional TTE
examination showed the devices were both in the proper position and there
was neither residual shunting nor regurgitation of the aortic, tricuspid, and
mitral valves before discharged. But they developed asymptomatic late
CLBBB at one-month follow-up post-procedure. The first case, a 2.5-year-
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old boy weighing 12.5 kg, detected CLBBB at 35-day follow-up. Operators
decided to definitively retrieve the device and to send the patient to surgery.
Therefore, at 42-day after interventional treatment, he underwent surgical
removal of the occluder and repaired the pmVSD simultaneously in November
2018. Sinus rhythm restored at 5-day examination after the surgical procedure
and was stable.at one-month follow-up. The second case, a 3.5-year-old boy
weighing 15.5 kg, also detected CLBBB at 1-month after the procedure. Holter
monitoring showed the CLBBB was intermittent. Oral prednisone
1.5 mg/kg/d treatment was ineffective for 1 month. Left ventricular end
diastolic diameter (LVEDD) enlarged gradually to 45 mm and the left
ventricular ejection fraction (LVEF) decreased to 48% at 12-month followup by TTE. Tissue doppler showed that the left ventricular wall was systolic
dyssynchrony The boy underwent surgical removal of the occluder and
repaired the pmVSD simultaneously in December 2018. CLBBB was still
noted at 10-day after the surgical repair before discharged. It was lucky that
sinus rhythm restored at 1-month after hospital discharge, with the LVEDD
restored to 38mm and LVEF increased to 65%.
Conclusion: The device should be removed as soon as possible when occurred
CLBBB.
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The Clinical, Electrocardiographic, Echocardiographic Profile
and In-patient Outcomes of Adult Filipino Patients with
Methamphetamine Drug Use Associated Cardiomyopathy at a
Tertiary Hospital: A Prospective Study
JE Duya, FE Punzalan, EJ Llanes, PF Reganit
University of The Philippines-Manila, Philippines
Background: Methamphetamine (MAP) abuse is a sociopolitical-medical
issue causing cardiac toxicity (cardiomyopathy, arrhythmias, myocardial
infarction). Review of literature showed dearth of information on the clinical
profile, diagnostic data and outcomes of Filipinos with MAP cardiovascular
events and we aim to fill this knowledge gap.
Objective: A 1 year prospective-descriptive study on consecutive patients
admitted with a diagnosis of MAP induced cardiomyopathy presenting with
Heart Failure (HF) with a positive urine MAP test and/or use of MAP based
on history.
Methods: This is a prospective descriptive study on adult patients admitted
at the UP PGH emergency room with a clinical diagnosis of MAP induced
cardiomyopathy presenting with symptoms and signs of Heart Failure (HF)
based on the New York Heart Association Functional Classification (NYHA
FC) with a documented positive urine MAP test and/or use of MAP based on
history. Patients with known cardiac or systemic comorbidities known to
cause cardiomyopathy have been excluded. Convenient sampling method
(total enumeration) was employed in the study. Descriptive statistics were
reported.

8
The Evolving Clinical and Echocardiographic Profile of Patients
Admitted for Acute Cardioembolic Stroke at a Tertiary Hospital
in the Philippines
JE Duya, K Hernandez, MC San Jose
University of The Philippines-Manila, Philippines

Results: Twenty-two patients were enrolled. 40% were MAP users for >10
years, 77% were smokers, 82% were alcoholic and 5% had cocaine abuse.
30% had a previous HF hospitalization. 35% were urine MAP positive. Six
of 10 patients were in NYHA FC II-III and 30% were in cardiogenic shock.
Mean duration of HF symptoms is 1.3 mo. ECG profiling revealed 82% in
sinus rhythm, atrial fibrillation(14%) and complete heart block(5%). 40%
were tachycardic, 14% had wide QRS complex, 55% had LVH, 45% had left
atrial abnormality, 41% had low voltage complexes, 36% had significant Q
waves, 18% had acute STEMI, 27% had evidence of ischemia and 23% had
fragmented QRS. Echocardiography revealed multi-chamber dilatation, with
reduced ejection fraction (60%). Mean duration of hospitalization is 9 days.
Majority (95%) were discharged improved. One patient died due to ventricular
fibrillation.
Conclusions: To our knowledge, this is the first prospective study detailing
the clinical, electrocardiographic and echocardiographic features as well as
in patient outcomes of adult Filipino patients with MAP CM that can guide
Filipino and Asian cardiologists/internists in the early recognition and prompt
management of this escalating sociopolitical and clinical concern in Asia.

Discussion: To our knowledge this is the largest Filipino cohort with CES
reported in local literature. The profile of Filipino CES patients was similar
to the previous international studies in terms of the patients' age, neuroimaging
findings, rate of hemorrhagic conversion, and low anticoagulation rate.
Contrary to western data, what is interesting is that Filipino CES patients are
younger, with majority of them having RHD in contrast to degenerative.

Background/Introduction: One of 5 ischemic strokes is cardioembolic in
nature. Despite the robust data on cardioembolic stroke (CES) in western
literature, there is scarcity of local data on Asians. Higher prevalence of
rheumatic heart disease (RHD) in developing countries and the growing
availability of NOACs may contribute to an evolving patient profile. This
study aims to define the profile, management and in hospital acute outcomes
of Filipino patients with CES.
Methods: A 2-year retrospective study of patients with CES admitted at UPPGH. Data were obtained through review of records using a standardized
data collection form. One hundred and twenty-six patients were enrolled.
Mean age was 59.9 years. Majority (88%) had a CHADS-VASC Score of
>2. Atrial fibrillation remains the most common rhythm abnormality (67%)
and 20% has RHD (mitral stenosis). On echo, 92% had LVH and 58% had
left atrial enlargement. Interestingly, only 5% had thrombus and merely 8%
had rheologic stasis. Majority had moderate-large artery territory infarctions
with 40% hemorrhagic conversion within 4 days. Two of 3 patients were
given initial anticoagulation. Only half of those who survived were discharged
on oral anticoagulation. Only 10% of patients were given NOACs. Mean
HASBLED score was 1.9±0.96. Bleeding complications was 6%. CES were
associated with longer hospital stay (16 days) and development of nosocomial
pneumonia (46%).
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"Fatal Eosinophilic Myocarditis" from Hypereosinophilic
Syndrome and Intestinal Parasitism Mimicking Acute Coronary
Syndrome in a 39 Year Old Filipino Female
JE Duya,1 PA Alad,2 M Cruz,1 RH Tiongco,3 JA Tindoc4
1
Fellow in Training, Section of Cardiology, Department of Medicine;
2
Resident in Training, Department of Medicine; 3Consultant, Section of
Cardiology, Department of Medicine; 4Resident in Training, Department of
Laboratories, Manila, Philippines
Introduction: Eosinophilic myocarditis (EM) is an under recognized disease
(0.5% of autopsy series) leading to progressive myocardial damage, heart
failure and death. Although parasitism is a common in developing countries,
marked eosinophilia from trichuriasis causing myocardial infiltration and
progressive heart failure is rare.
The Case: An interesting case of a healthy 39 years old post-partal multigravid
Filipina, came in for chest heaviness. She was diagnosed case of uncontrolled
bronchial asthma. She had ascariasis as a child. She came in with a two week
history of fever followed by chest heaviness, diaphoresis and heart failure
symptoms. She was hypotensive, tachycardic with signs of congestion on
admission. EKG showed sinus tachycardia, left axis deviation and complete
left bundle branch block. The patient was managed as a case of acute coronary
syndrome and was thrombolysis with inotropic support. Serial ECGs showed
evolution with low voltage QRS complexes on limb leads and recent
anteroseptal wall infarct. Troponin I was > 10X elevated. Echo revealed
concentric left ventricular remodelling with multi-segmental wall motion
abnormalities and an EF 30% with doppler evidence of restrictive filling

11
The Efficacy of Oral Trimetazidine In Preventing ContrastInduced Nephropathy Among Patients Undergoing Elective
Coronary Procedures: A Meta-Analysis of Randomized
Controlled Trials
JE Duya, R Angeles, R King, J Anonuevo, FE Punzalan
University of The Philippines-Manila, Philippines
Background: Contrast-induced nephropathy (CIN) is a serious but
preventable complication of coronary procedures. Trimetazidine (TMZ) has
recently been explored for use in preventing post-procedural CIN due to its
cellular anti-ischemic and antioxidant properties. Research Question Among
adult patients undergoing elective percutaneous coronary procedures, how
effective is oral TMZ in addition to standard therapy in preventing contrastinduced nephropathy?
Objectives: To assess the efficacy of oral TMZ in the prevention of contrast
induced nephropathy during elective coronary angiography and PCI.
Methods: We searched the Cochrane Central Register of Controlled Trials,
Pubmed/MEDLINE, EMBASE, clinicaltrials.gov for articles published until
June 2016 for randomized controlled trials examining the effects of adding
oral TMZ to standard therapy in preventing CIN. Outcome measures were
incidence of CIN, defined as a 0.5 mg/dl or ≥25% increase in serum creatinine
48-72 hours after contrast exposure, and incidence of dialysis-requiring CIN.
Validity of studies was assessed through a risk assessment tool available from
Cochrane. Treatment effect was estimated by calculating the Mantel-Haenszelweighted risk ratio (RR) using a fixed-effects model available from RevMan
5.3.
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pattern. She had leukocytosis (27,940) with an absolute eosinophil count of
16,700. There was persistent marked eosinophilia on serial CBCs. EM was
considered. Work up for hypereosinophilic syndrome was requested. Patient
underwent coronary angiography (CA) with endomyocardial biopsy (EB) on
the 3rd hospital day. CA showed normal coronary arteries. An EB was done.
Post procedure, patient developed progressive hypotension and transient 3rd
degree AV block. A temporary pacemaker was inserted. Post procedure echo
did not show pericardial fluid nor tamponade. Hypotension progressed leading
to death. EB showed fibromuscular tissue with florid infiltrating eosinophils
and lymphocytes. BMA biopsy did not show acute leukemia. Post mortem
fecalysis showed Trichuris trichura infestation. Unfortunately, due to the
rapid demise of the patient, high dose steroids were only started post biopsy.
Discussion: Eosinophilic myocarditis causes diffuse myocardial inflammation
from eosinophilic infiltration. Trichuriasis is shown to be a cause of EM in
1 case report its relative tissue invasion (Ames et.at.). Over 99% of trichuriasis
leads to asymptomatic infestation. Blood eosinophilia rarely exceeds
1500/ul in asthma despite respiratory tract eosinophil infiltration. The
combination of these two pathologies might have given rise to a marked
reactive hypereosinophilia causing eosinophilic degranulation leading to
increased tissue permeability, platelet activation and inhibition of cardiac
mitochondrial respiration. EM may mimic symptoms of ACS, nonspecific
ECG and echocardiographic findings with increased cardiac enzymes. If there
is a strong clinical suspicion of EM, there is a need to perform a prompt EM
in order to arrive at a diagnosis and to initiate empiric high-dosage
corticosteroid therapy without waiting for definite diagnosis.

Results: A total of four studies comprising 714 patients (TMZ group = 352,
Control group = 362) were included in the final analysis. Pooled results
revealed the TMZ group was associated with significantly fewer incidences
of CIN compared to control (RR 0.33, 95% confidence interval [CI], 0.20, 0.53;
P<0.00001), with a relative risk reduction of 67% and an absolute risk
reduction of 11.04% (NNT= 9). No dialysis-requiring CIN was observed in
the included studies. Our analysis included mostly patients with mild to
moderate renal impairment. We are unable to generalize results to patients
with more severe renal impairment.
Conclusion: The addition of oral TMZ to standard hydration confers a
significant benefit in preventing CIN after coronary procedures among patients
with mild to moderate renal impairment. We recommend the addition of TMZ
to standard prevention strategies. However, a large well-designed trial should
be conducted to determine its effect on other outcomes such as prevention of
dialysis-requiring CIN and mortality.
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The Spectrum of Cardiovascular Involvement in
Hypereosinophilic Syndrome Among Filipinos: A Case Series and
Review of Literature
JE Duya,1 ADM Divinagracia-Alban,2 J Taquizo,1 SM Obillos,1 RHP Tiongco,1
EB Alajar,1 MTB Abola,1 JDA Magno,1 FE Punzalan,1 FP Reganit,1 EJ Llanes,1
CM Macalintal2
1
Section of Cardiology, Department of Medicine, University of the
Philippines − Philippine General Hospital; 2Department of Cardiology,
Makati Medical Center, Makati City, Philippines
Introduction: Hypereosinophilic syndrome(HES) is an under-recognized
disease (0.5% of autopsy series) leading to progressive myocardial damage,
heart failure, thrombosis and death. At present, there are only about 30
individually published cases internationally. Given its peculiarity, the
diagnosis is often delayed due to its myriad presentations. Eosinophilic
myocarditis(EM) occurs in 60% of HES patients, however, there is paucity
of Philippine data regarding this entity. We report 4 Filipino patients with
documented HES focusing on their cardiovascular presentation, work up,
management and clinical outcomes from 2 tertiary institutions.
Summary of Cases: All patients were between 19-42 years old with good
functional capacity with no comorbidities. A history of atopy was strong in
50%. Common causes of explained hypereosinophilia (i.e. parasitism and
drug allergy) were absent in 75%. Two cases presented with severe chest
pain mimicking ACS, 1 case presented as acute limb ischemia (ALI) of the
upper extremity while 1 patient presented with chronic heart failure. Half
presented with classic findings of heart failure and only 25% had skin findings
suggestive of hypereosinophila. ECG revealed regular sinus rhythm (100%),
normal axis (75%), and nonspecific ST T wave changes (50%). Half of patients
had baseline ECG findings simulating ischemia, but later resolved upon
resolution of hypereosinophilia. Echocardiographic findings showed
concentric left ventricular remodelling to hypertrophy (75%), preserved EF

15
The Reproducibility of Myocardial and Liver T2* for Iron Load
Quantification – A Dual-center Multi-platform Study
V Chan,1 L Yip,1 C Chan,1 KT Wong,2 CF Cheung,1 W Kwong,2 YY Law,2
M Lai,2 A Wat,2 S Cheung1
1
Queen Mary Hospital; 2Prince of Wales Hospital, Hong Kong
Background: T2* relaxation refers to the decay of transverse magnetization
caused by spin-spin relaxation and magnetic field inhomogeneity, with an
inverse relationship to intracellular iron stores. The measurement of ventricular
function and T2* levels in the myocardium and liver are hence essential in
the management of the iron-overload. This is particularly important in
transfusion-dependent thalassaemia major, a disease common in Asia. Patients
may sometimes be treated at more than one centre, and the reproducibility of
T2* is paramount in tailoring the appropriate treatment regimen.
Methods: Clinical data was retrospectively collected from 50 patients who
underwent magnetic resonance imaging (MRI) for iron quantification
(myocardium and liver) at two major tertiary referral radiology departments
in Hong Kong – namely, Queen Mary Hospital (QMH) and Prince of Wales
Hospital (PWH). The QMH group had 25 patients with MRI performed on
the Siemens 1.5T MAGNETOM Aera scanner (Siemens Healthcare, GmbH
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(75%), multi-segmental hypokinesia (50%) and Grade III diastolic dysfunction
(75%). Cardiac MRI revealed findings of myocarditis in 25%. Troponin was
elevated (10-1000x) in 50%. Coronary angiogram revealed normal coronaries
(100%). Baseline mean absolute eosinophil count (AEC) was 12,752 (normal
value 30-350 cells/uL). Bone marrow biopsy consistent with HES was present
in 75%. Endomyocardial biopsy done in 1 patient was consistent with EM.
Histologic evidence of other organ involvement was documented in 75%.
Majority (75%) received high dose prednisone and anti-histamines. All
patients with HF received standard HF regimen. Half were initially managed
as ACS until the diagnosis was ruled out. One underwent embolectomy with
anticoagulation. Dramatic improvement in HF symptoms was documented
in 50% after steroid initiation. The patient who presented with ALI showed
resumption of arterial flow with collateral formation. Majority (75%) showed
dramatic improvement in hyperosinophilia on 6 month follow up (mean AEC:
318 cells/uL). One patient died of fatal arrhythmia and cardiogenic shock.
Discussion: While regarded as an extremely rare myelopoietic disease, in 4
cases from 2 institutions in the Philippines. EM appears to be the more
common presentation in 75% of our cohort. EM mimics ACS in
symptomatology, ECG/echocardiographic findings and elevated cardiac
enzymes making the diagnosis elusive. There is a robust role of cardiac
imaging in clinching HES, detecting typical findings of myocarditis and
obviating the need for cardiac biopsy. HES promotes hypercoagulability
leading acute upper limb ischemia (<1%). After exhaustive search for common
causes of persistent eosinophilia, timely initiation of corticosteroids and
antihistamines improves clinical outcomes without waiting for the final
histologic diagnosis. To our knowledge, this is the only Filipino HES cohort,
the largest of all international case series reporting the diverse cardiovascular
manifestations. By knowing the varied cardiovascular presentation of this
disease among Filipinos, physicians can be better equipped in recognizing
this elusive diagnosis promptly.

2018). The PWH group had 25 patients with MRI performed on the Philips
1.5 T Ingenia scanner (Koninklijke, Philips N.V. 2004-2018). Acquired T2*
values from the QMH group were compared between those obtained from
the syngo  . via workstation and values obtained on CMRtools
(Cardiovascular Imaging Solutions Ltd). Acquired T2* values from the PWH
group were compared between those obtained from the Philips IntelliSpace
Portal workstation and values obtained on CMRtools. Intra and interobserver agreement were also assessed in the data collected from the QMH
group.
Results: Bland-Altman analysis for the quantification of agreement between
the various quantitative platforms for T2* measurements of the myocardium
and liver demonstrated good agreement in both the QMH and PWH groups.
Excellent intra-class correlation coefficient values were obtained for intra
and inter-observer agreement by both measurement platforms in the QMH
group.
Conclusions: T2* measurements are reproducible and consistent on multiple
platforms in our dual-center study, with excellent intra and inter-observer
agreement.
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Histone Deacetylase 1 (HDAC1) Was Involved in Regulation of
Placental Multidrug Resistance-associated Protein 2 In Vitro and
Vivo: Possible Implications for Congenital Heart Disease
Prevention
H Duan
West China Second University Hospital, Sichuan University, Chengdu, China
Background: Environmental origins of congenital heart disease (CHD)
highlights the significant role of heart-placenta connection. Multidrug
resistance-associated protein 2 (MRP2), an efflux transporter at the apical
surface of syncytiotrophoblast, is indispensable for fetal protection from
xenobiotics and teratogens. Histone deacetylase (HDAC) 1/2/3, core
epigenetic enzymes for deacetylation modification, are abundantly expressed
in trophoblast cells. We have recently found that these three HDACs inhibition
induced MRP2 expression in placental cells. The purpose of this study was
to validate the specific HDAC subtypes regulating placental MRP2 expression
and function in vitro and vivo, illuminating epigenetic implications for CHD
prevention in terms of fetal protection.
Methods: BeWo cells (human placenta choriocarcinoma) were transfected
with HDAC1/2/3 specific siRNA. Real time PCR, Western-Blot,
immunofluorescence and fluorescent dye efflux assay were utilized tor
evaluate placental MRP2 expression, localization, and efflux function after
transfection, respectively, aiming to identify the HDAC subtype regulating
placental MRP2 in vitro. Next, siRNA for the identified HDAC was
intraperitoneally injected to pregnant mice every 48 h from E7.5~E15.5.
Pravastatin, a well established drug substrate of MRP2, was administered at
20 mg/Kg by gavages 2 h prior to euthanasia at E16.5. Dams were sacrificed

29
High-Density Mapping of Atrial Tachyarrhythmia in Complex
Congenital Heart Diseases – Single Tertiary Centre Experience
in Hong Kong
SY Kwok,1 TC Yung,1 NL Ho,1 JJ Hai,2 S Tsao,1 HF Tse2
1
Department of Paediatric Cardiology; 2Division of Cardiology, Department
of Medicine, Queen Mary Hospital, Hong Kong

via cervical dislocation, and samples were collected. Expression and
localization of HDAC1/2/3 and MRP2 in placentas were detected by real
time PCR, Western-blot and immunohistochemistry, respectively; pravastatin
concentration in maternal plasma and fetal-unit were analyzed by highperformance liquid chromatography/mass spectrometry (HPLC-MS) assay.
Results: In vitro, knockdown of HDAC1 expression enhanced placental
MRP2 mRNA and protein production, without alteration of its intracellular
localization, which corresponded with an decrease in cellular uptake of the
MRP2 substrate-5 (and 6)-carboxy-2',7'-dichloroflourescein (CDF). HDAC1
siRNA exhibited similar effect on MRP2 expression in mouse placentas,
accompanied with reduced pravastatin transplacental rate, while insignificant
changes in fetal weights, placental weights, and maternal plasma pravastatin
concentrations were noted.
Conclusion: Inhibition of HDAC1 could enhance placental MRP2 expression
and function in vitro and in vivo, which might have possible implications for
prevention of CHD in the context of fetal protection from environmental
contributors.

There was recurrence of AT in 3 patients (37.5%). Targeted substrate ablation
with aid of voltage mapping was performed in 6 patients with multiple IART
circuits.
Conclusion: We report the high success rate in the use of high-density
mapping system to aid transcatheter ablation of AT in complex CHD. Multiple
IART circuits were usually identified. Over 10,000 eletrograms per tachycardia
could be collected. Voltage map could be created to guide substrate ablation.

Background: High-density electroanatomical mapping is increasingly
employed in complex arrhythmia ablation. The use of the technology in
Chinese population for congenital heart disease (CHD) is not well reported.
Methods: Retrospective review of consecutive transcatheter ablation of atrial
tachyarrhythmia (AT) using high-density mapping was conducted for CHD
patients from 2017 to 2019, in the only tertiary congenital heart centre in
Hong Kong. Orion mapping catheter in RhythmiaTM system (Boston
Scientific) was used to create activation and voltage maps. Parameters
including mechanism of arrhythmia, acute procedural success, and followup data were recorded.
Results: Eight patients with CHD (moderate complexity) were identified
(mean age 38.0±9.0 years) who underwent transcatheter ablation of AT (focal
atrial tachycardia-1; intra-atrial reentry tachycardia (IART)-3; both-4). More
than one reentry circuits of IART were identified in 5 patients. The median
collected electrograms per tachycardia was 15,745 (IQR 14,242 to 17,989).
Six out of the seven patients with IART had cavo-annulus isthmus dependent
IART. Acute success can be achieved in all patients (Partial success in 2).
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Establishment of Open Descending and Thoracoabdominal
Aortic Surgery in Hong Kong
T Fujikawa, R Wong, M Kwok, J Ho, S Chow, P Yu, J Chan, S Wan
Prince of Wales Hospital, Hong Kong
Background: Open surgeries for descending and thoracoabdominal aorta
were known their high mortality and high invasiveness. Although thoracic
endovascular aortic repair (TEVAR) has evolved in the recent years, there
are still anatomically un-favorable pathologies that TEVAR fails to address.
Since 2017, we introduced a new approach adopted from a high volume
Japanese Aortic Center. In this study, we examined and summarized our early
results of open descending and thoracoabdominal aortic surgery.
Methods: We retrospectively reviewed consecutive patients who underwent
open descending and thoracoabdominal aortic replacement in Prince of Wales
Hospital from February 2017 to February 2019. Patients' demographics
including sex, age, indications of operation, intra-op parameters and postoperative outcomes are collected and analyzed.
Results: From February 2017 to February 2019, we performed 20 cases of
open descending and thoracoabdominal aortic surgery. Mean age was 52.1
year-old. All patients were male. Connective tissue disorder was noted in 4
cases (Marfan's syndrome; 3 cases, Ehlers-Danlos; syndrome 1 case). There
were 18 cases of chronic aortic dissection. Ruptured or impending rupture
were 9 cases. All cases were discussed in aortic multi-disciplinary team and

33
Left Ventricular Stiffness in Adolescents and Young Adults after
Arterial Switch Operation for Complete Transposition of the
Great Arteries
C Wang,2 VW Li,1 Y Cheung1
Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital,
The University of Hong Kong, Hong Kong; 2Department of Pediatric
Cardiology, West China Second University Hospital, Sichuan University,
Chengdu, China
1

Aims: We tested the hypothesis that left ventricular (LV) myocardial stiffness
is altered in complete transposition of great arteries (TGA) patients after
arterial switch operation (ASO) and explored its associations with myocardial
calibrated integrated backscatter (cIB) and LV systolic and diastolic myocardial
deformation.
Methods: A total of thirty-one patients and twenty-two age-matched controls
were retrospectively recruited. LV myocardial stiffness was assessed by
diastolic wall strain (DWS) and stiffness index including E/e/LV end-diastolic
dimension (LVEDd), (E: global longitudinal early diastolic strain rate)/enddiastolic volume (EDV), and (E: global circumferential early diastolic strain
rate)/EDV. Myocardial cIB was measured as a maker of fibrosis. LV systolic
and diastolic myocardial deformation was determined by conventional and
speckle tracking echocardiography.
Results: Patients had lower DWS, higher stiffness index and greater
myocardial cIB (all P<0.05). The mitral annular s velocity, global longitudinal
and circumferential systolic strain and strain rate were lower in patients (all
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deemed not suitable for TEVAR. Among the 20 cases, 14 cases were
descending aortic surgery and 6 cases were thoracoabdominal aortic
replacement. As for extracorporeal circulation, we used partial cardiopulmonary bypass (10 cases), left heart bypass (6 cases), and circulatory arrest
(4 cases). One operative death due to retrograde ascending aortic dissection
and 1 in-hospital death due to residual vertebral aneurysm rupture were noted.
One patient got permanent paraplegia after emergent surgery for ruptured
descending aortic aneurysm, otherwise the other patients were discharged
home on foot (17 cases of 18 survival cases).
Conclusion: Our open descending and throacoabdominal aortic surgery has
shown excellent early outcomes since the system was induced to our center.
We believe open aortic surgery is still the gold standard for descending and
thoracoabdominal aortic pathologies in the era of TEVAR.

P<0.05). Worse LV diastolic mechanics in patients was noted evidenced by
greater transmitral E velocity, higher E/A ratio, shorter E deceleration time,
lower mitral annular a velocity, higher E/e ratio, lower global longitudinal
and circumferential early and late diastolic strain rate (all P<0.05). DWS
correlated inversely with average myocardial cIB, positively with mitral
annular s velocity, mitral annular a velocity, global longitudinal systolic strain
and strain rate, early and late diastolic strain rate, global circumferential
systolic strain and late diastolic strain rate (all P<0.05). Stiffness index
correlated inversely with mitral annular s velocity, mitral annular a velocity
and global longitudinal early diastolic strain rate (all P<0.05).
Conclusions: LV myocardial stiffening occurs in adolescents and young adults
with TGA after ASO, and is associated with impairment of both ventricular
systolic and diastolic myocardial deformation, and myocardial fibrosis.
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"Detaching Knowledge vs Advancing Technology" - The Need
of CIED training for Frontlines in an Acute Hospital
KY Kwan,1 YW Leung,2 CS Yue,2 PL Ngan,1 YB Ng2
United Ambulatory Care Centre, Department of Medicine and Geriatrics;
2
Division of Cardiology, Department of Medicine and Geriatrics, United
Christian Hospital, Hong Kong

1

Background: In 21st century, Cardiovascular Implantable Electronic Device
(CIED) had become bumping important in cardiac disease management and
dramatically enhanced both patient quality and quantity of life. Number of
new CIED implantation in Hong Kong has been doubled since 2000, and the
population is still accumulating with over a thousand new cases annually in
Hong Kong (CDARS). Meanwhile, advancing technology are emerging, such
as leadless pacemaker, subcutaneous implantable cardioverter-defibrillator
(SICD) and MRI conditional CIED. Frontline healthcare professionals should
equip updated knowledge, as mishandling of CIED may lead to unnecessary
suffer and increase potential risk, for example: pre- and post-operation or
MRI management.
Objectives: To explore the training need of CIED care for frontline healthcare
professionals in acute hospital. To enhance staffs' competence on CIED care.
Methods: A 2-day programme "Cardiac In-service Training on CIED Care"
was launched in 2018, with 3-hour theoretical input by cardiologists and
nurses specialized on CIED care. Frontline nurses from all specialties and
allied health professionals in cardiac rehabilitation team (n=35) were recruited.
Design of Pre-/Post-test was employed illustrating candidates' knowledge on

48
Generation and Characteristic of UCs-iPS-derived Cardimyocyte
from Patient with Noncompaction of Ventricular Myocardium
A Liu
Department of Cardiology, Children's Hospital of Chongqing Medical
University, Chongqing, China

CIED care. 4 multiple-choice questions about basic concepts of CIED, living
with device and perioperative care were selected by cardiac nurse who was a
certified cardiac device specialist. Evaluation survey based on content and
candidates' satisfaction was conducted.
Results: A noteworthy knowledge gap on CIED care was demonstrated in
the Pre-/Post-test. In the Pre-test correct responses ranged from 20.7% to
58.6% only, while prominent improvement in correct responses was
demonstrated in the Post-test ranging from 69.2% to 92.3%. Among the
programme evaluation, candidates agreed that the programme achieved its
objectives rated 4.29 (using a 5-point Likert scale). They acknowledged that
the content was practical in workplace rated 4.33. They were overall satisfied
with the course rated 4.29. The programme was highly recommended by
candidates.
Conclusion: Our programme illustrated significant knowledge detachment
of frontline healthcare professionals on CIED care. Coping with the rising
population with CIED and advancing technology, and with such remarkable
learning experience and enhanced competence of candidates, there is a crucial
need of continuous training on CIED care for frontline healthcare
professionals.

Conclusion: Collectively, these results demonstrated that iPS cells and iPSCMs were generated from the NVM patient. Moreover, these cells had a similar
genetic profiles to the patient, which will provide a sound basis for the future
study of the genetic mechanisms of NVM.

Background: To generate cardiomyocytes using urinary cell-derived-IPS from
patients with noncompaction of the ventricular myocardium (NVM) and
identify the genetic characteristics of the cardiomyocytes.
Methods and Results: Urinary cell-derived-IPS and cardimyocyte (CMs)
were obtained from a NVM patient and a normal. The immunofluorescence
assay indicated the iPS cells expressed stem pluripotent genes (Oct4, SSEA4, TRA-1-82 and SOX2). Alkaline phosphatase (AP) staining displayed high
AP activity of the iPS cells. Karyotype analysis showed the iPS cells had a
normal karyotype. Embryonic body (EB) formation showed their abilities
for differentiating into three germ layers. IPS-CMs showed robust spontaneous
beating and electrophysiological studies revealed functional cardiac-specific
voltage-gated Na+ currents and action potentials. TNNT2 and α-actinin are
specific markers for cardiomyocytes and were indicated in our
immunocytochemical analysis. WES and bioinformatics analysis revealed
similar genetic profiles between the blood samples, iPS cells, and the iPSCMs of the NVM patient. Notably, potential pathogenic genes related to NVM
were also found in this analysis.
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Mutant Cardiac Troponin I Down-regulate Phosphodiesterase
4d Via Epigenetic Regulation in Cardiomyocytes
W Zhao
Children's Hospital of Chongqing Medical University, China
Background: Restrictive cardiomyopathy (RCM) is a genetically
heterogeneous heart disease and has been linked to mutations in the thin
filament regulatory protein cardiac troponin I (cTnI). However, the
pathogenesis of RCM from genotype to clinical phenotype is not fully
understood. Our previous studies showed that low expression of
Phosphodiesterase 4d (PDE4d) associated with histone acetylation
modification in cTnIR193H mutation hearts might be one of the causes of
RCM. This study was designed to investigate the relationship between the
mutated cTnI and decrease of PDE4d.
Methods: We over expressed wild type cTnI, cTnIR193H and HDAC1
respectively in primary culture of cardiomyocytes. Western blot was performed
to detect PDE4d expression. Chip assays was performed to detect the level of
HDAC1 binding and H3K4 acetylation near the promoter of PDE4d. Co-IP
assays was performed to detect the interaction between cTnI/cTnIR193H and
HDAC1.
Results: Our study shows that histone deacetylase HDAC1 could reduce the
expression of PDE4d via repressing the level of H3K4 acetylation near the
promoter of PDE4d. over expression of cTnIR193H could reduce PDE4d.
Compared with wild type cTnI cTnIR193H is more likely to combine with

75
Family of Calcium-dependent Potassium Channels in CABG
Grafts: Distribution Profile and Contribution to Vasorelaxation
WT Sun, HT Hou, HX Chen, J Wang, GW He, Q Yang
TEDA International Institute of Cardiovascular Research, TEDA International
Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin,
China
Background and Research Aim: Calcium-dependent potassium channels
(KCa) are involved in the regulation of vascular tone. This study examined
the expression, distribution, and contribution to vasodilatation of the members
of KCa family, including large (BKCa), intermediate (IKCa), and small
(SKCa) conductance-KCa in human internal mammary artery (IMA)
and saphenous vein (SV), with the aim of providing a comprehensive
understanding of the role of KCa in the grafts commonly used for coronary
artery bypass surgery (CABG).
Methods: The mRNA and protein levels of KCa subtypes in the IMA and SV
tissue were determined by q-PCR and Western Blot. Immunohistochemistry
was applied to examine the distribution of KCa subtypes in the endothelial
and smooth muscle layer. Individual KCa subtype-mediated vasorelaxation
was studied using wire myography.
Results: Both IMA and SV expresses all three subtypes of KCa, with
distribution of each subtype observed in both endothelium and smooth muscle.
In IMA, BKCa is the most abundantly expressed subtype and SKCa is
the least (p<0.01, BKCa or IKCa vs. SKCa, p<0.05 BKCa vs. IKCa). In
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HDAC1 and enhance its activity. As a HDAC1 inhibitor, EGCG could reverse
low-expression of PDE4d in cardiomyocytes over expressing cTnIR193H
via inhibition of HDAC1 activity and the interaction between HDAC1 and
cTnIR193H.
Conclusion: Our data indicate that cTnIR193H could cause PDE4D low
expression via interaction with HDAC1. These findings provide new insights
into epigenetic mechanisms of a mutant thin filament protein, which may
contribute to the understanding of RCM pathogenesis.

comparison, the abundance of KCa subtypes in SV is insignificantly different
although SKCa tends to be less than BKCa (p=0.081). Further analysis of the
distribution of each KCa subtypes showed that in IMA BKCa is more
abundantly expressed in smooth muscle cells than in endothelial cells while
SKCa exhibits more abundance in the endothelial layer. The difference of
IKCa distribution was observed in SV revealing a more pronounced
localization in the endothelium than in the smooth muscle. Relaxant responses
of IMA and SV to the BKCa agonist and the IKCa and SKCa opener were
similar in terms of the maximal response. The EC50 of the BKCa agonist
was lower for SV compared to IMA (-5.8±0.1 vs. -5.4±0.1 Log M, p<0.05).
The contribution of BKCa to acetylcholine-induced relaxation was more
significant than IKCa and SKCa in both IMA and SV.
Conclusions: KCa family is abundantly expressed in IMA and SV and plays
a significant role in the relaxation of these vessels. By revealing for the first
time the distribution profile and the individual contribution of KCa subtypes
to vasorelaxation in IMA and SV, this study clarified the differences between
arterial and venous grafts and added knowledge to the physiological
significance of KCa family in the human vasculature.
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Distribution of CYP2C19 Polymorphism Related to Clopidogrel
Metabolism in Patients with Coronary Artery Disease in Tianjin
and Clinical Significance
HX Chen,1 WH Lin,2 Q Yang,1 HT Hou,1 GW He1
Center for Basic Medical Research; 2Department of Cardiology,TEDA
International Cardiovascular Hospital, Chinese Academy of Medical Sciences
& Peking Union Medical College, Tianjin, China

1

Conclusion: The present study analyzed the distribution of CYP2C19 gene
polymorphism for patients with coronary heart disease, particularly the
patients undergoing PCI in Tianjin, China. The result will provide a scientific
basis for personalized medicine by detecting CYP2C19 gene polymorphism
and guide the use of antiplatelet drugs.

Purpose: As an antiplatelet drug, clopidogrel is widely used clinically.
CYP2C19 is a key enzyme in the metabolism of clopidogrel. In this study,
CYP2C19 gene polymorphism was detected in patients with coronary artery
disease undergoing percutaneous coronary intervention in order to provide
personalized treatment and to accurately guide patients with clopidogrel dose.
Methods: Whole blood of 861 patients with coronary heart disease in Tianjin
were obtained and polymorphism of CYP2C19 *2, *3, *17 (more common
in Chinese population) was detected by real-time PCR with fluorescent probes.
Results: The distribution of CYP2C19 gene polymorphism was *1/*1 (343
cases, 39.84%), *1/*2 (333 cases, 38.68%), *2/*2 (87 cases, 10.1%), *1/*3
(44 cases, 5.11%), *2/*3 (27 cases, 3.14%), *1/*17 (18 cases, 2.09%), *2/
*17 (7 cases, 0.81%), *3/*3 (2 cases, 0.23%). According to the metabolic
type, attention was paid to ultra-rapid metabolizers (*1/*17) for bleeding
risk under routine dose administration while extensive metabolizers (*1/*1)
were given conventional dosage. The intermediate metabolizers (*1/*2, *1/
*3 & *2/*17) were either given increased dose or the drug was changed. The
slow (poor) metabolizers (*2/*2, *2/*3 & *3/*3) may produce clopidogrel
resistance and required change of the drug.

82
Baicalin Attenuates Myocardial Ischemia-reperfusion Injury
κB Pathway
Through Akt/NF-κ
Y Luan, W Jiang, Q Qin, J Wang, C Sun
Central Research Laboratory, Institute of Medical Science, The Second
Hospital of Shandong University, Jinnan, China

could significantly up-regulation the protein expression of PI3K, p-Akt and
Akt, but down-regulation of NF-κB p65 in myocardial tissues
Conclusion: Taken together, these findings suggested that baicalin inhibits
I/R-induced myocardial injury with a dose-dependent through activates PI3K/
Akt signaling and suppression NF-κB signaling.

Background: The aim of this study was to investigate baicalin attenuates
myocardial ischemia-reperfusion (I/R)-induced injury in heart and revealed
the underlying mechanism.
Methods and Results: Male rats were subjected to Ligation of left anterior
descending branch (LAD) for 30min followed by reperfusion for 24 h to
establish I/R model. Baicalin was intragastric administration after ischemia
onset, and the animals were randomly divided into five groups: I, sham; II,
I/R; III, 50 mg/kg; IV, 100 mg/kg; and V, 200 mg/kg baicalin. Our results
showed that baicalin could significantly improvement left ventricular ejection
fraction (EF), Left ventricular systolic pressure (LVSP), the maximum velocity
of LV contraction (dP/dtmax) and the maximum velocity of LV diastole (dP/
dtmin). Histology and immunohistochemistry results showed that the infarct
size and apoptosis of cardiomyocyte were significantly decreased, the vessel
density was increased in the groups III, IV and V as compared with group II.
Furthermore, qRT-PCR results showed that the mRNA levels of inflammation
factors TNF-α, IL-1β, IL-6, IL-8 and antiapoptotic gene Bcl2 were downregulated, but the anti-inflammation factor of IL-10, the proapoptotic genes
caspase-3 and the ratio of Bax/Bcl2 were up-regulated was up-regulated when
the I/R rats were treatment with baicalin. Moreover, treatment with baicalin
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Initial Experience with the Micra Leadless Pacemaker at a
Regional Hospital in Hong Kong
S Ching, D Lo, MC Choi, SCS Yue
United Christian Hospital, Hong Kong
Background: The advent of leadless pacemakers revolutionized the
management of patients who are at high risk of complications from traditional
pacemakers. We describe our initial experience with the Micra Transcatheter
system (Medtronic, Minnesota) including its safety, efficacy and indications.
Methods: Clinical data of patients who received the Micra pacemaker from
July 2017 to February 2019 was retrieved and retrospectively analyzed,
including demographics, acute pacing parameters after implantation,
pacemaker position, and pacing threshold one month after implantation.
Results: Twenty-three patients, in whom thirteen (56%) were female and ten
were male (44%), received the Micra pacemaker during the specified period.
Mean age was 81 years. The most common indication was sick sinus syndrome
and atrial fibrillation with slow ventricular rate (96%); one patient received
the device following a lead fracture of his conventional pacemaker implanted
for complete heart block. Implantation was successful following one attempt
in nineteen patients (82%), two attempts in three patients (13%), and three
attempts in one patient (4%). No serious complications occurred. There were
two deaths (8%), both unrelated to the procedure. At implantation, average
R wave amplitude was 10.6 mV, average pacing threshold was 0.67V
at 0.24 milliseconds. Two patients (8%) had pacing thresholds greater than
1V at implantation. At one month, only one patient had pacing threshold

88
Pre-operative Sildenafil for Patients with Pulmonary
Hypertension Undergoing Mitral Valve Surgery: A Systematic
Review and Meta-analysis
DL Villanueva
Philippine General Hospital, Manila, Philippines
Background: Pulmonary hypertension is a usual complication of long
standing mitral valve disease. Perioperative pulmonary hypertension is a risk
factor for right ventricular failure and is an important cause of morbidity and
mortality in patients with pulmonary hypertension undergoing mitral valve
surgery. Phosphodiesterase 5-inhibitors particularly Sildenafil citrate have
proven clinical benefit for pulmonary arterial hypertension but have shown
discordant results in group 2 pulmonary hypertension patients. We sought to
determine the effect of pre-operative Sildenafil on the intra-operative
hemodynamic parameters of these patients.
Inclusion Criteria: Studies were included if they satisfied the following
criteria: 1) Randomized Controlled Trials; 2) Adult patients with pulmonary
hypertension scheduled for elective mitral valve surgery; and 3) Reported
data on changes in pre-, intra-, and post-operative hemodynamic parameters.
Methods: Using PUBMED, Clinical Key, Science Direct, and Cochrane
databases, a search for eligible studies was conducted from September 1 to
December 31, 2018. The quality of each study was evaluated using the
Cochrane Risk of Bias Tool. The primary outcome of interest is on the effect
of pre-operative Sildenafil on the improvement of intra-operative
hemodynamic parameters such as systolic pulmonary artery pressure, mean
pulmonary arterial pressure, mean arterial pressure, pulmonary and systemic

66

greater than 1V. All but one patients had their devices placed at the
interventricular septum; the device was placed at the right ventricular apex
in the remaining patient.
Conclusion: The Micra Transcatheter system is safe in patients considered
high risk for traditional pacemakers. Implantation is successful with one
attempt in most patients. It achieves excellent pacing thresholds both acutely
and at one month.

vascular resistances. We also investigated its effect on the post-operative
mortality, length of cardio-pulmonary bypass time, ventilation time, and
inotrope support requirement. Review Manager 5.3 was utilized to perform
analysis of random effects for continuous outcomes.
Results: We identified 3 studies involving 153 patients with pulmonary
hypertension undergoing mitral valve surgery, showing that among those
who received pre-operative Sildenafil there is a significant decrease in intraoperative systolic pulmonary arterial pressure [mean difference -11.19 (95%
CI, -20.23 to -2.15) p<0.05] and post-operative systolic pulmonary artery
pressure [mean difference -13.67 (95% CI, -19.56 to -7.78) p<0.05] without
significantly affecting the mean arterial pressure [mean difference 1.94 (95%
CI, -5.49 to 9.37) p<0.05]. The systemic and pulmonary vascular resistances
were not affected as well.
Conclusion: Administration of pre-operative Sildenafil to patients with
pulmonary hypertension undergoing mitral valve surgery decreases intraoperative and post-operative systolic pulmonary arterial pressure without
significantly affecting other systemic hemodynamic parameters.
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Use of Bromocriptine for the Treatment of Peripartum
Cardiomyopathy: A Meta-Analysis of Randomized Controlled
Trials
DL Villanueva
Philippine General Hospital, Manila, Philippines
Background: Peripartum cardiomyopathy is a rare, pregnancy associated
cause of left ventricular heart failure in previously healthy women. It remains
an important cause of cardiac-related maternal morbidity and mortality
worldwide. Half of the patients will recover left ventricular function after 6
months. However, in the remainder of patients who do not recover cardiac
function, they will require advanced heart failure therapies. Bromocriptine, a
dopamine agonist which inhibits prolactin release, has demonstrated
improvement in left ventricular recovery and clinical outcome. We sought to
determine the effect of adding Bromocriptine to standard heart failure therapy
on the improvement and recovery of left ventricular function of these patients.
Inclusion Criteria: Studies were included if they satisfied the following
criteria: (1) Randomized Controlled Trials; (2) Pregnant patients who fulfilled
the criteria for diagnosis of peripartum cardiomyopathy and (3) Reported
data on improvement in left ventricular ejection fraction and clinical outcomes.
Methods: Using PUBMED, Clinical Key, Science Direct, Scopus, and
Cochrane databases, a search for eligible studies was conducted from June to
December 31, 2018. The quality of each study was evaluated using the
Cochrane Risk of Bias Tool. The primary outcome of interest is on the effect
of Bromocriptine on the improvement of left ventricular function and clinical
outcomes among these patients. Review Manager 5.3 was utilized to perform
analysis of random effects for continuous outcomes.

90
Efficacy of Ivabradine in Patients with Acute ST-Elevation
Myocardial Infarction Who Underwent Primary Percutaneous
Coronary Intervention: A Systematic Review of Clinical Trials
DL Villanueva
Philippine General Hospital, Manila, Philippines
Background: Ivabradine is a heart rate reducing agent which enables longer
diastolic perfusion time and reduced myocardial oxygen consumption without
detrimental changes in blood pressure and ventricular contractility. It is
currently used and added to conventional therapy for stable angina pectoris
and chronic heart failure patients to improve clinical outcomes. However, its
used in acute ischemic patients has not been established. This study aims to
investigates its potential role in acute ST-elevation myocardial infarction.
Inclusion Criteria: Studies were included if they satisfied the following
criteria: (1) Randomized clinical trials; (2) Adult patients with ST-elevation
Myocardial Infarction (STEMI) who underwent primary percutaneous
intervention (PCI) and treated with Ivabradine on top of standard guideline
directed medical treatment; and (3) Reported data on mortality, major adverse
cardiovascular events (MACE), heart rate reduction, and improvement in
both left ventricular ejection fraction (LVEF) and infarct size.
Methods: A search for eligible studies was conducted from November 1,
2018 to January 31, 2019. The quality of each study was evaluated using the
Cochrane Risk of Bias Assessment Tool. Given the significant methodological
and statistical differences between published studies, combining the data
using meta-analysis methods was not appropriate. Our primary outcome of
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Results: We identified 2 randomized controlled trials of 58 pregnant patients
diagnosed with peripartum cardiomyopathy, showing that among those who
received Bromocriptine on top of standard heart failure therapy, there is a
significant improvement in the left ventricular ejection fraction at 6 months
[mean difference 15.14 (95% CI, 6.53 to 23.75) p <0.05] compared to standard
heart failure therapy alone. It was also observed that those who received
Bromocriptine had better clinical outcomes.
Conclusion: The addition of Bromocriptine on top of standard heart failure
therapy significantly improved the left ventricular ejection fraction of patients
with peripartum cardiomyopathy at 6 months post-partum. This novel therapy
may be considered in the to improve the management of these patients.

interest was all-cause or cardiovascular (CV) mortality. We also investigated
the effect of Ivabradine on major adverse cardiovascular events (MACEs),
heart rate reduction, and improvement in left ventricular ejection fraction.
Results: We identified 7 studies involving 1097 STEMI patients who were
treated with Ivabradine on top of guideline directed medical therapy. Six
studies showed significant heart rate reductions in the Ivabradine group
without any detrimental effect in blood pressure. Significant LVEF
improvement with concomitant decrease in LV end systolic and end diastolic
volumes in the Ivabradine group was reported by three studies. However,
two studies did not demonstrate significant differences in mortality and
MACEs between the two treatment groups.
Conclusion: This systematic review revealed that the addition of Ivabradine
to standard guideline directed medical therapy causes significant heart rate
reductions with a concomitant improvement in LVEF among STEMI patients.
Further dedicated large scale trials in STEMI patients with defined clinical
endpoints are still needed to improve clinical decision making.
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The New SHSMA Patent Ductus Arteriosus Occluder: Single
Center Experience
Y Shi, J Huang, T Wu, S Zhang, H Li, Q Wang, P Li, R Wu
The Second Affiliated Hospital of Wenzhou Medical University , Wenzhou,
China

closure in all 13 patients,100% at 30 days, and in 100% of patients at 2
years. There was no device embolization, hemolysis, or obstruction to the
pulmonary artery or descending aorta.
Conclusion: The new type SHSMA  PDA occluder is feasible, safe and
effective.

Background: The new type SHSMA  patent ductus arteriosus (PDA)
occluder is novel, self-shaping Nitinol wire device with nano fabric patches
integrated into the shank of the device to assure a better obturation of the
ductus. The SHSMA PDA occluder has undergone animal test. This report
presents our experience to evaluate the feasibility, safety, and efficacy of the
SHSMA PDA occluder for closure of PDA.
Methods: A prospective, randomized pilot study was started in August 2014.
13 patients were included until June 2017. Patients weighing less than 6kg
or those with associated cardiac anomalies that required surgery were
excluded. All patients were followed up by transthoracic echocardiography,
electrocardiogram, and chest radiographs at 24 hours, 30, 90, 180, 360 and
720 days after implantation. All occluders were delivered via 7-9F long sheaths
and PDA closures were performed following standard techniques.
Results: Thirteen patients (6 nano fabric patches single-rivet, 7 double-rivet),
were included. All the 13 patients were closed successfully using SHSMA
ductal occluder, 5 patients (83.3%) in nano fabric patches single-rivet group,
and 7 patients (100%) in double-rivet group had immediate and complete
closure on angiography. Within 24 hours, color Doppler revealed complete

111
A Retrospective Study on the Predictors of Outcome in Patients
with Infective Endocarditis
YF Yiu, NY Chan
Princess Margaret Hospital, Hong Kong
Background: Infective endocarditis (IE) is associated with significant
mortality and morbidity. Recent western studies have demonstrated a change
in epidemiology in the past decade but the local data is sparse. This study
aims to provide an update on the epidemiology of IE and to identify predictors
of adverse outcome of IE in the Chinese population in Hong Kong.
Methods: The Clinical Data Analysis and Reporting System was searched
for all cases with a diagnosis of IE in Princess Margaret Hospital in the period
2002-2016. All cases which fulfilled the modified Duke’s criteria for IE were
recruited. Primary outcome was defined as in-hospital mortality. Secondary
outcomes included 1-year mortality, valvular surgical intervention, heart
failure, stroke and systemic embolization.
Results: A total of 196 patients with 166 definite (84.7%) and 30 possible
(15.3%) IE were included in the study. The median age was 60.2 (IQR 45.472.1) years and 90.3% of patients had native valve IE. 32% of cases were
classified as health care-associated IE (HCAIE). The overall incidence (event
per 100,000 person) of IE was 2.26 and had remained stable. An increasing
trend of HCAIE (p for trend = 0.04) was observed during the study period.
Staphylococcus aureus was the most frequently isolated organism in the overall
study population (37.8%) and among intravenous drug users (85.2%). The
most common complications were heart failure (43.4%), systemic
embolization (19.4%) and stroke (18.9%). Early surgery was performed
in 8.6% of patients before discharge. In-hospital mortality remained high
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(29.1%) and was independently associated with higher Charlson Comorbidity
Index (OR 1.24, p=0.001), heart failure (OR 5.65, p<0.001) and the presence
of large vegetation ≥1 cm (OR 4.67, p<0.001). IE due to Streptococcus
viridans was associated with a better outcome (OR 0.40, p=0.048). The crude
survival rate at one-year follow-up was 89.2% but up to 10% of survivors
suffered an episode of relapse or recurrence at 1 year.
Discussion: The present study showed that the incidence of IE remained
stable during 2002-2016. There was an increasing proportion of HCAIE and
Staphylococcus aureus has become the most common causative organism.
The diagnosis of IE was associated with high mortality and morbidity.
Independent predictors for in-hospital mortality were patient's medical
comorbidity, large vegetation size and heart failure, while infection by Viridans
group streptococci was associated with decreased risk.
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Nurse-led Chest Pain Clinic: Safe and Effective
SH Chiu, PT Tsui
Cardiac Team, Department of Medicine & Geriatrics, Princess Margaret
Hospital, Hong Kong
Background: There are many causes of chest pain, some of which are benign
with a non-cardiac origin, while others are potentially life-threatening, such
as acute myocardial infarction (AMI) and coronary heart disease (CHD). In
Princess Margaret Hospital (PMH), long waiting time for the first cardiology
consultation, slow progress to definite diagnosis or treatment and clinic
overtime has reached critical point. Such prolonged duration of time to
diagnosis inadvertently put patients to a greater risk.
Methods: The nurse-led out-patient Chest Pain Clinic (CPC) was established
in June 2017 in PMH. Patients with atypical chest pain, and suspected to
have CHD, having a general medical appointment exceeding 12 months,
would be invited to attend the CPC. An objective risk stratification algorithm
based on symptomology and Framingham risk scores were used to classify
patients into low, moderate and high-risk groups. After the comprehensive
assessment, further investigations with protocol guided would be prescribed.
The nurse evaluated patients' symptoms and explained the results to them
during the follow-up consultation. Lastly, patients were referred to
Cardiologist for the decision of case closed. The records were reviewed
retrospectively to evaluate management outcome by nurse-led CPC versus
the usual care. Patients were randomly chosen from usual pathway with both
sex and age (+/-1) matched from CPC. The revision of treadmill result was
counted as the study endpoint.

113
Establishment of Minimally Invasive Mouse Transverse Aortic
Constriction Model without Mechanical Ventilation
L Liu, W Zhao, Y Gan, L Liu, J Tian
Children's Hospital of Chongqing Medical University, Chongqing, China
Background: The transverse aortic constriction (TAC) model is widely used
in research of heart failure. In the past, tracheal intubation and mechanical
ventilation were mostly used to establish this animal model. Endotracheal
intubation is time consuming in mice, and the classic TAC surgery is highly
traumatic, resulting in a high mortality rate in mice. The aim of this study
was to establish TAC model by inhalation anesthesia via mask without
endotracheal intubation.
Methods: (1) SPF class c57 mice aged 3 months were randomly divided into
sham operation group (Sham), mechanical ventilation TAC group (MVT)
and non-mechanical ventilation TAC group (NMVT) to establish the TAC
models. In MVT group, the classic TAC surgery was performed under
mechanical ventilation with endotracheal intubation. In NMVT group,
minimally invasive TAC surgery was performed without endotracheal
intubation; In Sham group, the surgical procedure was the same as that of the
NMVT group except contraction of aortic arch. (2) Four weeks after operation,
left ventricular anterior wall (LVAW), left ventricular internal dimension
(LVID) and left ventricular posterior wall (LVPW) were detected respectively
by high frequency ultrasound, and the left ventricular EF was calculated.
(3) The myocardial tissue of mice in all the groups were collected after surgery
four weeks later, and ultrastructure of myocardium was observed by
microscope after HE staining.
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Result & Outcome: From June 2017 to April 2018, there were 29 patients
attended the CPC. One (3.4%) high-risk patient received early invasive
intervention. Thirteen (10.3%) patients defaulted the medical follow up after
investigations result was reviewed by nurse. Thirteen (44.8%) of them did
not show any evidence of CHD with case closed after first medical
consultation. The remaining 12 (41.4%) patients continued medical followed
up due to other medical diseases were suspected. The total episodes of medical
consultation was 26 (median 1) in CPC versus 147 (median 5.5) in usual
pathway. The follow-up duration (months) per patient from the first
consultation to case closed was greatly shorten from median 18.5 (7-23) in
usual pathway to median 4 (3-8) in CPC. Result also showed that advanced
patients to CPC can greatly reduce accident & emergency department (AED)
utilization from 24.5% to 3.4% with 6 months at study endpoint. Moreover,
there was no acute cardiac event or unplanned admission reported. The nurseled CPC is safe and more cost effective than the usual care in managing
patients with atypical chest pain.

Results: (1) The operating time (10.86±2.36 min, including endotracheal
intubation time) of the NMVT group was significantly reduced compared
with that of the MVT group (24.44±3.55 min) (P<0.05), the survival rate of
mice was improved (93.3% versus 73.3%) (p<0.05). (2) There was no
significant differences in arterial arch diameter and blood flow velocity,
LVAW, LVID, LVPW and LVEF among sham group, MVT group and NMVT
group before operation. Postoperatively, MVT group and NMVT group
showed statistically differences in theose above indicators compared with
themselves preoperatively and the Sham group postoperatively, and there
was no statistically significant differences between the two groups
postoperatively (p<0.05). (3) Compared with the sham group (14.11±
1.90 mm), diameter of cardiac myocytes in the MVT group (21.28±
3.17 mm) and the NMVT (21.12±2.84 mm) group were enlarged (p<0.05).
Conclusion: (1) The pressure overload TAC model can be established
successfully by minimally invasive surgery without mechanical ventilation.
(2) Minimally invasive TAC without mechanical ventilation in mice can
reduce operation time and improve survival rate.
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Gene Therapy for Hypertrophic Cardiomyopathy Targeting
Myh7 Based on CASAAV
Y Li, C Wang, K Zhou, Y Hua
West China Second Uni Hospital, Sichuan University, China
Objective: To investigate the role of Myh6 and Myh7 in cardiomyocyte
maturation and the hypertrophic procedure. Besides, try to get the basic
understanding of related gene therapy based on Cas9-AAV system.
Methods and Results: We developed CASAAV (CRISPR/Cas9-AAV9-based
mutagenesis), a platform in which AAV9 delivers tandem guide RNAs
targeting a gene of interest and cardiac troponin T promoter (cTNT)-driven
Cre to RosaCas9GFP/Cas9GFP and Calcineurin+RosaCas9GFP/Cas9GFP
mice. Two single guide RNA had been designed in to AAV9-U6-gRNA-TnTCre to delete Myh6 and Myh7. When directed against Myh6 with high dose
AAV, which is a gene described as main isoform postnatally in RosaCas9GFP/
Cas9GFP mice, we achieved efficient, rapid, and CM-specific Myh6 depletion.
After that, all the mice demonstrated severe heart dysfunction and death within
1 month. So, we used low-dose AAV injection to delete Myh6 and preserve
normal heart function. In this situation, CMs lacking Myh6 had severely
disrupted sarcomere and T-tubules with a much smaller CM area, especially
in width. Interesting, high-dose AAV9 ablated Myh7 in 75% neonatal CMs
and would still cause lethal heart failure in 5 months as Myh7 is a gene
considered as useless after birth in normal condition, whereas low-dose AAV9
ablated Myh7 in 25% CMs and preserved normal heart function. In the context
of preserved heart function, CMs lacking Myh7 developed T-tubules that
were nearly morphologically normal, indicating that Myh7 does not have a

major, essential, cell-autonomous role in Sarcomere and T-tubule formation.
However, it still made some roles in the total heart function maturation. And
if Myh7 had been deleted from P28, there was no heart dysfunction and mice
d e a t h o b s e r v e d . T h e w e i n j e c t e d A AV- M y h 7 - T n T- C r e i n t o
Calcineurin+RosaCas9GFP/Cas9GFP mice at P28 to explore whether such
kind of gene therapeutic method could reverse the hypertrophic morphology.
After deletion Myh7 in Calcineurin+RosaCas9GFP/Cas9GFP mice, normal
sarcomere and T-tubule formation had been identified. And almost normal
cell size and morphology could be observed among such mice with a
better heart function in 6 months compared to non-treated
Calcineurin+RosaCas9GFP/Cas9GFP mice.
Conclusions: Myh6 could be a major isoform in maintain heart function and
morphological maturation in mice postnatally. However, Myh7 still plays a
crucial role in preserving heart function in very early stage after birth, and
makes no contribution after 1 month. So that, if we knock out Myh7 at P28
using CASAAV system in hypertrophic mice could help it to preserve heart
function and reverse the hypertrophic morphology.

121
Computed Tomography Pictorial Review of Coronary Artery
Anomalies
WK Li, CH Chui, SK Cheung, YL Leung
Department of Radiology, North District Hospital, Hong Kong
Background: Computed Tomography Coronary Angiogram(CTCA) is a noninvasive approach in preliminary investigation of heart condition with high
accuracy. This pictorial review aims to identify and illustrate the findings
from CTCA done in NDH.
Materials and Methods: It is a retrospective study of coronary angiogram
done in North District Hospital from 2008 to 2018. All scans were performed
on two 64-slice CT scanner (GE Medical System, Lightspeed VCT, 64x0.625
mm and Siemens SOMATOM Definition AS), under electrocardiographic
(ECG)-gated. Contrast medium(Omnipaque 350) was injected into venous
system at 5 ml/s with saline chase. The findings were categorized and images
being post-processed with Siemens Syngo.via platform.
Results: 424 CTCAs were done on average annually in NDH. Rare coronary
artery anomalies were identified, including abnormal origin of vessel,
hypoplasia, ectopic ostium, fistulae, myocardial bridging, tortuous enlarged
vessel and aneurysm.
Conclusion: CTCA is a useful tool to identify coronary artery conditions.
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Impact of Vagal Denervation on Recurrence of Atrial Fibrillation
after Pulmonary Vein Isolation
U Do, J Kim, M Kim, MS Cho, GB Nam, KJ Choi, YH Kim
Asan Medical Center, Seoul, South Korea
Background and Objectives: Besides elimination of pulmonary vein trigger,
vagal denervation is one of mechanisms of atrial fibrillation prevention after
pulmonary vein isolation (PVI). We sought to evaluate (1) vagal denervation
as assessed by change of sinus cycle length (SCL), AV block cycle length
(AVBCL) and refractory period of AV node (AVNERP) after PVI and impact
of vagal denervation on recurrence of AF in (2) paroxysmal AF and (3)
persistent AF patients.
Methods: A total of 50 consecutive paroxysmal AF (PAF) patients who
underwent their first PVI was selected from our prospective AF registry. All
patients underwent measurement of SCL, AVBCL, AVNERP before and after
PVI. Additional 103 patients with persistent AF patients underwent
measurement of SCL, AVBCL, AVNERP after PVI. Systematic follow-up for
recurrence of atrial fibrillation was done in all patients.
Results: (1) SCL, AVBCL and AVNERP decreased by 231±143, 87±75,
98±137 ms respectively after PVI in PAF patients. (2) AF recurred in 14
patients (28.0%) within 3 months after PVI in PAF patients. There was no
difference AVBCL, AVNERP between PAF groups with and without
recurrence. The SCL post PVI was the only significant different between no
recurrence and recurrence group (762±96 ms vs 683±101 ms, P=0.015).
Optimal cut-off post-PVI SCL for predicting the early recurrence was

124
Pulmonary Vein Isolation Using High Power (50 Watts)
Radiofrequency Energy in Patients Undergoing Atrial Fibrillation
U Do, J Kim, M Kim, MS Cho, GB Nam, KJ Choi, YH Kim
Asan Medical Center, Seoul, South Korea

693 ms. During the median follow up period 220 days, AF recurred in 12
patients. There was no difference in SCL, AVBCL, AVNERP after PVI, delta
SCL, delta AVBCL, delta AVNERP between groups with AF recurrence and
without recurrence in PAF group. (3) Post ablation SCL, AVBCL, AVNERP
was not different in persistent AF patients with and without both early and
late recurrence.
Conclusions: Vagal denervation was observed in majority of AF patients
undergoing PVI. However, markers of vagal denervation were not associated
with recurrence of AF in paroxysmal and persistent AF patients.

Conclusions: High power RF ablations for pulmonary vein isolation was
associated with short procedural and RF time. It was effective and safe.
Efficacy outcome beyond 3 months will be presented.

Background and Objectives: High power-short duration (50 W/5s)
radiofrequency (RF) energy has been used in a few centers for atrial fibrillation
(AF) ablation. We sought to evaluate efficacy and safety of high power RF
energy in patients undergoing AF ablation.
Methods: Of prospective AF ablation registry 44 patients who underwent
high power ablation were included in this study. All patients underwent PV
isolation using a contact force catheter with automatic annotation module.
The primary efficacy outcome was any recurrent atrial arrhythmia after index
ablation. The safety outcome was any complication related to the procedure.
Results: Total procedure time, ablation time and fluoroscopy time was 143±39,
29±10 and 8±3 minutes, respectively. During the 3 months period, any atrial
arrhythmia recurred in 16 patients (36.4%). Among initial 30 patients in
whom RF energy was delivered for 5 seconds per lesion, atrial arrhythmias
recurred in 13 (43.3%). After prolongation of RF time to 10 seconds in anterior
and superior antrum, atrial arrhythmias occurred in 3 patients (21.4%). Cardiac
tamponade or stroke did not occur in any patient. Among 38 patients who
underwent upper gastrointestinal endoscopy after ablation, superficial
esophageal ulcer was found 1 patient.

J HK Coll Cardiol, Vol 27

April 2019

71

HK COLLEGE OF CARDIOLOGY, TWENTY-SEVENTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS
Abstracts for Poster Presentations:
BEST POSTERS PRESENTATION
126
Burden of CVD in Very Young Patients Admitted in a Tertiary
Care Hospital, Bangladesh
CMS Kabir
Ibrahim Cardiac Hospital & Research Institute, Shahbag, Bangladesh
Background: Coronary Heart Disease (CHD) remains a major cause of death
in Bangladesh. CHD in younger age is not, simply a problem of sufferers but
a huge emotional & economical loss to the family. This study looked at the
demographic data & risk profile of very young patients presenting to a busy
tertiary PCI centre in Dhaka, Bangladesh.
Methods: Prospective data was collected on patients who underwent coronary
angiography over a 6-month period from January-June 2018. "Young" was
defined as ≤35 years of age.
Results: Young patients comprised of 15.4% (n=60) of all patients in this
period. Mean age was 32.1±3.1 years & only 15% (n=9) were obese. Male
sex (70%), hypertension (41.7%), dyslipidaemia (30%) & smoking (23.5%)
were the major conventional risk factors followed by diabetes mellitus
(23.3%). Family history of pre mature CHD were seen in 12.9%. Mean
ejection fraction was 52.4±12.3%. Clinical presentation was STEMI in 24
(40%) patients, NSTEMI in 5 (8.3%) & UA in 9 (15%) patients. 8.3% (n=5)
received thrombolytic therapy. Angiography was performed via the right radial
access in 90% & via left radial access in 10% patients. SVD was seen in 20
(33.3%) young patients while 12 (20%) & 2 (3.3%) patients had double
vessel & triple vessel disease respectively. Normal coronaries were noted in
18 (30%) patients while 4 (6.7%) had recanalized IRA & 1 (1.6%) had pure
ectasia. LAD was main artery involved in 28 (46.6%) patients while LCx &

127
Outcome of PCI to CTO Lesion Through Transradial Approach
Using 5Fr vs. 6Fr Guiding Catheter with Least Hardware
CMS Kabir
Ibrahim Cardiac Hospital & Research Institute, Shahbag, Bangladesh

RCA were involved in 11 (18.3%) & 15 (25%) patients respectively. Twentyseven of the young patients required coronary revascularization. Twentyfour (33.3%) were performed percutaneously with DES & 3 (5.0%) had
surgical revascularization. Of the PCI cohort, 3 (12.5%) patients underwent
primary PCI & 1 (4.1%) underwent POBA. Nineteen (79.2%) patients required
1 stent while 5 (20.8%) patients required 2 stents during PCI. Mean stent
diameter & length were 2.7±0.2 & 21.0±8.4 mm respectively. There were no
in-hospital deaths, MI or cerebrovascular events.
Conclusion: Very young adults had significant CAD which warrants extremes
of preventive steps and also revascularization to prevent reoccurrence of
fatalities due to CAD.

Conclusion: Backup support of guide catheter is an important prerequisite
for PCI to CTO. "Active back up support" by 5 F guide catheter is better in
our experience especially for left system. Other than using bulky devices like
IVUS catheter and rotablation, 5 F guide catheter can be feasible comfortable
choice for CTO PCI.

Background: Treating CTOs by antegrade approach needs skill and
appropriate devices. Guide catheter is an important factor for success.
5 F guide catheter for treating CTO is an alternate choice for diabetic
population with narrow caliber radial artery.
Methods: In an absolute radial center like ours, PCI to CTO lesion for last
1 year since July 2017 to June 2018 were evaluated retrospectively by
antegrade approach through transradial access. Total 147 CTO lesions were
attempted by this period of time. Using 5 F or 6 F guide catheter was operator's
choice.
Results: Out of 147 CTOs in diabetic patients, 66 (45%) was by 5 F guide
catheter and 81 (55%) was by 6 F guide catheter. Success rate in both group
was almost similar (63.6% vs 65.4%, p=0.82). Smaller profile balloon support
was needed in both groups in similar number (66.7% vs 69.1%, p=0.75).
Workhorse CTO guide wire in our lab was thin hydrophilic PT2 (Boston)
and used in similar percentage (94% vs 89%, p=0.28). Only in 5 cases each,
micro catheter was used. CTO of LAD was more in 5 F group (45.5% vs
34.6%). CTO lesion of RCA was 35% vs 40%. Contrast volume is lower in
5F group though not statistically significant (152 vs 165 ml, p=0.26).
Fluoroscopy time was similar in both groups.
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Seasonal Variation of the 12-lead ECG, Cardiac Structure and
Function on 2D and Speckle Tracking Echocardiography in the
Elite Senior Rugby League Athlete
L Forsythe,1 J Somauroo,1 K George,1 M Papadakis,2 N Mill,3 M Daniels,3
D Oxborough1
1
Liverpool John Moores University, Liverpool; 2St. George's University
Hospitals NHS Foundation Trust, London; 3St. Helens Rugby Football Club,
St. Helens, United Kingdom
Background: Pre-Participation cardiac screening (PPCS) of rugby league
players (RLP) competing in the English Superleague is mandatory and may
be undertaken at any time during the season. We aimed to assess ECG and
echocardiography in RLP at clearly defined stages of the season.
Methods: 20 elite male RLP from a single club underwent PPCS using ECG,
2D echocardiography and speckle tracking echocardiography (STE) at four
sequential time points across RLP season; 1) End of pre-season training
(ENDPRE), 2) mid-season competition (MIDSEAS), 3) end-season
competition (ENDSEAS) and 4) End of off-season detraining (ENDOFF).
Training loads for each time point were determined. A one-way ANOVA with
post-hoc Bonferroni assessment were used for statistical analyses.
Results: There were no differences in RLP demographics and heart rates
across the season. Average daily training during pre-season training
(ENDPRE) was significantly higher (more than double) compared to all other
points (P<0.001) with no differences between MIDSEAS and ENDSEAS.
Training-related ECG changes (normal on International Criteria) were
commonly seen and the percentage of RLP presenting with one, two or three

139
10-year outcomes of isolated Coronary Artery Bypass Grafting
in Hong Kong
JWY Chan, K Lim, T Fujikawa, WT Kwok, S Wan, YP Wan, J Underwood,
RHL Wong
Division of Cardiothoracic Surgery, Prince of Wales Hospital, The Chinese
University of Hong Kong, Hong Kong
Background: Isolated coronary arterial bypass grafting (CABG) was one of
the most commonly performed procedures in cardiac surgery. However, long
term clinical results are not available in Hong Kong. In this study, we
examined and summarized 10-years results after isolated CABG.
Method: We retrospectively reviewed consecutive patients who underwent
isolated CABG in Prince of Wales Hospital from January to December 2008.
Patients’ demographics including sex, age, intra-operative parameters, and
post-operative outcomes and long-term results are collected and analyzed.
Results: From January to December 2008, we performed 158 cases of isolated
CABG. Mean age was 62.1 year old. One hundred twenty-two patients
(77.2%) were male. One hundred thirty-nine (88.0%) patients underwent
elective operation and 19 (12.0%) underwent non-elective operation. Sixtythree patients (39.9%) had significant left main trunk disease. One hundred
and two (64.6%) patients had angina, 56 (35.4%) patients had previous
myocardial infraction and 16 patients (10.1%) had prior coronary intervention.
Mean pre-operative Canadian Cardiovascular Society(CCS) classification was
2.55±0.78. On-pump CABG was performed in 155 patient (98.1%). Numbers
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training-related changes did not vary significantly throughout the season.
There were no abnormal (non-training related) changes at any of the timepoints. There were no differences across the season in LV, RV or atrial
structural parameters or conventional functional indices. Although LV and
RV global strain (ε) and strain rate (SR) were similar across all three planes
of contraction (P>0.05), LV apical rotation and derived twist were higher in
ENDPRE (9.83° and 16.55°), compared to MIDSEAS (6.13° and 12.62°;
P=0.004 and P=0.027 respectively), ENDSEAS (5.84° and 12.12°; P=0.002
and P=0.0009) and ENDOFF (6.60° and 12.35°; P=0.019 and P=0.017).
Conclusion: Despite seasonal variation in training load, there were no
significant changes in ECG and cardiac structure in elite RLP indicating that
PPCS can be performed at any time point throughout the season. Cardiac
function was also unchanged with exception of LV twist which was higher
during periods of higher training loads. Twist may be a more sensitive marker
to acute training effects in RLP and may provide additional diagnostic value
in the setting of PPCS to aid the differentiation from cardiomyopathies.

of revascularised vessels were 2.87±0.62. There were no in-hospital death,
and mean hospital stay after operation was 7.2±5.5 days. Mean CCS
classification was 1.08±0.29 post-operatively. Mean follow up months were
113.6±27.9 months. Survival rate by Kaplan-Meier analysis and MACCE
(Major Adverse cardiac and cerebrovascular events) free rate at 1-, 3-, 5-, 7-,
and 10-years was 98.1%, 95.6%, 91.8%, 86.1% and 75.9%; and 96.2%,
91.8%, 86.0%, 78.9% and 65.2% respectively. Follow-up rate was 99.6%.
Conclusion: Our isolated CABG is a well-established procedure and proven
to have excellent long-term clinical outcomes.
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Role of Statins for the Prevention of Anthracycline-Induced
Cardiomyopathy: A Meta-analysis
J Reymatias, DL Villanueva, V Ramiro, JD Magno
University of the Philippines - Philippine General Hospital, Manila,
Philippines
Background: Anthracyclines are key components of many chemotherapeutic
regimens, having demonstrated efficacy in lymphomas and many solid tumors.
However, a major factor limiting their use is a cumulative, dose-related
cardiotoxicity which ultimately leads to asymptomatic and symptomatic heart
failure. Oxidative stress is considered as a major mechanism in anthracyclineinduced cardiomyopathy. Statins have been shown to possess anti-oxidative,
pleiotropic effects besides their anti-inflammatory and lipid-lowering effects.
This study evaluated the potential role of statin for the prevention of
anthracycline-induced cardiomyopathy.
Methods: Using MEDLINE, EMBASE, ScienceDirect, Scopus, Google
Scholar, ClinicalKey, Cochrane Database of Systematic Reviews, clinicaltrials.
gov, and Cochrane Central Register of Controlled Trials databases, a search
for eligible studies was conducted until December 2018. Included studies
were evaluated based on the Cochrane Collaboration's tool for assessing risk
of bias. Our primary outcome of interest was the development of anthracyclineinduced cardiomyopathy. We also investigated the mean change in LVEF
pre- and post-chemotherapy with anthracycline. Review Manager (RevMan)
5.3 was utilized to compute for relative risk and mean change in LVEF. A
random effects model was applied for all meta-analyses.

141
Follow-Up of Percutaneous Transcatheter Closure of Pulmonary
Arteriovenous Fistulas: Experiences from a Single Center
S Xi
Guangdong Cardiovascular Institute, Guangdong General Hospital,
Guangdong Academy of Medical Sciences, China
Background: Percutaneous transcatheter occlusion is an alternative therapy
for pulmonary arteriovenous fistulas (PAVFs). However, the evidence related
to the efficacy and safety of transcatheter closure of PAVFs is still lacking
due to the rarity of this condition. We aimed to evaluate at our center the
efficacy, safety, and prognosis of transcatheter closure of PAVFs.
Methods: The medical records of patients who underwent heart
catheterization or (and) transcatheter closure of PAVFs between April 2006
and April 2015 at Guangdong Cardiovascular Institute (Guangdong, China)
were reviewed.
Results: Thirteen consecutive patients (median age: 22.3±15.7 years; range:
1-55 years) with PAVFs underwent heart catheterization and ten patients had
successful transcatheter closure. Three patients were diagnosed with a PAVF
that was associated with hereditary hemorrhagic telangiectasia. During a mean
follow up of 7.1±2.7 years (range: 3-12 years), two patients (2/10) underwent
a re-intervention procedure. One patient (1/10) underwent a lobectomy due
to recanalization, and two patients underwent reperfusion from an untreated
adjacent pulmonary feeding artery. The recanalization and reperfusion rates
were 30% (3/10), respectively. Three patients with closure or without closure
developed pulmonary hypertension (PH) during the follow-up. Two patients
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Results: We identified 3 studies involving 332 cancer patients, showing that
in cancer patients undergoing anthracycline-based chemotherapy, pretreatment with statins was associated with a lower risk of developing
anthracycline-induced cardiomyopathy (RR 0.33, 95% CI 0.14-0.79,
p<0.05). There was a significant decrease in LVEF among patients who were
not treated with statins (Mean difference -6.25, 95% CI -11.68 - (-) 0.82,
p=0.02)
Conclusions: Pre-treatment with statins on cancer patients undergoing
anthracycline chemotherapy may prevent the development of anthracyclineinduced cardiomyopathy and reduction in LVEF. This will expand the utility
of statin as a medication for the prevention and treatment of cardiovascular
diseases.

developed central nervous system complications from cerebral infarction.
The rate of complications such as cerebral infarction, PH, recanalization,
and even death during the follow-up that was associated with PAVF was 46%
(6/13).
Conclusions: Percutaneous transcatheter is an effective and safe therapeutic
method for PAVFs in both adult and pediatric populations. The occurrence
rate of complications associated with occlusion and (or) PAVF and the
recanalization rate were relatively high. Therefore, patients with a PAVF need
more prudent treatment and more rigorous follow-up.
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Growth Differentiation Factor–15 Predicts Major Adverse
Cardiac Events in Patients Undergoing Percutaneous Coronary
Intervention: A Systematic Review and Meta-analysis
L Liu, 1,2,3 J Chen,1,3 Y Liu1,3
Guangdong Cardiovascular Institute; 2 Southern Medical University;
3
Guangdong Provincial People's Hospital, China

Conclusion: Compared with low plasma GDF-15 levels, high plasma GDF15 levels are associated with an increased risk of the MACEs in patients
undergoing PCI. It suggests that plasma GDF-15 levels should be evaluated
to prevent MACEs events after coronary revascularization.

1

Background: Recent studies have shown Growth differentiation factor-15
(GDF-15) might be a potential predictive cytokine for the prognosis of
coronary heart disease (CHD). The aim of this study was to systematically
evaluate Major Adverse Cardiac Events (MACEs) following Percutaneous
Coronary Intervention (PCI) in patients with high GDF-15 through a metaanalysis.
Methods: Publication searches of the Ovid MEDLINE, EMBASE and
Cochrane Central databases were performed without any time or ethnicity
restrictions. The inclusion and exclusion criteria were clearly addressed. Two
authors independently screened studies for inclusion, consulting with a third
author where necessary to resolve discrepancies. Data analysis was performed
by computing the hazard ratios (HR) with 95% confidence interval (CI).
Publication bias was tested using funnel plots and the Egger test.
Results: We identified five eligible studies including a total of 8743 CHD
patients undergoing PCI following the inclusion criteria. The maximal
duration of follow-up ranged from 6 months to 5 years. Random effects models
were used for the analysis and we found that high GDF-15 was associated
with a higher risk of the MACEs in patients undergoing PCI (hazard ratios
(HR), 1.69; 95% confidence interval (CI), 1.26-2.28).

144
Non-acute Myocardial Infarction Patients with Chronic Renal
Failure May Not be Benefit from Myocardial Revascularization
L Lei,1,2 J Liu,1 S Chen,1 W Guo,1 F Song,1 G Sun,1 Y He,1 Z Guo,1 B Liu,1
L He,1 L Liu,1,2 G Chen,1 Y Liu1
1
Guangdong Provicial People's Hospital; 2The Second School of Clinical
Medicine, Southern Medical University, Guangzhou, China
Background: Patients with chronic renal failure (CRF) have been excluded
from many trials on myocardial revascularization, hence its benefits remains
controversial.
Aim: To investigate whether myocardial revascularization will lead to
decreased mortality in non-acute myocardial infarction patients with CRF.
Method: A total of 1440 consecutive non-acute myocardial infarction patients
with CRF undergoing coronary angiography (CAG) or percutaneous coronary
intervention (PCI) were divided into a PCI group (n=970) and a non-PCI
group (n=470) depending on whether they have PCI or not. CRF was defined
as estimated glomerular filtration rate (eGFR) <90 mL/(min×1.73 m2). The
endpoint was all cause mortality, which was defined as any death recorded
after the date of enrollment. Multivariable logistic regression and Cox
proportional hazards regression analyses were performed to identify the
association between myocardial revascularization and long-term mortality.
Result: Overall, during the mean follow-up of 3.34±0.02 years, mortality
was 5.1 (n=49) and 5.7% (n=27) in PCI group and non-PCI group,
respectively. Multivariable logistic regression analysis showed that CRF stage
IV (eGFR 15-30 mL/min/1.73 m 2), diabetes mellitus, pre-procedure
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hypotension, heart failure and the use of beta blocker were significantly
associated with long-term mortality [HR of 7.043 (3.385-14.656), HR of
1.849 (1.119-3.053), HR of 2.498 (1.099-5.677), HR of 2.460 (1.475-4.102)
and HR of 0.428 (0.261-0.701), respectively]. There was no difference in all
cause mortality between PCI group and non-PCI group. [HR of 1.594
(0.927-2.739)].
Conclusion: Myocardial revascularization may not be associated with
decreased mortality in non-acute myocardial infarction patients with chronic
renal failure.
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Variations in Pulmonary Artery and Systemic Blood Pressures
During the Induction Period of General Anesthesia in Elderly
Patients: A Pilot Study
Y Liu,1 H Fu,1 FKS Woo,2 A Wei,3 Y Zhu,1 W Zhao,4 F Chen1
1
Anesthesia Department of Chongqing Emergency Medical Center (Affiliated
Central Hospital of Chongqing University), Yuzhong District, China; 2Institute
of Future Cities, The Chinese University of Hong Kong, Hong Kong;
3
Department of Anesthesiology, The Second Affiliated Hospital of Chongqing
Medical University, Yuzhong District, China; 4Department of Anesthesiology,
Chongqing Public Health Medical Center, Shapingba District, China

Results: PASP and PAMP both increased with aging (PASP: 23.25±3.58,
28.15±4.70, and 31.27±3.22 mmHg; PAMP: 14.32±1.12, 19.22±2.15, and
23.62±1.85 mmHg; for 65-74 years old, 75-84 years old, and ≥85 years old,
respectively, P<0.05). MABP at one minute before induction significantly
increased with aging (92±10.8, 108±11.2, and 116±12.8 mmHg), while
MABP measured at 1, 3 and 5 minutes after anesthetic induction were
significantly decreased with aging (P<0.05). MABP was significantly and
inversely correlated with the PASP before anesthesia induction (r= -0.54).
Conclusion: Our study highlights the significant correlation between the
reduction of MABP and age-related increased PAP, during the induction
period of general anesthesia in elderly patients.

Background: Aging is a predictor of hypotension during the induction of
general anesthesia. However, the potential mechanisms underlying this
association are scarcely investigated. The present study aims to correlate aging,
increased pulmonary artery pressure (PAP) and the reduction of mean arterial
blood pressure (MABP) during anesthetic induction in elderly patients.
Methods: 180 elderly patients, receiving surgeries under general anesthesia
were recruited. They were allocated into different age groups (n=60, each
group): 65-74 years old, 75-84 years old, and 85 years old groups. Systolic
and mean PAP (PASP, PAMP) was invasively measured using a right heart
floating catheter before induction, and MABP was measured using an invasive
radial artery catheter, at one minute before and within five minutes after
anesthetic induction.

149
Clinical Outcome of Percutaneous Coronary Intervention on
Chronic Total Occlusion , Single Centre Experience
RCY Fung,1 MH Jim,2 A Ng2
1
Princess Margaret Hospital; 2Grantham Hospital, Hong Kong
Background: In this study, consecutive patients with chronic total occlusions
(CTO) undergoing percutaneous coronary intervention (PCI) in Grantham
Hospital between 1 Jan 2015 and 31 Jan 2019 were recruited. Their clinical
outcomes were analyzed.
Method: Patients' data were retrospectively collected from percutaneous
coronary intervention records. Demographic data was retrieved from our
clinical records. Patients' baseline parameters including clinical presentation,
age, gender, smoking status, left ventricular ejection fraction, previous history
of cardiovascular disease, previous coronary intervention, comorbidities
including diabetes mellitus, hypertension, hyperlipidaemia, peripheral vascular
disease, renal impairment and medications prescribed were collected.
Intervention data including target vessel, intervention technique and outcome
were collected. Clinical outcomes data were retrieved from the computer
based clinical record. Major adverse cardiac events (MACE) were defined as
a combined endpoint of cardiac death, target lesion revascularization (TLR)
and myocardial infarction.
Results: A total of 201 patients were included. The mean age was 64.6±11.0.
The mean follow up time was 22.3±12.8 months. Thirty two patients have
reattempt PCI to target CTO lesion. One hundred and fifty five (77.1%) CTO
lesions were successfully treated. Among the successful PCI cases, 121 cases
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were achieved by antegrade approach and 34 cases were achieved by retrograde
approach. MACE were seen in 22 patients (11%) over a mean time of
15.8±12.6 months. Nine patients (4.5%) had cardiac death. Seven patients
(3.5%) had myocardial infarction. Six patients (3.0%) had target lesion
revascularization.
Conclusion: With the advent of new intervention technique and devices,
most of the chronic total occlusive lesions can be successfully treated with
PCI.
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Antegrade Dissection Reentry Device in Chronic Total Occlusion
Intervention
RCY Fung,1 PT Tsui,1 MH Jim2
1
Princess Margaret Hospital; 2Grantham Hospital, Hong Kong
Background: Crossboss Catheter and Stingray Balloon System are
interventional devices designed for the treatment of coronary chronic total
occlusion (CTO). We report our early experience in the use of these devices
in our centers. In this study, consecutive patients with chronic total occlusions
(CTO) undergoing percutaneous coronary intervention (PCI) in Princess
Margaret Hospital and Grantham Hospital between 1 January 2015 and
31 March 2019 were recruited. Their clinical outcomes were analyzed.
Methods: Patients' data were retrospectively collected from percutaneous
coronary intervention records from both hospitals. Demographic data was
retrieved from our clinical records. Patients' baseline parameters including
clinical presentation, age, gender, smoking status, left ventricular ejection
fraction, previous history of cardiovascular disease, previous coronary
intervention, comorbidities including diabetes mellitus, hypertension,
hyperlipidaemia, peripheral vascular disease, renal impairment and
medications prescribed were collected. Intervention data including target
vessel, intervention technique and outcome were collected. Clinical outcomes
data were retrieved from the computer based clinical record. Major adverse
cardiac events (MACE) were defined as a combined endpoint of cardiac death,
target lesion revascularization (TLR) and myocardial infarction.

J HK Coll Cardiol, Vol 27

Results: A total of 9 patients were included. The mean age was 67.0±10.5.
The mean follow up time was 13.9±14.7 months. Seven cases were reattempt
PCI to CTO. Eight CTO lesions (88.9%) were successfully treated. One
patients (11.1%) required target lesion revascularization 14.7 months after
the index procedure. There was no cardiac death nor myocardial infarction.
Conclusion: Our experience showed that antegrade dissection reentry device
has reasonable successful rate in the treatment of chronic total occlusion.
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Not as Smooth as Expected - From ECPR, Impella Venting,
Shifting from ECMO to Impella, to Impella Weaning
SY Au
Intensive Care Unit, Queen Elizabeth Hospital, Hong Kong
Background: A case of ECPR with an Impella added for left ventricular
venting with subsequent VA-ECMO shifted to full Impella support was
presented. Impella has complex interaction with ECMO, and its application,
however physiologically sound, could cause adverse haemodynamic effects.
The case: A 50 year-old man developed cardiac arrest during primary PCI
for anterior STEMI. E-CPR was performed and revascularization was
complete. The total down time was 30 minutes. The left ventricle was stunted
and the patient developed acute pulmonary edema. An Impella-CP was
inserted to vent the left ventricle with 1.2 L/min flow at P2 revolution. The
optimal Impella flow needed careful titration as it interacted closely with the
ECMO and afterload. While too low flow led to inadequate venting, excessive
venting resulted in collapse of left ventricle, triggering suction alarm and
potential irritation to the myocardium. The Impella position also drifted and
needed readjustment when the ECMO or the Impella flow was changed. His
heart function gradually recovered. He was however complicated by tricuspid
valve Bacillus infective endocarditis, and respiratory failure, likely from septic
embolization. We suspected catheter related infection and decided to remove
the mechanical devices as soon as possible. We planned to decannulate the

22
Double Trouble (MI in Trouble?): Ventricular Septal Rupture
Complicating Acute Myocardial Infarction: A Case Report
JL Daluz, JD Magno, J Sibal, A Medina
Angeles University Foundation Medical Center, Angeles City, Philippines
Introduction: Ventricular Septal Rupture (VSR) is rare with 0.2% to 0.34%
incidence and remains to be a lethal complication of acute myocardial
infarction.
Case: A 76 year-old female, hypertensive for 10 years non diabetic, non
asthmatic, with no history of kidney or thyroid diseases, presented with sudden
onset of acute anterior chest heaviness, squeezing in character non-radiating
with associated diaphoresis to the Emergency Department. Patient has familial
history of hypertension and Diabetes Mellitus. She is non smoker and non
alcoholic drinker. She was admitted as a case of ST Elevation Myocardial
Infarction. On the third hospital day, was noted to have a new onset murmur.
Patient was in respiratory distress with no hypotensive episodes. Physical
examination revealed distended neck veins and coarse crackles on lung bases.
The cardiac apex was displaced with grade 3/6 harsh holosystolic murmur at
the lower left sternal border between the 4th and 5th ICS. No edema, cyanosis
or clubbing noted. Chest Xray revealed pulmonary congestion with infiltrates
on the right cardiac boarder. Cardiac enzymes were 3x elevated. ECG revealed
Sinus Rhythm with ST elevation on Anterolateral wall. Transthoracic
ecocardigram revealed VSR with aneurysmal apical wall with segmental
wall motion abnormality and depressed systolic function (EF 49%). Coronary
Angiogram revealed 70% proximal stenosis and totally occluded mid segment
of the LAD.
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VA ECMO and shifted it to VV configuration, while stepping up the Impella
flow upon removing VA-ECMO. We planned to wean off Impella subsequently.
However, upon ECMO decannulation, the patient developed recurrent
ventricular fibrillation. No obvious 5H5T was revealed. Empirical MgSO4
was given in view of long QTc. The Impella suction alarm rang and
echocardiography was performed, showing the Impella was drifted with its
tip at the aortic valve level. The VF storm terminated after Impella
repositioning. There was no more arrhythmia for the coming 2 days and we
decided to wean off Impella. We shifted to P2 and confirmed the Impella
position by echocardiography. The patient developed recurrent VF again, all
initiated by ventricular ectopics. The Impella was urgently decannulated and
there was no more VF afterwards.
Decision-making: Among causes for his VF, stimulation of the vulnerable
left ventricle by the Impella was believed to be significant. This was especially
marked during haemodynamic changes when the Impella could drift.
Clinicians should always do echocardiography to confirm Impella position
and prepare for need for position adjustment, when the haemodynamic
changes.
Conclusion: Due to the complex physiology of ECMO and Impella and their
interaction, close monitoring and repeated echocardiographic assessment are
paramount.

Decision-making: With the history, physical examination, and TTE findings,
a multidisciplinary team approach was called in directing the management
of the patient. With the decision of the team, surgery was done on the 7th
hospital day and 10th post MI day with the aim of reducing the end organ
damage. Intraoperative TEE was also a tool in identification of the specific
anatomic classification (landmark and location) and the diameter of the VSR.
Intraoperatively, there was note of a 1 cm x 1.5 cm ventricular septal rupture
at the apex with note of friable tissues. Minimal amount of thrombus was
also seen attached to the ventricular septal wall.
Conclusion: VSR management remains to be complicated requiring
substantial critical care, imaging, interventional and surgical expertise. VSR
repair carries a high operative mortality.
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Up Against the Tide
CB Ho, PH Lee, TC So, MH Wong, MCS Chiang, YH Fong, MW Chu,
CF Tsang, YW Cheng, NH Luk, SF Chui, KC Chan, CY Wong, CL Fu,
KY Lee, KT Chan
Queen Elizabeth Hospital, Hong Kong
A 58-year-old gentleman with history of hypertension and hyperlipidaemia
was admitted for anterior STEMI. Primary PCI was activated. Pre-operative
Echo showed LVEF ~20% with global hypokinesia. Coronary angiogram
showed triple vessel disease, distal left main bifurcation lesion with Medina
Classification 1:1:1. IABP supported PCI was started but patenet progressively
developed acute pulmonary edema and then cardiac arrest. ECMO was
initiated and PCI to LM-LAD/LCx bifurcation was done. However, patient's
LVEF was stunned post-operatively to 5-10%, and echo showed poor aortic
valve opening. LV was distended with spontaneous echo contrast. LV venting
was needed. Therefore, Impella device was implanted to vent the LV and
patient's LV recovered post-operatively and serial echo showed LVEF
improved to 40%. ECMO, Impella and inotropes were weaned off on postop D10. Unfortunately patient developed hospital accquired pnuemonia and
died of pneumonia on post-op D31. This case discuss the current management
of post-cardiac arrest care, the pros and cons of ECMO for heart recovery
and methods to overcome its limitation.

52
Echocardiography Diagnosis of Aortic Arch Pseudoaneurysm
Y Wu,1,2 M Wang,3 Q Lv,1,2 M Xie1
1
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology; 2Hubei Province Key
Laboratory of Molecular Imaging; 3The First Affiliated Hospital of Zhengzhou
University, Wuhan, China
Clinical Presentation: A 47-year-old woman was admitted to our hospital
with back pain for 3 months, cough and hoarseness for one month. Twodimensional transthoracic echocardiography showed a 2.3×3.7 cm echolucent
structure and a "mass" measuring 5.5×6.5×4.7 cm, adjacent to the aortic and
pulmonary artery roots. The pulmonary artery was compressed by them. The
echolucent structure seems to originate from the small curved side of aortic
arch. Blood flow within it revealed that blue blood flow on color Doppler
imaging. To better delineate the origin of the blue blood flow, an intravenous
ultrasound contrast agent (3 mL; Bracco Group, Milan, Italy) was
administered. After contrast agent injection, aortic arch, echolucent structure
and a rupture (0.8 cm) can be clearly displayed. In addition, no contrast agent
was found in the "mass". RT-3D with contrast the allowed visualization of
more detailed morphologic information about the pseudoaneurysm. CT with
contrast and surgery confirmed the diagnosis.
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Imaging Findings: Preoperative imaging. A, TTE showed an echolucent
structure and a "mass" (pentagram) adjacent to the small curved side of aortic
arch. B, color Doppler imaging revealed blue blood flow in echolucent
structure. C, A rupture was displayed by CEU (yellow arrow). D and E, TTE
showed pulmonary artery compression. F RT-3D of CEU. G, CT with contrast
showed pulmonary artery compression (red arrow). H, CT with contrast
showed the rupture (black arrow). (AAO: ascending aorta; DAO: Descending;
AO: aorta; PA: pulmonary artery; LPA: left pulmonary artery; RPA: right
pulmonary artery)
Summary: As a fast, convenient and non-invasive examination method,
echocardiography plays an important role in the screening and diagnosis of
aortic arch pseudoaneurysm. In addition, combined contrast-enhanced
ultrasound can make up for the deficiency of conventional ultrasound in
vascular exploration and provide more basis for diagnosis.
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"The Tear of Death": An Extensive Type A Aortic Dissection
Successfully Managed Medically: A Case Report
JL Daluz, JD Magno, J Sibal, MJ Garcia
Angeles University Foundation Medical Center, Philippines
Background: A known collective term for life threatening aortic condition
is Acute Aortic Syndrome.
Clinical Presentation: A 33-year-old male who presented at the Emergency
Department due to sudden onset of severe tearing chest pain (Pain scale of
10/10) radiating to the back with associated shortness of breath which occurred
few minutes prior to admission. Patient is a known hypertensive maintained
on Candesartan 8 mg/tab OD with usual BP of 130/80 mmHg and the highest
recorded was 220/100 mmHg. Work up done for Primary Causes of
hypertension was unremarkable. Familial history revealed hypertension on
maternal side. No other pertinent heredo-familial disease noted. Patient is a
call center agent, denied illicit drug use with unremarkable sexual history.
Patient is awake, restless, and in severe pain. Patient is obese with no noted
marfanoid features. Was hypertensive with BP of 220/100 mm Hg on all
extremities. There is no carotid bruit and lungs are clear. Heart sounds are
distinct with no murmurs and no extra heart sounds. No edema, cyanosis or
clubbing noted, pulses are full and equal on both upper and lower extremities.
ABI was normal. There were no marfanoid features noted. Normal neurologic
examination.Chest X-ray revealed cardiomegaly with no pulmonary
congestive changes. Mediastinum is widened with clear lung fields.

62
Takotsubo Cardiomyopathy ("Takot-s-Ubo") from Tussaphobia:
A Case Report
JL Daluz, JD Magno, J Sibal, EW Timbol
Angeles University Foundation Medical Center, Angeles, Philippines
Introduction: It was in 1990, when Takotsubo Cardiomyopathy was first
recognized in Japan. Reported cases were triggered by physical or emotional
stress.
Clinical Presentation: A 69-year-old hypertensive female, who developed
severe anxiety to cough after her history of intubation due to Pneumonia few
years back, presented at the emergency department with 8 days history of
cough and dyspnea. Patient was initially admitted as a case of Pneumonia.
On the third hospital day, was intubated for progressive dyspnea. Physical
examination revealed hypotension, distended neck veins, and coarse crackles
on lung bases. The cardiac apex was displaced, but heart sounds were distinct
with no murmurs. No edema, cyanosis or clubbing noted. X-ray revealed
minimal pleural effusion with hazy infiltrates on the right lower lung, fibrotic
densities on right upper lobe, increased vascular markings, and cardiomegaly.
ECG showed sinus rhythm with ST-segment elevation at the Inferoanterolateral wall. Troponin was 2x elevated. TTE revealed apical ballooning
of the left ventricle, with associated segmental motion abnormality. Coronary
angiography has no obstructive coronary lesions. Left ventriculogram
confirmed the ballooning configuration, with hypokinesia of left ventricular
apex and relative hyperkinesia of the base. Repeat TTE showed resolution of
previously noted ballooning of LV and wall motion abnormalities.
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Electrocardiograph showed regular sinus rhythm, left axis deviation with
non specific ST T wave changes. Transthoracic Echocardiogram (TTE)
revealed Concentric Left Ventricular Hypertrophy, good wall motion and
overall systolic function. Aortic root dimensions are normal with no flap
noted. CT-Aortogram revealed dissection from aortic root involving the entire
aorta: innominate, left carotid and subclavian arteries down to both femoral
arteries. Patient was managed as a case of Hypertensive Emergency, Aortic
Dissection, De Bakey Type 1; Stanford Type A.
Decision-making: Upon arriving at the diagnosis, surgical and Interventional
approach were offered to the patient but due to limited funds was not done.
Hence, maximal medical management with IV Beta Blocker (Esmolol drip)
for rate and pressure control, Vasodilator (Nitroglycerine drip) and Pain
reliever (Morphine) were given. Patient was discharged and improved on
the eight day and was advised on close follow up.
Conclusion: Aortic Dissection should always be included in the differential
diagnosis of patients with acute chest pain on all age group. Diagnostics
should be immediately done in suspected patient to maximize urgent care
and outcome.

Decision-making: Diagnosis of Myocardial infarction with nonobstructive
coronary artery was a dilemma in this case after fulfilling the diagnostic
criteria. However, LV gram showed the classic finding of apical ballooning
pointing to the diagnosis. The proposed diagnostic criteria of Mayo Clinic
such as transient hypokinesia or dyskinesia in the left ventricular mid segments
with or without apical involvement, the regional wall motion abnormalities;
a stressful trigger often present, the absence of obstructive coronary disease,
new ECG abnormalities either ST segment elevation and/or T wave inversion
or modest elevation of cardiac troponins were seen and fulfilled in this case.
Patient was managed as a case of Takotsubo Cardiomyopathy, Pneumonia
High Risk and Hypertension.
Conclusion: Taskotsubo Cardiomyopathy should be considered in the setting
of a historical predisposition to emotional or physical stress, transient LV
geometry changes, and angiographically normal coronaries. Early clinical
consideration is crucial in properly directing management and patient
education.
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Infectious Endocarditis After Device Closure of Perimembranous
Ventricular Septal Defect with a Residual Shunt
S Shao, K Zhou, Y Hua, C Wang
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, China
Backgrounds: Transcatheter closure of perimembranous ventricular septal
defect (PmVSD) has been proved to be a safe and effective alternative to
surgery in selected patients. Theoretically, residual shunt could increase risk
for post-interventional IE via endothelial damage resulting from mechanical
lesions provoked by turbulent blood flow across the defect.
Case: A three-year old female weighing 10.5 Kg, with a PmVSD and a history
of recurrent lower respiratory tract infections, was referred to at the
Department of Pediatrics in West China Second University Hospital of
Sichuan University (WCSUH-SCU) for transcatheter closure of the defect.
The procedure was undertaken under general anesthesia. Dynamic ECG
monitoring was applied during and after the procedure for 3 days. Right and
left cardiac catheterization was performed via percutaneous transfemoral
route. Hemodynamics of the pulmonary vessels were measured and pulmonary
vessel resistance was evaluated before the final occlusion. Real-time TTE
imaging was performed during the procedure to assess the profile VSD in
the left ventricular long-axis oblique view. The defect measured 5.0 mm on
left ventricular angiography and an 8-mm modified symmetric double-disk
occluder (SHAMA) was chosen. Heparin (100 U/kg) was administered after
successful femoral artery access. Antibiotics were infused intravenously for
3 days, including the procedure day and 2 postoperative days.
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Very Late-onset Endocarditis Complicated by Aortic Regurgitation
After Device Closure of Perimembranous Ventricular Septal Defect
S Shao, C Wang, K Zhou, Y Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, China
Backgrounds: Transcatheter closure of perimembranous ventricular septal
defect (PmVSD) has been proved to be a safe and effective alternative to
surgery in selected patients. Aortic regurgitation (AR), attributable to
impingement of device on aortic valve, was recognized as a major, but rare
complication after device closure for PmVSD, and could increase risk for
post-interventional infectious endocarditis (IE).
Case: A fifteen-years old male was admitted into emergency department of
West China Hospital in January 2019 due to persistent fever for 16 days and
nonresponse to 2-weeks course of amoxicillin and cefoxitin. The child had
received transcatheter closure of a 6.4 mm sized PmVSD with a 9-mm
modified symmetric double-disk occluder (SHAMA) 11 years ago in our
Hospital. A new-onset mild eccentric AR was noted on transthoracic
echocardiography (TTE) examination one-year post procedure, without
progression until latest follow-up in January 2018.
Decision-making: On admission, the child was conscious with temperature
of 39°C. Physical examination was only remarkable for a diastolic murmur
in auscultation area of aortic valve. Laboratory tests revealed an elevated
white blood cell count of 15.89×109/L, neutrophil percentage of 80.1%,
C-reactive protein of 36.3 mg/L, erythrocyte sedimentation rate of 62.0 mm/
h, and mild anemia (hemoglobin: 116 g/L). Transesophageal echocardiography
(TEE) demonstrated a vegetation (14×4 mm) attached to tricuspid valve, an
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Decision-making: The device was released despite a small residual shunt
was noted immediately after the procedure. After procedure, oral
administration of aspirin (50 mg daily) was initiated. Two months later, the
child had a persistent fever up to 41°C for 11 days. Transthoracic
echocardiography (TTE) demonstrated a vegetation (13×9 mm) attached to
tricuspid valve and the occluder, and a small residual shunt. Staphylococcus
aureus was isolated from all three-blood cultures. Defervescence occurred in
20 days following dosage adjustment of vancomycin. After 6 weeks of
treatment, the vegetation disappeared with no sign of valvular dysfunction.
Three weeks later, a second device was implanted to abolish persistent residual
flow. Unfortunately, the child was ultimately transferred to surgical
department due to severe hemolysis after the second device implantation.
During the surgical procedure, the occluders were removed, VSD was closed
with a pericardial patch and tricuspid valvuloplasty was also performed.
Conclusion: The present report was of clinically amount significance for
illustrating the need to reassess the prognostic implications of non-significant
residual shunt after PmVSD device closure and consider the most reasonable
therapeutic regimen.

anechoic area (8×7 mm) on left upper side of ventricular septum and below
right aortic sinus, and severe eccentric AR. The diagnosis of IE was
established. Staphylococcus aureus was isolated from all three-blood cultures.
Treatment with vancomycin was continued since the isolates were resistant
to penicillin but sensitive to vancomycin. The patient ultimately underwent
surgical intervention because of recurrent fever and a new-onset complete
atrioventricular block 12-days later. During the procedure, contracture of
right aortic valve, fusion of upper margin of occluder with right aortic valve,
perforation of interventricular septal abscess below right aortic valve and
vegetation on tricuspid valve were documented. Removal of vegetation,
abscess and occluder, closure of VSD with a pericardial patch, tricuspid
valvuloplasty (TVP) and aortic valvuloplasty (AVP) were performed. The
child continued with antibiotic therapy up to six weeks post operation. The
temperature gradually returned to normal with alleviation of AR (mild) and
heart block (first degree).
Conclusion: Given the worldwide acceptance and increasing utilization of
device closure for Pm VSD, there are likely additional patients with delayed
incorporation that could present a late risk for AR and IE. Reassessing longterm prognostic implications of non-significant post-procedure AR is
necessary.
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Infected Sinus of Valsalva Pseudoaneurysm Replaced with Handsewn Composite Root Graft with Everted Cuff
JWC Chan, T Fujikawa, WT Kwok, SY Yu, HL Wong
Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Background: Surgery for aortic root pathologies often impose significant
challenge in terms of technique and hemostasis, especially when tissue quality
is poor. We present a case of infected Sinus of Valsalva (SoV)
pseudoaneurysm treated by aortic root replacement with hand-sewn composite
graft and coronary artery bypass grafting (CABG).
Case: A 55-year-old lady presented with fever and orthopnea. Blood culture
grew Streptococcus bovis and a murmur was heard. Echocardiogram showed
bicuspid aortic valve with severe aortic stenosis, in addition to two collections
at aortic root. Computer tomography (CT) demonstrated two contrast outpouches near aortic valves, measuring up to 4.8 cm and 1.4 cm respectively,
highly suspicious of SoV aneurysms. She was treated as infective endocarditis
with intravenous antibiotics. Initially we intended to perform Bentall
procedure, however upon exposing the aortic root, it was noted that the
infective cavity of pseudoaneurysm involved both coronary ostia, rendering
the coronary buttons unhealthy for anastomosis, thus decided for CABG.
The pseudoaneurysm cavity including part of the aortic annulus and left
ventricular outflow tract was repaired with Bovine pericardium. A size 22
hemashield graft was everted and hand-sewn to a size 19 Regent mechanical
aortic valve, after which the cuff of everted graft was unfolded to anastomose
with the neo-aortic root. The distal anastomosis was performed under
circulatory arrest and antegrade cerebral protection. CABG to all 3 major
coronary vessels was performed. The patient had an uneventful recovery.

151
A Complicated Case of de Winter Syndrome
M Liu
Hebei Yanda Hospital, Langfang, China
Background: This is a case of de Winter syndrome complicated with
electrical storm, treated successfully.
Case: A 51 years old man admitted for substantial chest pain for 3 hours, he
had experienced cardioversion due to "ventricular tachycardia" in another
medical facility. He has HTN for 5 years; Smoking index 600; Hyperlipidemia
for 5 years. His ECG is a typical de Winter pattern with 2 mm horizontal ST
segment depression in leads I, AVL; 4-6 mm J point depression and 4-8 mm
upsloping ST segment depression in leads V2-V6; poor R wave progression
in precordial leads; 1 mm dome-shaped ST segment elevation in lead AVR.
Lab results are TnI 0.10 ng/ml (3h after onset of chest pain), BNP 21.87 pg/
ml, D-dimer 600.87 ng/ml, K+ 4.1 mmol/L, Normal liver and kidney function.
Decision-making: Recognizing the case a de Winter syndrome which
suggests a proximal LAD occlusion. It is a STEMI equivalent case. So we
decided to manage with a loading dose of Aspirin 300 mg and Ticagrelor
180 mg followed by urgent CAG.
Diagnostic finds of CAG are:
Right Dominant
LM: 80%
LAD: Occlusion
Prox LCX: 90%
Mid RCA: 80%.
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Decision-making: The difficulty of the case lies in the uncertain anatomy of
the infected aortic root, thus pre-operative trans-esophageal echocardiogram
and ECG-gated computer tomography of the region was pertinent to the
planning of operation. We also have a choice to use commercially available
composite root grafts versus a hand-sewn composite graft. We chose the
latter because the graft diameter and length, and the type of valve can be
complete controlled. More importantly, by everting the graft during sewing
of valve and subsequently unfolding the everted part to serve as cuff for
anastomosis, it prevents tearing of the fragile reconstructed infected aortic
annulus, and much reduces the risk of bleeding and subsequent rupture.
Conclusion: In cases with complex aortic root anatomy, it is crucial to have
detailed pre-operative planning and quick intra-operative decision making
to ensure a smooth operation. The hand-sewn composite root graft with everted
cuff is an important armamentarium for anastomosis with fragile annulus
tissue.

We found the Infarct-related vessel: LM-LAD. We inserted IABP and
performed PCI in LM-LAD
Prox LAD: Firebird 3.5*33 mm DES
LM: Firebird 4.0*33 mm DES.
The medication after PCI are
Tirofiban
0.1 ug/Kg/min
Aspirin 100 mg
qd
Ticagrelor 90 mg
bid
Atorvastatin 20 mg
qd
Ezetimibe 10 mg
qd
Enoxaparin 0.6 ml
q12h.
Patient had electrical storm on day 2. ACLS was provided, we sought the
cause for the storm, ECG and AED record revealed Polymorphic ventricular
tachycardia with prolonged QT. Cardiac Biomarkers did not suggest Acute
stent thrombosis, Hypokalemia, Hypomagnesemia and hypocalcemia are
excluded. Other than the medications above, no med would prolong the QT.
Ischemia was likely the cause. We managed the storm with (1) Temporary
pacemaker, pacing rate 80 bpm; (2) Lidocaine 2 mg/min, mexiletine 150 mg
tid; (3) Potassium and magnesium supplementation. Outcome was
satisfactory. Patient is on Secondary prevention of CAD, he had No angina
or arrhythmia since.
Conclusion: Success of managing the case: (1) Prompt recognition of de
Winter syndrome as a STEMI equivalent condition, leading to urgent,
appropriate revascularization; (2) Managing ES with overdrive pacing,
potassium, magnesium and antiarrhythmic agents. However, the key was
successful revascularization.

April 2019

J HK Coll Cardiol, Vol 27

HK COLLEGE OF CARDIOLOGY, TWENTY-SEVENTH ANNUAL SCIENTIFIC CONGRESS
ABSTRACTS
Abstracts for Poster Presentations:
PAEDIATRIC CARDIOLOGY
5
The Application of "Left Innominate Vein-aortic Branches View"
in Prenatal Diagnosis of Congenital Cardiovascular Anomalies
H Cao, M Xie, L Hong, Y Peng, Y Zhang
Department of Ultrasound, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan, China
Background: Sonographic screening of fetal heart includes a series of
standard views, which focus on the structure of cardiac chambers and great
vessels. But little attention is paid to aortic branches and innominate veins.
However, variations of these vessels can occasionally be detected and may
provide a clue to diagnose certain congenital heart diseases (CHDs). In order
to demonstrate the aortic branches and innominate veins, we suggest a new
additional ultrasound plane in fetal heart screening, that is "left innominate
vein-aortic branches (LINV-AoB) view". This study aims to explore its value
in the diagnosis of fetal CHDs.
Methods: From October 2016 to October 2017, 2011 fetuses underwent
echocardiography in our hospital. Based on 3VT view, moving the transducer
slightly cranially to demonstrate the long axis of LINV and short axis of aortic
branches, which is "LINV-AoB view". The number, course, dimension, relative
position, flow direction of LINV and aortic braches were carefully observed
in "LINV-AoB view". Meanwhile, other related intracardiac anomalies were
also evaluated.

21
Echocardiography in Diagnosis and Prognosis of Vascular Sing
J Zhang, Y Gao, XJ Ma, B Jia, F Liu, GY Huang
Children's Hospital of Fudan University, Shanghai, China
Background: Vascular ring is a rare congenital disease that leads to variable
degrees of respiratory problems. We aimed to analyze the diagnosis and
prognosis of different types of vascular rings by echocardiography.
Method: Patients with vascular rings confirmed by multi-slice spiral
computed tomography (MSCT) between January 2010 and July 2017 in our
hospital, were retrospectively assessed by echocardiography. The clinical
symptoms, demographic characteristics, and images of the patients with
vascular rings were evaluated. Operative data and postoperative follow-up
data of echocardiography, and outcomes were also collected in details.
Result: Seventy-eight patients confirmed as vascular rings by MSCT. Male
versus female was 45 to 33, and the median age was 7 months old ranging
from 1 day old to 9 years old. Among these patients, 56.4% (n=44) cases had
pulmonary artery sling, 25.6% (n=20) cases had double aortic arch, and 18.
4% (n=14) cases were other types, including seven cases of left-sided aortic
arch with aberrant right subclavian artery, six cases of right-sided aortic with
aberrant left subclavian artery, and one case of right-sided aortic arch with
left patent ductus arteriosus. Echocardiography diagnosed 95% of pulmonary
artery sling, 55% of double aortic arch, and 14% of other types. Totally,
forty-eight cases underwent surgery. Before operation, three cases of
pulmonary artery sling died, and five cases of pulmonary artery sling died of
respiratory failure after surgery. Other operated cases were followed-up by
echocardiograghy and with good prognosis.
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Results: A total of 227 (227/2011, 11.29%) fetuses demonstrated abnormal
findings in "LINV-AoB view" during the detailed echocardiography, including
131 cases (131/227, 57.71%) of LINV anomalies and 115 cases (115/227,
50.66%) of aortic branching anomalies. LINV anomalies included 103 cases
of absent LINV (double SVC), 25 cases of anomalous courses of LINV
(including 1, 10 and 14 cases of intrathymic LINV, subaortic LINV and PLSVC
with absent RSVC, respectively), 3 cases of supracardiac-type APVC. Aortic
branching anomalies included 37 cases of aberrant right subclavian artery,
42 cases of right aortic arch with aberrant left subclavian artery, and 36 cases
of RAA with mirror-image branching. Nineteen fetuses (19/227, 8.37%) had
multiple LINV and aortic branching anomalies. Fetal cardiac conventional
views combined with "LINV-AoB view" had obvious advantage in the
demonstration of subaortic/intrathymic LINV.
Conclusion: "LINV-AoB view" plays a vital role in the prenatal diagnosis of
congenital cardiovascular anomalies, it can help us detect different variations
of LINV and aortic branches. Fetal cardiac conventional views combined with
"LINV-AoB view" can improve the detection rate of subaortic/intrathymic
LINV. We recommend to add this view into the routine fetal cardiac screening.

Conclusion: Echocardiograpy is a convenient and safety tool which can be
the preliminary diagnosed tool for vascular ring. It could make diagnosis of
pulmonary artery sling with carefully screening, while the sensibility of other
vascular ring is poor. The prognosis of pulmonary artery sling may be the
worst of all vascular ring.
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Follow Up Outcomes and Risk Factors of Complete
Atrioventricular Block After Transcatheter Closure of
Perimembranous Ventricular Septal Defect in Children
C Wang, K Zhou, Y Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, Sichuan, China
Backgrounds: Complete atrioventricular block (cAVB) still remains the main
issue of concern following transcatheter closure of perimembranous ventricular
septal defect (VSD). Data regarding the incidence, risk factors and prognostic
implications of post-procedure cAVB is limited, particularly in children.
Objectives: The present study intended to determine the overall incidence,
risk factors and follow up outcomes of cAVB after transcatheter closure of
perimembranous VSD in children.
Methods: All available clinical and follow-up data of children with cAVB
(n=13) after transcatheter closure of perimembranous VSD using modified
symmetric double-disk occluders between January 2005 and December 2017
were retrospectively reviewed, and were compared with that of children
without arrhythmias (n=1572).
Results: cAVB after transcatheter closure of perimembranous VSD occurred
in 13 cases, with an incidence of 0.61% (13/2114). Eleven cases developed
cAVB within 2 weeks post procedure. Late-onset cAVB was noted in two
cases, with one occurring at eighteen days and the other occurring at four
years post procedure. Reversible cAVB were observed in one case. Nine of
13 cases recovered to normal conduction or reverted to other types of bundle
branch block three weeks post operation after steroids treatment. Two patients
were ultimately transferred to surgical department for occluder removal due
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Cardiac MRI Improves Diagnostic Accuracy and
Characterization in Children with Cardiomyopathy
Y Zhang,1 J Tian2
1
Department of Radiology; 2 Department of Cardiology, Children's Hospital
of Chongqing Medical University, Chongqing, China
Background: Recent advances in cardiac magnetic resonance imaging (cMRI)
have made this scan an important tool for evaluating heart disease. The
objectives of this study were to evaluate the role of cMRI in the diagnosis of
children cardiomyopathy.
Methods: Images of 53 pediatric patients with cardiomyopathy were
retrospectively evaluated. Several morphological characteristics of the various
cardiomyopathies were observed with cMRI.
Results: cMRI could accurately display the characteristic morphological
changes of cardiomyopathy, and late gadolinium enhancement on cMRI might
suggest myocardial fibrosis, which had obvious advantages in the diagnosis
of cardiomyopathy than Echo. In hypertrophic cardiomyopathy (HCM)
patients, cMRI showed diffuse left-ventricular (LV) myocardial wall
thickening, mainly involving the interventricular septum and LV anterior
wall at central and base parts, which was often accompanied by a significant
LV cavity narrowing and LV outflow tract stenosis. In patients with dilated
cardiomyopathy (DCM), cMRI showed LV or double-ventricle dilatation,
normal or thin myocardial wall thickness, and reduced LV ejection fraction
(EF) and stroke volume, and segmental or whole abnormal ventricular
movement was observed. In patients with restrictive cardiomyopathy (RCM),
cMRI showed atrial enlargement, vena cava and portal vein expansion, and
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to unresponsiveness of steroid therapy for three weeks and restored the sinus
rhythm following operation. Persistent cAVB was presented in two cases.
One of them suffered from recurrent syncope and received permanent
pacemaker implantation. The other case was followed up regularly owing to
asymptomatic and pacemaker refusal. Larger occluder size was identified as
risk factor for both occurrence and persistence of cAVB.
Conclusions: The overall incidence of cAVB after transcatheter closure of
perimembranous VSD was relatively low and the outcome was satisfactory.
Close follow-up needs to be applied since late-onset and reversible cAVB
could occur. Oversized occluder should be avoided.

single- or double-ventricle diastolic dysfunction. In patients with leftventricular noncompaction (LVNC), cMRI may reveal prominent multiple
trabecular subendocardial and deep trabecular fossae communicating within
the LV cavity. Diffuse subendocardial myocardial delayed enhancement
(MDE) was noted in 2 patients with RCM, suggesting the fibrosis formation.
Conclusion: Cardiomyopathy is a common cardiac disease during childhood
with a poor prognosis. The establishment of an early diagnosis and early
treatment initiation are critical. Our data demonstrate that cMRI can accurately
visualize morphological changes as well as functional alterations in pediatric
patients with cardiomyopathy.
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Neurological Involvement in Kawasaki Disease
X Liu,1,4,5 K Zhou,1,2,4,5 Y Hua,1,2,4,5 M Wu,1,3 L Liu1,3, S Shao,1,3 C Wang1,2,4,5
1
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University; 2The Cardiac Development and Early Intervention Unit,
West China Institute of Women and Children's Health, West China Second
University Hospital, Sichuan University; 3West China Medical School of
Sichuan University; 4Key Laboratory of Birth Defects and Related Diseases
of Women and Children (Sichuan University), Ministry of Education Chengdu;
5
Key Laboratory of Development and Diseases of Women and Children of
Sichuan Province, West China Second University Hospital, Sichuan
University, Chengdu, Sichuan, China
Background: Kawasaki disease is an acute febrile systemic vasculitis affecting
multiple organ and tissues, with coronary artery lesions as the most serious
sequelae. Although neurological involvement as a complication of Kawasaki
disease has been recognized, pediatricians lacked a recognition of the
background, course, clinical characteristics, diagnostic and treatment issues,
prognosis of neurological involvement in Kawasaki disease. Importantly, it
still remains unknown whether the neurological involvement in Kawasaki
disease is a marker of more severe disease and put patients at a higher risk of
intravenous immunoglobulin resistance and coronary artery lesions. Herein,
we carried out this study to systemically analyzed neurological involvement
in Kawasaki disease, aiming to assess its relationship with intravenous
immunoglobulin resistance and coronary artery lesions.
Method: Kawasaki disease patients at West China Second Hospital of Sichuan
University were retrospectively reviewed between January 2013 and December
2017. The profiles of patients who had neurological symptoms (group A,

42
Grisel Syndrome in Kawasaki Disease
X Liu, 1,4,5 K Zhou, 1,2,4,5 Y Hua, 1,2,4,5 M Wu, 1,3 L Liu, 1,3 Shuran Shao, 1,3
Chuan Wang1,2,4,5
1
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University; 2The Cardiac Development and Early Intervention Unit,
West China Institute of Women and Children's Health, West China Second
University Hospital, Sichuan University; 3West China Medical School of
Sichuan University; 4Key Laboratory of Birth Defects and Related Diseases
of Women and Children (Sichuan University), Ministry of Education Chengdu;
5
Key Laboratory of Development and Diseases of Women and Children of
Sichuan Province, West China Second University Hospital, Sichuan
University, Chengdu, Sichuan, China
Background: 50%-75% Kawasaki disease patients present cervical
lymphadenopathy associated with deep neck inflammation, which might result
in Grisel syndrome defined as a rare non-traumatic, atlantoaxial subluxation.
However, this disorder with Kawasaki disease has not been systemically
discussed in previous literatures for limited available data. Therefore, we
carried out this study to describe Grisel syndrome with Kawasaki disease
comprehensively, aiming to develop pediatricians' recognition and awareness.
Methods: A computerized search without language restriction was carried
out via PubMed, Google Scholar, Scopus and China Medical website. An
article was considered eligible for inclusion in the systematic review if it
reported data on patient(s) with Grisel syndrome in Kawasaki disease. Our
patients were also retrospectively recruited.
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n=80), were compared with that of gender- and admission date-matched
patients without neurological involvement (group B, n=512).
Results: A total of 80 Kawasaki disease patients had neurological involvement,
with a constituent ratio of 5.1% (80/1582). The neurological manifestations
were diffuse, presenting as headache (13/80, 16.3%), convulsion (14/80,
17.5%), somnolence (7/80, 8.8%), extreme irritability (21/80, 26.3%),
positive sign of meningeal irritation (15/80, 18.8%), bulgin fontanel (7/80,
8.8%), dispirited (33/80, 41.3%), facial palsy (1/80, 1.3%). 47.5% (38/80)
patients had neurological symptoms as the initial and/or predominant
presentation. The patients from group A had higher incidence of intravenous
immunoglobulin resistance combining with higher level of inflammatory
markers in comparison with patients from group B. However, it demonstrated
that neurological involvement was not an independent risk factor of
intravenous immunoglobulin resistance and coronary artery lesions in
Kawasaki disease.
Conclusions: The incidence of neurological complications in Kawasaki
disease patients was relatively low. No delayed diagnosis and intravenous
immunoglobulin treatment were observed, but this complication developed
a higher incidence of intravenous immunoglobulin resistance in Kawasaki
disease patients for a severe inflammatory burden.

Results: Ten articles reporting fourteen Kawasaki disease patients with Grisel
syndrome were considered. Four patients were identified in our population,
with the incidence of 0.3% (4/1582). Totally, this disorder affected 6 males
and 12 females (M/F ratio was 0.5), aged from 4 to 9 years old. The duration
before the identification of this disorder with Kawasaki disease ranged from
3 to 22 days. Cervical lymphadenopathy was identified with all patients.
Grisel syndrome with Kawasaki disease all presented Fielding classification
type 1, manifesting tilted position (5/18, 27.8%), torticollis (9/18, 50.0%),
neck pain (7/18, 38.9%) and stiffness (5/18, 27.8%). They had no coronary
artery affected. After conservation treatment, neurological impairment was
not observed with these patients.
Conclusions: Grisel syndrome is a rare complication of Kawasaki disease,
with a incidence of 0.3%. It mainly affects older children with dominant
females. Prompt and adequate recognition of this disorder in Kawasaki disease
remains a well prognosis.
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Application Values of Transesophageal Echocardiograghy in
Hybrid Therapy for Pulmonary Atresia with Intact Ventricular
Septum in Younger Infants
P Zou, SQ Sun, Q Liu, JS Huang, WB Xu, H Li
Guangdong Women and Children Hospital, Guangzhou, China
Objective: To explore application values of transesophageal echocardiograghy
(TEE) in the hybrid therapy to balloon pulmonary valvuloplasty for younger
infants of pulmonary atresia with intact ventricular septum (PA/IVS).
Methods: 25 younger infants with PA/IVS were diagnosed by transthoracic
echocardiography (TTE) before operation. After general anesthesia with
endotracheal intubation, all patients were inserted TEE probe to evaluate
development of pulmonary valve annulus and right ventricle and instruct the
surgeon to select the appropriate balloon. Pulmonary valve was punctured by
needle, and then sheath and balloon were inserted with the guidance of TEE.
All patients were performed by the balloon pulmonary valvuloplasty
monitored by TEE, and the effect of valvuloplasty was evaluated by TEE
immediately.
Results: All patients were performed successfully for balloon pulmonary
valvuloplasty with the guidance of TEE, and no severe complications occurred
during the operation. The forward flow of pulmonary valve was unobstructed
in 88.0% of the patients., and 80.0% of the patients had mild pulmonary
valve insufficiency; The degree of tricuspid valve insufficiency was
significantly reduced in 80.0% of the patients. The pulmonary valve blood
flow velocity in the three patients was more than 3.0 m/s after surgery, who
had to need right ventricle outflow tract reconstruction 10~25 months after
balloon pulmonary valvuloplasty.
Conclusions: TEE accurately make preoperative evaluation for the patients
with PA/IVS, real-time monitor the placement of sheath and balloon during
operation, and may evaluate the effect of dilation. immediately. TEE is a safe
and effective guidance technique for the hybrid therapy of young infant
patients with PA/IVS.

76
Comparison of Amplatzer Duct Occluder II and Modified
Symmetric Double-disk Occluder in Transcatheter Closure of
Small Perimembranous Ventricular Septal Defect
C Tang, Y Hua, K Zhou, C Wang
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, Sichuan, China
Aims: The present study was carried out to compare the effectiveness and
mid-term follow up results following transcatheter closure of perimembranous
ventricular septal defect (PmVSD) using Amplatzer duct occluder II (ADOII) and modified symmetric double-disk occluder in children.
Methods: All available clinical and follow-up data of children with PmVSD
sized below 6.5 mm receiving transcatheter closure with ADO-II (n=121) or
modified symmetric double-disk occluder (n=133) from January 2016 to
December 2018 in our hospital were retrospectively reviewed and compared.
Results: The mean age (3.7±2.4y vs 3.4±1.6y, P=0.205) and mean diameter
of defect (2.37±0.76 vs 2.51±0.57, P=0.100) were not comparable, while
the transfersheath size (4.45±0.53F vs 5.79±0.61F, P<0.001) and occluder
size (3.55±0.80 vs 4.59±0.53, P<0.001) were significantly different between
the two groups. Operation time seemed slightly longer and the cost was higher
in ADO-II group compared with symmetric double disk occluder group
(37.96±16.80 min vs 30.85±11.88 min, P<0.001; 45000¥ vs 37000¥).
However, retrograde transcatheter closure was successful with ADO-II in 42
patients. No severe complications including death, new-onset significant aortic
valve regurgitation, complete or high-degree heart block and infectious
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61
Congenital Heart Defects and Other Congenital Anomalies in
Situs Inversus Totails: A Hospital-based Study
W Chen
Children's Hospital of Fudan University, Shanghai, China
Background and objective: Few studies have assessed the comorbid diseases
in situs inversus totalis (SIT) comprehensively. The aim of this study was to
provide insight into the spectrum and prevalence of congenital heart defects
and other congenital anomalies in SIT.
Methods: Children ≤18 years of age with SIT were enrolled in this
retrospective observational study. Situs status and comorbidities were
independently confirmed by 2 physicians, based on review of radiologic and
ultrasonic examination, operative records, and case notes.
Results: A total of 150 children (median age: 1.23 years; range: 1 day-17.8
years) confirmed to have SIT were recruited between January 2009 and
December 2018. Associated conditions were diagnosed in 115 children
(76.7%). Among them, 27 children (18.0%) had multiple anomalies affecting
two or more organ systems. The most commonly associated conditions were
congenital heart defects (n=75, 50.0%), followed by primary ciliary dyskinesia
(n=15, 10.0%), renal disorders (n=12, 8.0%), biliary atresia (n=9, 6.0%),
skeletal dysplasia (n=8, 5.3%) and mental retardation (n=4, 2.7%). Other
comorbidities included dwarfism, hernia, cleft lip and palate, hypospadias,
precocious puberty and so on. These comorbid diseases highly overlap with
the typical phenotypes of ciliopathy.
Conclusion: A substantial proportion of children with SIT have comorbidity
with ciliopathy-like phenotypes, which is suggestive of the important role of
cilia in left-right asymmetry development.

endocarditis were observed in both groups. The incidence of post-procedure
arrhythmias (38/121(31.40%) vs 46/133(34.59%); 21/99(21.21%) vs 24/107
(22.43%); all P>0.05) and mild valve insufficiency (5/99(5.05%) vs
5/107(4.67%), P>0.05) were similar in both groups.
Conclusion: Transcatheter closure of small type PmVSD using ADO-II was
safe and effective with simple manipulation and small delivery sheath, but
appeared to be not obviously superior to modified symmetric double-disk
occluder owing to its higher costs and similar post-procedure complications.
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Effect of Human Cytomegalovirus UL135 Protein on Vascular
Endothelial Cell and Its Mechanism in Kawasaki Disease
L Yu,1 X Xue,2 X Rong,1 C Jia,1 M Chu1
1
Children's Heart Center, The Second Affliated Hospital & Yuying Children's
Hospital, Institute of Cardiovascular Development & Translational Medicine,
Wenzhou Medical University; 2Institute of Molecular Virology and
Immunology, Wenzhou Medical University, Wenzhou, China
Background: Kawasaki disease (KD) is an acute febrile self-limited disease,
whose complication typically refers to severe coronary artery damage. The
ULb 'region which encodes 133-138 genes of human cytomegalovirus
(HCMV) is the specific sequence of clinical viral strains associated with the
infection and damage to endothelial cells. This study aims to investigate the
effect of UL135 protein in HCMV ULb 'region on human vascular endothelial
cells and its mechanism.
Methods: The serum titer levels of UL135 protein was detected by ELISA
in Kawasaki patients, fever children and healthy children. HCMV UL135
protein was expressed in vascular endothelial cells with eukaryotic expression
vector. Cell proliferation was detected by CCK8 assay, cell migration by
both cell scratch and Transwell assay, apoptosis and cell cycle by flow assay,
and angiogenesis was conformed by tube formation. Related protein
interacting with UL135 protein was explored by immunoprecipitation and
thereafter verified by western blot. SiRNA interference technology was
applied to explore the function of CD2AP protein on endothelial cells.
Homologous recombination was adopted to construct plasmids with different
mutation to further the mechanism.

86
Interventional Treatment of Patent Ductus Arteriosus Combined
with Congenital Bronchial Artery Pulmonary Arteriovenous
Fistula: Clinical Outcomes and Follow-up
P Li, S Zhang, Y Yan, B Cheng, Y Ren, X Rong, Z Wang, H Qiu, Y Shi,
R Wu
Children's Heart Center, The Second Affiliated Hospital and Yuying
Children's Hospital of Wenzhou Medical University, Institute of
Cardiovascular Development and Translational Medicine, Wenzhou, China

Results: The UL135 antibody titer was significantly higher in Kawasaki
children than that in healthy children (P<0.05) and fever children (P<0.05).
Endothelial cells have expressed UL135 protein, whose proliferation and
migration was inhibited, along with unaffected apoptosis and cell cycle.
According to immunofluorescence, the result indicated that UL135 protein
mainly located in the perinuclear and cell membrane remodeled the actin
cytoskeleton. The co-immunoprecipitation and western blot laid out the
interaction between CD2AP and UL135 protein. SiRNA interferes with
CD2AP, which promoted the proliferation and migration of endothelial cells.
The inhibitory effect of UL135 protein on proliferation and migration was
significantly reduced in 151-213 mutant.
Conclusion: Human cytomegalovirus UL135 protein antibody was detected
to be specifically elevated in children with Kawasaki disease, suggesting
HCMV is likely to incur and exacerbate endothelial damage to some extent.
The study results demonstrate that human cytomegalovirus UL135 protein
could inhibit the proliferation and migration of endothelial cells by binding
CD2AP in its 151-213 region.

Conclusions: One-stage interventional closure of BA-PAVF and PDA can be
used safely and effectively in children coexisted with BA-PAV and PDA and
selective bronchial arteriography is an optimal examination to precisely
localize BA-PAVF, but the establishment of specific therapy criteria needs
more clinical data and summary.

Background: Congenital bronchial artery to pulmonary artery or vein fistula
(BA-PAVF) is a rare abnormality which may induce recurrent pulmonary
infection, fatal hemoptysis, and respiratory failure and it is even scarcely
reported that BA-PAVF coexisted with patent ductus arteriosus (PDA).
Therefore, BA-PAVF can be easily neglected or misdiagnosed in clinic
without being treated timely.
Methods and results: In our study, 22 children were diagnosed with
congenital BA-PAVF and PDA by cardiac catheterization and selective
bronchial arteriography. For BA-PAVF which was greater than the horizontal
adjacent bronchial artery, vascular plug, MicroNester embolization coils,
and interlock fibered IDC occlusion system were respectively used to close
BA-PAVF after the transcatheter closure of PDA. And the size, shape, number,
tortuosity degree of the fistula, the location of the lesions, the specific
complications and family economic status were seriously considered before
the procedure. Two of the patients respectively existed small atrial septal
defect (ASD) and small ventricular septal defect (VSD). Finally, 9 of them
accepted transcatheter embolization (TCE) according to the size of the fistula.
After intermediate to long-term follow-up, all patients have no abnormal
discovery.
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Research on Relevant Factors and the Value on Prenatal
Ultrasound Diagnosis for Coarctation of the Aorta
J Shen
Guangdong Cardiovascular Institute, Guangzhou, China
Background: Prenatal diagnosis for Coarctation of the Aorta (CoA) was
very difficult. Both false-positive and false-negative diagnosis were common.
Objective: To improve the accuracy of prenatal diagnosis for CoA by
comparatively analyzing the relevant factors and their application value.
Methods: 138 fetuses of disproportion of ventricles and great vessels were
selected between January 2011 and May 2018 at Guangdong Cardiovascular
Institute. Only liveborn fetuses with complete postnatal follow-up were
included in the study. One hundred and twelve cases were retrieved and
analyzed. Different fetal echocardiography parameters and features were
selected to evaluate the diagnostic value. Logistic regression analysis was
used to select the best predictors of CoA and optimal cut-offs for these
parameters were identified by ROC analysis.
Results: We studied 112 cases, including 59 (52.9%) with CoA and 53
(47.3%) without. According to our analysis, the parameters most predictive
of postnatal CoA and the cut-off values were: gestational age of the first
diagnosis <34.5 weeks, Z-score of left ventricular diameter <-1.8, Z-score of
aortic isthmic diameter <-2.7, diameter ratio of pulmonary/aortic valve >1.6.
AUC yielded by these parameters in combination was 0.94 (95%CI: 0.89-0.99).
The study group was divided into two subgroups by gestational age of the
first diagnosis. The parameters and cut-off values in subgroups were selected
by the same analysis as above: Group I (≤34.5 weeks), Z-score of right

98
Prenatal Ultrasound Diagnosis of Isolated Total Anomalous
Pulmonary Venous Connection
J Shen, W Pan
Guangdong Cardiovascular Institute, Guangzhou, China
Background: Prenatal diagnosis of isolated total anomalous pulmonary
venous connection (TAPVC) was important for appropriate prenatal
counseling and perinatal management.
Objective: To explore the echocardiographic features of fetal TAPVC in
order to assess accuracy of prenatal diagnosis.
Methods: 35 fetuses with suspected isolated TAPVC were observed between
January 2011 and May 2018 at Guangdong Cardiovascular Institute. Fetal
echocardiographic images, confirmed by pathology or postnatal assessment,
were reviewed. We systematically analyzed echocardiographic features as
follow: presence of a pulmonary venous confluence behind the left atrium or
a vertical vein, the complete pulmonary venous return pathway (obstructive
or not), ventricular disproportion, the left atrium-descending aorta distance
and Doppler flow patterns.
Results: Within the study period, 35 fetuses were diagnosed with suspected
isolated TAPVC at a mean gestational age of 27.5±4.5 weeks (range from 22
to 38 weeks). Twenty-three cases were terminated and their diagnosis was
confirmed by autopsy. Twelve cases were born and 9 of them were diagnosed
with TAPVC by postnatal assessment, whereas the rest were considered as
false-positive cases. The direct and indirect signs of ultrasonography were
summarized. Pulmonary venous confluence was detected in 100% (32/32) of
the cases, while a complete pulmonary venous return pathway in 90.6% (29/
32), an obstructed venous return in 77.8% (7/9), and a vertical vein in 88.9%
(16/18). We found a dilatation of vein (including vena cava or coronary sinus)

88

ventricular diameter >2.1, diameter ratio of pulmonary/aortic valve >1.6;
Group II (>34.5 weeks), diameters ratio of pulmonary /aortic valve >1.7,
diameters ratio of arterial duct/isthmus >2.3. Meanwhile, some ultrasound
features (including aortic arch hypoplasia, retrograde blood flow of aortic
isthmus) should also be considered to improve diagnostic accuracy.
Conclusions: Combined with the use of different ultrasound parameters and
features at different gestational weeks can improve the accuracy of the prenatal
diagnosis of CoA in the right heart dominant fetus.

in 100% (32/32), and ventricular disproportion in 34.4% (11/32). There was
no correlation between right ventricular dominance and gestational age,
TAPVC subtype, pulmonary venous obstruction or the size of oval foramen.
An increased left atrium-descending aorta distance was observed in 73.3%
(22/30). This might due to the location of the pulmonary venous confluence.
Color Doppler was useful for ensuring the continuity of common pulmonary
vein and left atrium. Low-flow color mapping to identify individual pulmonary
vein could be a valuable tool for diagnosis.
Conclusions: Fetal echocardiography permits prenatal diagnosis of isolated
TAPVC. Leading sonographic features were very useful for the estimate of
subtype and obstruction site.
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The Surgical Outcomes of TAPVD and the Pre-operation Risk
Factors
H Shen, Y Pan, B Jia
Children's Hospital of Fudan University, Shanghai, China
Backgrounds: The surgical outcomes of total anomalous pulmonary venous
drainage (TAPVD) has been improved. However, the mortality rate of some
critically ill neonates is still high.
Methods: A retrospective review was conducted for all neonates and infants
(n=287) who underwent operations for isolated TAPVD from 2008 to 2018.
Results: Median weight was 4.6 kg, median age at operation was 36d. Thirtyfive (12.19%) patients were diagnosed with infracardiac TAPVD and 15
(5.23%) patients were diagnosed with mix type. There were 14 (4.88%) early
death. Age, LVDD, poor status, infracardiac or mix type, pulmonary venous
obstruction (>2 m/s), ventilation support before operation were associated
with higher mortality by univariable anlysis. Pre-op PVO (aHR 2.006,
p=0.027), infracardiac type (aHR 2.154, p=0.035), mix type (aHR 3.368,
p=0.004) and ventilation support (aHR 1.002, p=0.028) were the pre-operation
risk factors of early mortality after surgical repair by multilevel mixed-effect
model analysis.
Conclusion: The operation of isolated TAPVD is associated with high
mortality in neonates and infants with pre-operation risk factors.

104
Identification of Risk Factors for Arrhythmias Following
Transcatheter Closure of Perimembranous Ventricular Septal
Defect with Amplatzer Duct Occluder II
C Tang, K Zhou, C Wang, Y Hua
Department of Pediatric Cardiology, West China Second University Hospital,
Sichuan University, Chengdu, Sichuan, China
Backgrounds: Amplatzer duct occluder II (ADO-II) has recently been used
for transcatheter closure of small to moderate perimembranous ventricular
septal defect (PmVSD). Data regarding incidence of post-procedure
arrhythmias and associated risk factors are limited. We aimed to determine
the general incidence and associated risk factors for arrhythmias following
transcatheter closure of PmVSD with ADO-II.
Methods: All available clinical and follow-up data of children with PmVSD
receiving transcatheter closure using ADO-II (n=163) from March 2016 to
December 2018 in our hospital were retrospectively reviewed. The
demographic and clinical data were compared between the arrhythmias group
(n=47) and the control group (n=116). Logistic regression analysis was applied
to determine the independent factors for post-procedure arrhythmias.
Results: A total of 46 cases suffered from post-procedure arrhythmias, with
a general incidence of 28.83% (47/163). Most of them occurred during the
first two weeks after the procedure, but late-onset arrhythmias were still
observed. No complete or high-degree atrioventricular block (AVB) was
noted. Complete left bundle branch block (CLBBB) was noted in five cases,
with one case of incomplete left bundle branch block (ILBBB), three cases
of complete right bundle branch block (CRBBB), five cases of left anterihemiblock (LAH), seventeen cases of incomplete right bundle branch block
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(IRBBB), one case of LAH & IRBBB, two cases of first degree atrioventricular
bock (AVB) and four cases of ventricular premature beats and nine cases of
junctional escape rhythm. Most of them (21/47, 44.68%) recovered to normal
after steroids treatment. Longer operation time (OR:1.023, 95% CI:1.
002~1.045, P=0.032) were identified as the risk factors of arrhythmias after
transcatheter closure of PmVSD using ADO-II.
Conclusion: The incidence of arrhythmias after transcatheter closure of
PmVSD using ADO-II was acceptable since no complete or high-degree AVB
was noted and most of them were transient. Longer operation time should be
avoided. Longer follow-up with periodic electrocardiography examination
may be mandatory as late-onset arrhythmias could occur.
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Rare Variants in GATA4 Diminish the Interaction with ZFPM2
in Congenital Heart Defect Patients
Z Zhao
Children's Hospital of Fudan University, Shanghai, China

Conclusion: This study indicates that two rare variants of GATA4 might
disturb its own interaction with ZFPM2, which possibly explains abnormal
cardiac morphogenesis partly.

Background: Congenital heart defect (CHD) is one of the most common
pediatric cardiovascular diseases increasing the burden of society and family.
Both genetic and environmental factors contribute a lot to early elaboration
of the pathogenesis of this disease. Although the underlying mechanism of
abnormal cardiac development remains unclear, increasing evidence reveals
that genetic factors play a pivotal role in pathogenesis of CHD.
Methods: We recruited eight sporadic patients to perform whole exome
sequencing and verified the variants with Sanger sequencing. Co-IP/WB and
immunofluorescence were carried out to evaluate the interaction between
GATA4 and ZFPM2. Two candidate pathogenic variants were screened in
226 critical congenital heart disease patients via Sanger sequencing.
Results: We found three missense and three synonymous variants of GATA4
by whole exome sequencing and confirmed using Sanger sequencing. Function
studies showed that missense variants of GATA4 influence the status of
interaction between GATA4 and ZFPM2. Protein GATA4 with P163S or
P408Q variant may decrease the interaction with ZFPM2. What's more,
immunofluorescence confirmed that P163S and P408Q variant diminished
the co-localization between GATA4 and ZFPM2 protein contrast to WT
protein. However, we didn't find P163S and P408Q in 226 critical congenital
heart disease patient.

145
Stent Implantation in Severe Left Pulmonary Artery Stenosis
Developed After Surgery of Complex Congenital Heart Defects
D Hong, ZW Zhang, SS Wang, YM Xie
Guangdong Cardiovascular Institute, Guangzhou, China
Background: Patient had complex congenital heart defects and underwent
two times of surgical repairs about 3 years ago. Recently he had found severe
stenosis of left pulmonary artery (LPA) and finally corrected by implantation
of stent.
Case: Patient was a 3-year-old boy with the weight of 14 kg. He had found to
have aortic coacration, ventricular septal defect, atrial septal defect and patent
ductal arteriosus and received surgical repair in February 2016. Half year
later in August 2016, patient had another surgical repair because of stenosis
of aortic anastomosis. This year in Mar, patient had found of severe stenosis
in the origin of LPA and it seemed nearly atresia in cardiac CT. In order to
make definite diagnosis and therapeutic plan, patient was scheduled to have
cardiac catheterization and angiography. It demonstrated that marked dilation
of main pulmonary artery and right pulmonary artery. The beginning of LPA
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was narrow and about 1.2 mm in measurement. Fortunately, the distal part of
LPA was still well developed. It was considered good indication to place
stent. Firstly, a coronary dilation balloon (4.5 mm*15 mm) was used to predilate the stenotic origin. Then, a stent of 10 mm*37 mm was placed. After
stent implantation, a repeat cardiac catheterization and angiography showed
excellent result, with the pressure of right ventricle decreasing from
106/1 mmHg pre-procedure to 39/2 mmHg after procedure and improving
blood supplying of left lung.
Decision-making: Balloon dilation and stent implantation are effective
therapeutic strategies of branch pulmonary artery stenosis developing after
surgical repair of congenital heart defects. It could avoid reoperation and
reduce injury to patients. It was suitable for stent implantation in those cases
with well-developing distal pulmonary artery branches. Coronary balloon
dilation could be performed in extremely narrow vessel, in order to further
place the stent.
Conclusion: Balloon dilation and stent implantation are effective therapeutic
strategies of branch pulmonary artery stenosis developing after surgical repair
of congenital heart defects.
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